<SEC-DOCUMENT>0001193125-25-051564.txt : 20250311
<SEC-HEADER>0001193125-25-051564.hdr.sgml : 20250311
<ACCEPTANCE-DATETIME>20250311092421
ACCESSION NUMBER:		0001193125-25-051564
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250311
DATE AS OF CHANGE:		20250311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			METLIFE INC
		CENTRAL INDEX KEY:			0001099219
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				134075851
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268442
		FILM NUMBER:		25726049

	BUSINESS ADDRESS:	
		STREET 1:		200 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10166
		BUSINESS PHONE:		212-578-5500

	MAIL ADDRESS:	
		STREET 1:		200 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10166
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>d939353d424b2.htm
<DESCRIPTION>424B2
<TEXT>
<HTML><HEAD>
<TITLE>424B2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(2) <BR> Registration Statement No. 333-268442<BR> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P><DIV STYLE="position:relative; overflow:visible; width:651pt; height:20pt; transform-origin:bottom left; transform: rotate(-90deg) translate(-100%, 100%) translateX(20pt);">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information contained in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary
prospectus supplement nor the accompanying prospectus is an offer to sell nor does it seek an offer to buy the Debentures in any jurisdiction where the offer or sale is not permitted.
</B></FONT></P></DIV><DIV STYLE="position:relative; overflow:visible; margin-left:38pt; margin-right:38pt; transform: translateY(-20pt);"> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>SUBJECT TO COMPLETION, DATED MARCH&nbsp;11, 2025 </B></FONT></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Preliminary Prospectus Supplement </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(To Prospectus Dated
November&nbsp;17, 2022) </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g939353g01j01.jpg" ALT="LOGO" STYLE="width:1.40667in;height:0.270833in;">
 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>MetLife, Inc. </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>$&#8195;&#8195;&#8195;&#8195; </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>&#8195;&#8195;% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT> Reset Rate Subordinated
Debentures due 2055 </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The &#8195;% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT> Reset Rate Subordinated Debentures
due 2055 (the &#147;<I>Debentures</I>,&#148; are MetLife, Inc.&#146;s unsecured, subordinated debt instruments and will bear interest (i)&nbsp;from the date they are issued to, but excluding, March&nbsp;15, 2035, at an annual rate of &#8195;%, and
(ii)&nbsp;from, and including, March&nbsp;15, 2035, during each Interest Period at an annual rate equal to the Five-Year Treasury Rate as of the most recent Reset Interest Determination Date, in each case to be reset on each Interest Reset Date,
plus &#8195;%. Interest will be payable semi-annually in arrears on March&nbsp;15 and September&nbsp;15 of each year, beginning on September&nbsp;15, 2025. So long as no Event of Default (as defined herein) with respect to the Debentures has
occurred and is continuing, MetLife, Inc. has the right, on one or more occasions, to defer the payment of interest on the Debentures as described under &#147;Description of the Debentures&#151;Option to Defer Interest Payments&#148; in this
prospectus supplement for one or more consecutive Interest Periods up to five years (an &#147;<I>Optional Deferral</I>&#148;). Deferred interest will accrue additional interest at an annual rate equal to the annual interest rate then applicable to
the Debentures. See &#147;Description of the Debentures&#151;Interest Rate and Interest Payment Dates&#148; in this prospectus supplement for the definitions of &#147;Interest Period,&#148; &#147;Five-Year Treasury Rate,&#148; &#147;Reset Interest
Determination Date&#148; and &#147;Interest Reset Date.&#148; </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The principal amount of the Debentures will become due on March&nbsp;15,
2055. Payment of the principal on the Debentures will be accelerated only in the case of MetLife, Inc.&#146;s bankruptcy or certain other insolvency events with respect to MetLife, Inc. There is no right of acceleration in the case of default in the
payment of interest on the Debentures or the performance of any of MetLife, Inc.&#146;s other obligations with respect to the Debentures. </P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">MetLife, Inc. may redeem the Debentures at its option for cash, at the times and at the applicable redemption prices described in this
prospectus supplement. </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The Debentures will be unsecured and will be subordinated and junior in right of payment upon MetLife&#146;s
liquidation to all of its existing and future senior indebtedness, and will be effectively subordinated to all liabilities of MetLife, Inc.&#146;s subsidiaries, including obligations to policyholders. The Debentures will rank senior in right of
payment upon liquidation with MetLife, Inc.&#146;s trade accounts payable and with debt that by its terms does not rank senior to or on parity with the Debentures upon MetLife, Inc.&#146;s liquidation, including (i)&nbsp;the 10.750% <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2069 of MetLife, Inc. (the &#147;<I>2069 JSDs</I>&#148;), (ii) the 9.250% <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2068 of MetLife, Inc. (the &#147;<I>2068 JSDs</I>&#148;), (iii) MetLife, Inc.&#146;s obligations under the Financing Agreement relating to the 7.875% <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating-Rate</FONT></FONT> Exchangeable Surplus Trust Securities of MetLife Capital Trust IV (the &#147;<I>2067 <FONT STYLE="white-space:nowrap">X-SURPS</FONT></I>&#148;) and,
upon an exchange of the 2067 <FONT STYLE="white-space:nowrap">X-SURPS,</FONT> the related 7.875% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2067 of
MetLife, Inc. (the &#147;<I>2067 JSDs</I>&#148;) and (iv)&nbsp;the 6.40% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2066 of MetLife, Inc. (the
&#147;<I>2066 JSDs</I>&#148;). </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The Debentures are not deposits or savings accounts or other obligations of any bank and are not insured or
guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency. </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">By purchasing the Debentures in this offering you
will be deemed to consent to the termination of MetLife, Inc.&#146;s Replacement Capital Covenants relating to each of the 2069 JSDs, the 2068 JSDs and the 2067 <FONT STYLE="white-space:nowrap">X-SURPS,</FONT> respectively (collectively, the
&#147;<I>Replacement Capital Covenants</I>&#148;). <I>See </I>&#147;Description of the Debentures&#151;Consent to Terminate the Replacement Capital Covenants.&#148; </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B><B><I>See</I></B><B> &#147;<A HREF="#supptx939353_6">Risk Factors</A>&#148; beginning on page S-14 of this prospectus supplement and the
periodic reports MetLife, Inc. files with the Securities and Exchange Commission (the &#147;</B><B><I>SEC</I></B><B>&#148;) to read about important factors you should consider before buying the Debentures. </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:9pt; font-family:Times New Roman"><B>Neither the SEC nor any state securities commission or other regulatory body has approved or disapproved of the Debentures or passed upon the
adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per<BR>Debenture</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Price to the Public (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Underwriting Discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds, before expenses, to MetLife, Inc. (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Plus accrued and unpaid interest, if any, from&#8195;&#8195;&#8195;&#8195;, 2025. </P></TD></TR></TABLE>
<P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The Debentures will not be listed on any securities exchange. Currently, there is no public market for the Debentures. </P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The underwriters expect to deliver the Debentures, in book-entry form only, through the facilities of The Depository Trust Company
(&#147;<I>DTC</I>&#148;) for the accounts of its participants, including Clearstream Banking, S.A. (&#147;<I>Clearstream</I>&#148;), and/or Euroclear Bank SA/NV (&#147;<I>Euroclear</I>&#148;), on or about&#8195;&#8195;, 2025. </P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint Bookrunners </I></B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP ALIGN="center"><B>BNP PARIBAS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>BofA&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>Deutsche&nbsp;Bank Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>J.P. Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>Morgan Stanley</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>TD Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement dated&#8195;&#8195;&#8195;&#8195;, 2025. </B></P></DIV>
<p STYLE="clear:both; font-size:1pt; height:0">&nbsp;</p>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus Supplement </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_1">ABOUT THIS PROSPECTUS SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_2">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_3">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_4">NOTE REGARDING RELIANCE ON STATEMENTS IN OUR CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_5">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_6">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-18</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_8">CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-19</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_9">DESCRIPTION OF THE DEBENTURES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-20</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_10">CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-35</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_11">CERTAIN ERISA CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-40</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_12">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-42</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_13">LEGAL OPINIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-48</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supptx939353_14">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-48</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_2">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_3">SPECIAL NOTE&nbsp;REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_4">NOTE REGARDING RELIANCE ON STATEMENTS IN OUR CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_5">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_6">METLIFE, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_8">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_9">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_10">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_11">DESCRIPTION OF DEPOSITARY SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_12">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_13">DESCRIPTION OF PURCHASE CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_14">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_15">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_16">LEGAL OPINION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_17">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or incorporated by reference in this prospectus supplement
and the accompanying prospectus. Neither we nor the underwriters have authorized anyone to provide you with additional or different information. If anyone provided you with additional or different information, you should not rely on it. Neither we
nor the underwriters are making an offer to sell the Debentures in any jurisdiction where the offer or sale is not permitted. You should assume that the information contained in this prospectus supplement, the accompanying prospectus and the
documents incorporated by reference, is accurate only as of their respective dates. Our business, financial condition, results of operations and prospects may have changed since those dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures are offered for sale in those jurisdictions where it is lawful to make such offers. The distribution of this prospectus
supplement and the accompanying prospectus and the offering or sale of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Debentures in some jurisdictions may be restricted by law. Persons into whose possession this prospectus supplement and the accompanying prospectus come are required by us and the underwriters to
inform themselves about and to observe any applicable restrictions. This prospectus supplement and the accompanying prospectus may not be used for or in connection with an offer or solicitation by any person in any jurisdiction in which that offer
or solicitation is not authorized or to any person to whom it is unlawful to make that offer or solicitation. <I>See </I>&#147;Underwriting &#151; Offering Restrictions&#148; in this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus supplement along with the accompanying prospectus carefully before investing in the Debentures. This
prospectus supplement contains the terms of the Debentures. This prospectus supplement may add, update or change information in the accompanying prospectus. In addition, the information incorporated by reference in the accompanying prospectus may
have added, updated or changed information in the accompanying prospectus. If information in this prospectus supplement is inconsistent with any information in the accompanying prospectus (or any information incorporated therein by reference), this
prospectus supplement will apply and will supersede such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is important for you to read and consider all information
contained in this prospectus supplement and the accompanying prospectus in making your investment decision. You should also read and consider the additional information under the caption &#147;Where You Can Find More Information&#148; in this
prospectus supplement and the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise stated or the context otherwise requires, references in this
prospectus supplement to &#147;<I>MetLife</I>,&#148; the &#147;<I>Company</I>,&#148; &#147;<I>we</I>,&#148; &#147;<I>our</I>&#148; and &#147;<I>us</I>&#148; refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and
affiliates, while references to &#147;<I>MetLife, Inc.</I>&#148; refer only to the holding company on an unconsolidated basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_2"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. files reports, proxy statements and other information with the SEC. The SEC maintains an internet site at www.sec.gov that
contains reports, proxy and information statements and other information regarding companies that file electronically with the SEC, including MetLife, Inc. MetLife, Inc.&#146;s common stock is listed and trading on the New York Stock Exchange under
the symbol &#147;MET.&#148; These reports, proxy statements and other information can also be read at the offices of the New York Stock Exchange, 11 Wall Street, New York, New York 10005. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows &#147;incorporation by reference&#148; into this prospectus supplement and the accompanying prospectus of information that
MetLife, Inc. files with the SEC. This permits MetLife, Inc. to disclose important information to you by referencing these filed documents. Any information referenced this way is considered part of this prospectus supplement and the accompanying
prospectus. Information furnished under Item 2.02 and Item 7.01 of MetLife, Inc.&#146;s Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> is not incorporated by reference in this prospectus supplement and the accompanying
prospectus. MetLife, Inc. incorporates by reference the following documents which have been filed with the SEC: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921925000044/met-20241231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the year ended December&nbsp;31, 2024 filed on February&nbsp;21, 2025 (the &#147;<I>2024</I> <I>Form <FONT STYLE="white-space:nowrap">10-K</FONT></I>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The portions of MetLife, Inc.&#146;s <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921924000133/met-20240426.htm">Definitive
 Proxy Statement</A> filed on April&nbsp;26, 2024 for MetLife, Inc.&#146;s Annual Meeting of Stockholders incorporated by reference into the Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023 (other than
disclosure under the heading &#147;Pay versus Performance&#148; information responsive to Item 402(v) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> of SEC rules); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921924000193/met-20240618.htm">June
<U></U>&nbsp;24, 2024</A> (only with respect to the Item 5.02 information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312525004464/d923251d8k.htm">January<U></U>&nbsp;
10, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921925000039/met-20250205.htm">February<U></U>&nbsp;
5, 2025</A> (only with respect to the Item 8.01 information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921925000041/met-20250218.htm">February<U></U>&nbsp;
18, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312525039258/d874231d8k.htm">February<U></U>&nbsp;
27, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312525045644/d936619d8k.htm">March<U></U>&nbsp;
4, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921925000077/met-20250305.htm">March<U></U>&nbsp;5, 2025</A>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. incorporates by reference the documents listed above and any future filings made with the SEC in accordance with Sections 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;<I>Exchange Act</I>&#148;), other than information furnished under Item 2.02 or Item 7.01 of MetLife, Inc.&#146;s Current Reports on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> until the termination or completion of the offering of the Debentures made by this prospectus supplement and the accompanying prospectus. Any such reports filed by MetLife, Inc. with the SEC, other than
information furnished under Item 2.02 or Item 7.01 of MetLife, Inc.&#146;s Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> on or after the date of this prospectus supplement and before the date that the offering of the
Debentures by means of this prospectus supplement and the accompanying prospectus is terminated or completed will automatically update and, where applicable, supersede any information contained in this prospectus supplement and the accompanying
prospectus or incorporated by reference in this prospectus supplement and the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will provide without
charge upon written or oral request, a copy of any or all of the documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus, other than exhibits to those documents, unless those exhibits are
specifically incorporated by reference into those documents. Requests should be directed to Investor Relations, MetLife, Inc., 200 Park Avenue, New York, New York 10166 by electronic mail (metir@metlife.com), or by telephone <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(212-578-9500).</FONT></FONT> You may also obtain the documents incorporated by reference into this prospectus supplement and the accompanying prospectus at MetLife&#146;s website,
www.metlife.com. All other information contained on MetLife&#146;s website is not a part of this prospectus supplement or the accompanying prospectus, and any references to MetLife&#146;s website are intended to be inactive textual references only.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_3"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus may contain or incorporate by reference information that includes or is based upon
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events and do not relate strictly to historical or current facts. They use
words and terms such as &#147;anticipate,&#148; &#147;are confident,&#148; &#147;assume,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;if,&#148; &#147;intend,&#148;
&#147;likely,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;should,&#148; &#147;target,&#148; &#147;will,&#148; &#147;would&#148; and other words and terms of similar meaning or that are otherwise tied to
future periods or future performance, in each case in all derivative forms. They include statements relating to strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures,
liquidity and capital resources and other financial and operating information. By their nature, forward-looking statements: speak only as of the date they are made; are not statements of historical fact or guarantees of future performance; and are
subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However,
there can be no assurance that management&#146;s expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many factors determine MetLife&#146;s results, and they involve unpredictable risks and uncertainties. Our forward-looking statements depend
on our assumptions, our expectations, and our understanding of the economic environment, but they may be inaccurate and may change. We do not guarantee any future performance. Our results could differ materially from those we express or imply in
forward-looking statements. The risks, uncertainties and other factors identified in MetLife, Inc.&#146;s filings with the SEC, and others, may cause such differences. These factors include: (1)&nbsp;economic condition difficulties, including risks
relating to interest rates, credit spreads, declining equity or debt markets, real estate, obligors and counterparties, government default, currency exchange rates, derivatives, climate change, public health and terrorism and security;
(2)&nbsp;global capital and credit market adversity; (3)&nbsp;credit facility inaccessibility; (4)&nbsp;financial strength or credit ratings downgrades; (5)&nbsp;unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks
that arise from reinsurers&#146; credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks; (6)&nbsp;statutory life insurance reserve financing costs or limited market capacity; (7)&nbsp;legal, regulatory,
and supervisory and enforcement policy changes; (8)&nbsp;changes in tax rates, tax laws or interpretations; (9)&nbsp;litigation and regulatory investigations; (10)&nbsp;unsuccessful efforts to meet all environmental, social, and governance standards
or to enhance our sustainability; (11)&nbsp;MetLife, Inc.&#146;s inability to pay dividends and repurchase common stock; (12)&nbsp;MetLife, Inc.&#146;s subsidiaries&#146; inability to pay dividends to MetLife, Inc.; (13) investment defaults,
downgrades, or volatility; (14)&nbsp;investment sales or lending difficulties; (15)&nbsp;collateral or derivative-related payments; (16)&nbsp;investment valuations, allowances, or impairments changes; (17)&nbsp;claims or other results that differ
from our estimates, assumptions, or models; (18)&nbsp;global political, legal, or operational risks; (19)&nbsp;business competition; (20)&nbsp;technological changes; (21)&nbsp;catastrophes; (22) climate changes or responses to it;
(23)&nbsp;deficiencies in our closed block; (24)&nbsp;goodwill or other asset impairment, or deferred income tax asset allowance; (25)&nbsp;impairment of value of business acquired, value of distribution agreements acquired or value of customer
relationships acquired; (26)&nbsp;product guarantee volatility, costs, and counterparty risks; (27)&nbsp;risk management failures; (28)&nbsp;insufficient protection from operational risks; (29)&nbsp;failure to protect confidentiality, integrity or
availability of systems or data or other cybersecurity or disaster recovery failures; (30)&nbsp;accounting standards changes; (31)&nbsp;excessive risk-taking; (32)&nbsp;marketing and distribution difficulties; (33)&nbsp;pension and other
postretirement benefit assumption changes; (34)&nbsp;inability to protect our intellectual property or avoid infringement claims; (35)&nbsp;acquisition, integration, growth, disposition, or reorganization difficulties; (36)&nbsp;Brighthouse
Financial, Inc. separation risks; (37)&nbsp;MetLife, Inc.&#146;s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and (38)&nbsp;legal- and corporate
governance-related effects on business combinations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements should be read in conjunction with the other cautionary
statements, risks, uncertainties and other factors identified in the 2024 Form <FONT STYLE="white-space:nowrap">10-K</FONT> and elsewhere in this prospectus supplement and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the accompanying prospectus. You should read this prospectus supplement and the accompanying prospectus completely and with the understanding that actual future results may be materially
different from expectations. Further, any forward-looking statement speaks only as of the date on which it is made, and MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc.
later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in subsequent reports to the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_4"></A>NOTE REGARDING RELIANCE ON STATEMENTS IN OUR CONTRACTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In reviewing the agreements included as exhibits to any of the documents incorporated by reference into this prospectus supplement
and the accompanying prospectus, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about MetLife, Inc., its subsidiaries or
affiliates, or the other parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other
parties to the applicable agreement and: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the
risk to one of the parties if those statements prove to be inaccurate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have been qualified by disclosures that were made to the other party in connection with the negotiation of the
applicable agreement, which disclosures are not necessarily reflected in the agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may apply standards of materiality in a way that is different from what may be viewed as material to investors;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">were made only as of the date of the applicable agreement or such other date or dates as may be specified in the
agreement and are subject to more recent developments. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, these representations and warranties may not
describe the actual state of affairs as of the date they were made or at any other time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_5"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary contains basic information about us and the offering. Because it is a summary, it does not contain all of the information that
you should consider before purchasing any Debentures in the offering. You should read this entire prospectus supplement and the accompanying prospectus carefully, including the sections entitled &#147;Risk Factors&#148; in this prospectus supplement
and the periodic reports MetLife, Inc. files with the SEC, our financial statements and the notes thereto, and the other information incorporated by reference into this prospectus supplement and the accompanying prospectus, before making an
investment decision. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MetLife </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife is one of the world&#146;s leading financial services companies, providing insurance, annuities, employee benefits and asset
management. MetLife holds leading market positions in the United States, Asia, Latin America, Europe and the Middle East. MetLife is also one of the largest institutional investors in the United States with a general account portfolio invested
primarily in fixed income securities (corporate, structured products, municipals, and government and agency) and mortgage loans, as well as real estate, real estate joint ventures, other limited partnerships and equity securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife believes that its trusted global brand, diversified and resilient business, and position as a leader in attractive markets are the
powers of its business. Over the next five years MetLife will execute on its New Frontier strategy, which was designed to accelerate growth across MetLife&#146;s global platform while delivering attractive returns and
<FONT STYLE="white-space:nowrap">all-weather</FONT> performance. New Frontier builds upon the success of MetLife&#146;s Next Horizon strategy, which MetLife implemented in 2019, with an aim to focus, simplify and differentiate the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under MetLife&#146;s New Frontier strategy, MetLife intends to leverage the Company&#146;s strengths to prioritize growth across four key
areas of opportunity: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; text-indent:4%" ALIGN="center">


<IMG SRC="g939353g01j02.jpg" ALT="LOGO" STYLE="width:5.3125in;height:1.01083in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife is organized into six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin
America; Europe, the Middle East and Africa; and MetLife Holdings. In addition, the Company reports certain of its results of operations in Corporate&nbsp;&amp; Other.<I>&nbsp;See</I>&nbsp;&#147;Business &#151; Segments and Corporate&nbsp;&amp;
Other&#148; and Note 2 of the Notes to the Consolidated Financial Statements in the 2024 Form <FONT STYLE="white-space:nowrap">10-K</FONT> incorporated by reference herein for further information on MetLife&#146;s segments and Corporate&nbsp;&amp;
Other. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. is a holding company for its insurance and financial subsidiaries and does not have any significant operations of
its own. Dividends from its subsidiaries and permitted payments to it under its tax sharing arrangements with its subsidiaries are its principal sources of cash to meet its obligations and to pay preferred and common stock dividends. MetLife,
Inc.&#146;s insurance subsidiaries are subject to regulatory restrictions on the payment of dividends imposed by the regulators of their respective domiciles. The dividend limitation for U.S. insurance subsidiaries is based on the surplus to
policyholders at the end of the immediately preceding calendar year and statutory net gain from operations of the immediately preceding calendar year. Statutory accounting practices, as prescribed by insurance regulators of various states in which
we conduct business, differ in certain respects from accounting principles used in financial statements prepared in conformity with accounting principles generally accepted in the United States of America (&#147;<I>GAAP</I>&#148;). The significant
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
differences relate to the treatment of deferred policy acquisition costs, certain deferred income tax, required investment liabilities, statutory reserve calculation assumptions, goodwill and
surplus notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. is incorporated under the laws of the State of Delaware. MetLife, Inc.&#146;s principal executive offices
are located at 200 Park Avenue, New York, New York 10166-0188, its telephone number is (212) <FONT STYLE="white-space:nowrap">578-9500</FONT> and its internet address is www.metlife.com. Information contained on MetLife&#146;s website does not
constitute part of this prospectus supplement or the accompanying prospectus. This website address is an inactive textual reference and is not intended to be an actual link to the website. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Issuer </P></TD>
<TD>MetLife, Inc. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Securities Offered </P></TD>
<TD>$&#8195; aggregate principal amount of&#8195;&#8195;&#8195;&#8195; % <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Fixed</FONT></FONT> Reset Rate Debentures due 2055&nbsp;(the &#147;<I>Debentures</I>&#148;).
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Maturity Date </P></TD>
<TD>The Debentures will mature on March&nbsp;15, 2055 (the &#147;<I>Maturity Date</I>&#148;). If that day is not a Business Day, payment of principal and interest will be postponed to the next Business Day and no interest will accrue as a result of
that postponement. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Interest </P></TD>
<TD>Subject to the provisions below under &#147;&#151;Option to Defer Interest Payments,&#148; interest on the Debentures will accrue from &#8195;&#8195;, 2025. From, and including, &#8195;&#8195;&#8195;&#8195;, 2025 to, but excluding,
March&nbsp;15, 2035 (the &#147;<I>Initial Interest Reset Date</I>&#148;) or any earlier redemption date, the Debentures will bear interest at an annual rate of&#8195;&#8195;&#8195;&#8195;&#8195;%, and from, and including, the Initial Interest Reset
Date, during each Interest Period the Debentures will bear interest at an annual rate equal to the Five-Year Treasury Rate as of the most recent Reset Interest Determination Date, in each case to be reset on each Interest Reset Date,
plus&#8195;&#8195;&#8195;&nbsp;&#8195;%. MetLife, Inc. will pay that interest semi-annually in arrears on March&nbsp;15 and September&nbsp;15 of each year (each, an &#147;<I>Interest Payment Date</I>&#148;), beginning on September&nbsp;15, 2025, and
on the Maturity Date, subject to MetLife, Inc.&#146;s rights and obligations described under &#147;Description of the Debentures&#151;Option to Defer Interest Payments&#148; in this prospectus supplement. In the event that any Interest Payment Date
falls on a day that is not a Business Day, the interest payment due on that date will be postponed to the next day that is a Business Day, and no interest will accrue as a result of that postponement. <I>See</I> &#147;Description of the
Debentures&#151;Interest Rate and Interest Payment Dates&#148; in this prospectus supplement for the definitions of the terms &#147;<I>Business Day</I>,&#148; &#147;<I>Five-Year Treasury Rate</I>,&#148; &#147;<I>Interest Period</I>,&#148;
&#147;<I>Interest Reset Date</I>&#148; and &#147;<I>Reset Interest Determination Date</I>.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Option to Defer Interest Payments </P></TD>
<TD> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">So long as no Event of Default with respect to the Debentures has occurred and is continuing, MetLife, Inc. has the right to defer the payment of
interest on the Debentures for one or more consecutive Interest Periods that do not exceed five years for any single Optional Deferral Period (as defined herein) as described in &#147;Description of the Debentures&#151;Option to Defer Interest
Payments&#148; in this prospectus supplement. MetLife, Inc. may not defer interest beyond the Maturity Date, any earlier accelerated Maturity Date arising from an Event of Default or any other earlier redemption of the Debentures. During an Optional
Deferral Period, interest will continue to accrue on the Debentures at the then-applicable rate described above and deferred interest on the Debentures will bear additional interest at the then-applicable interest rate, compounded on each Interest
Payment Date, subject to applicable law. If MetLife, Inc. has paid all deferred </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman">
interest (including compounded interest thereon) on the Debentures, MetLife, Inc. can again defer interest payments on the Debentures as described above. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Subordination </P></TD>
<TD>The Debentures will be unsecured and will be subordinated and junior in right of payment upon MetLife&#146;s liquidation to all of its existing and future Senior Indebtedness, and will be effectively subordinated to all liabilities of MetLife,
Inc.&#146;s subsidiaries, including obligations to policyholders. The Debentures will rank senior in right of payment upon liquidation with MetLife, Inc.&#146;s trade accounts payable and with debt that by its terms does not rank senior to or on
parity with the Debentures upon MetLife, Inc.&#146;s liquidation, including (i)&nbsp;the 2069 JSDs, (ii)&nbsp;the 2068 JSDs, (iii)&nbsp;MetLife, Inc.&#146;s obligations under the Financing Agreement relating to the 2067 <FONT
STYLE="white-space:nowrap">X-SURPS</FONT> and, upon an exchange of the 2067 <FONT STYLE="white-space:nowrap">X-SURPS,</FONT> the 2067 JSDs and (iv)&nbsp;the 2066 JSDs (collectively, the &#147;<I>Junior Subordinated Obligations</I>&#148;).
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Senior Indebtedness will not include (1)&nbsp;indebtedness incurred for the purchase of goods or materials or for services obtained in the ordinary course of business (<I>i.e</I>., trade accounts payable), which will
rank junior to the Debentures and equally in right of payment and upon liquidation with the Junior Subordinated Obligations, (2)&nbsp;indebtedness which by its terms ranks equally with or subordinated to the Debentures or the Junior Subordinated
Obligations, as the case may be, in right of payment or upon liquidation, (3)&nbsp;indebtedness owed by MetLife, Inc. to its subsidiaries, which also will rank junior to the Debentures and equally in right of payment and upon liquidation with the
Junior Subordinated Obligations, and (4)&nbsp;any liability for federal, state, local or other taxes owed or owing by MetLife, Inc. or by its subsidiaries. In addition, the rights of the holders of the Debentures will be structurally subordinated to
all existing and future obligations of MetLife, Inc.&#146;s subsidiaries. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2024, MetLife, Inc.&#146;s short- and long-term debt owed to third parties ranking senior to the Debentures upon liquidation, on an unconsolidated basis, totaled approximately $14.4&nbsp;billion.
In addition, as of December&nbsp;31, 2024, MetLife, Inc.&#146;s short- and long-term debt owed to subsidiaries ranking senior to the Debentures upon liquidation totaled approximately $1.4&nbsp;billion. Payments on the Debentures will also be
effectively subordinated to all existing and future liabilities of MetLife, Inc.&#146;s subsidiaries to the extent of the assets of such subsidiaries. As of December&nbsp;31, 2024, MetLife, Inc.&#146;s subsidiaries had $2.3&nbsp;billion of debt
outstanding (excluding intercompany liabilities), all of which would be structurally senior in priority to the Debentures. <I>See</I> &#147;Description of the Debentures&#151;Subordination&#148; in this prospectus supplement for the definition of
&#147;<I>Senior Indebtedness</I>.&#148; </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Debentures will rank senior to all of MetLife, Inc.&#146;s equity securities, including its preferred stock, and&nbsp;the&nbsp;Junior Subordinated&nbsp;Obligations. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Certain Payment Restrictions Applicable to MetLife, Inc. </P></TD>
<TD>At any time when MetLife, Inc. has given notice of its election to defer interest payments on the Debentures but the related Optional Deferral Period has not yet commenced or an Optional Deferral Period is continuing, MetLife, Inc. and its
subsidiaries generally may not make payments on or redeem or purchase any shares of MetLife, Inc.&#146;s capital stock or any of MetLife, Inc.&#146;s debt securities or guarantees that rank upon MetLife, Inc.&#146;s liquidation on a parity with or
junior to the Debentures, subject to certain limited exceptions. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The terms of the Debentures permit MetLife, Inc. to make any payment of current or deferred interest on its indebtedness that ranks on a parity with the Debentures upon MetLife, Inc.&#146;s liquidation (&#147;<I>Parity
Securities</I>&#148;) that is made<I>&nbsp;pro rata</I>&nbsp;to the amounts due on such Parity Securities (including the Debentures), and any payments of principal or current or deferred interest on Parity Securities that, if not made, would cause
MetLife, Inc. to breach the terms of the instrument governing such Parity Securities. There are no Parity Securities outstanding as of the date of this prospectus supplement. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">For more information, <I>see</I> &#147;Description of the Debentures&#151;Dividend and Other Payment Stoppages During Optional Deferral Periods and Under Certain Other Circumstances&#148; in this prospectus supplement.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Redemption of the Debentures </P></TD>
<TD>MetLife, Inc. may elect to redeem the Debentures at its option for cash: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in whole, at any time, or in part, from time to time (i)&nbsp;on any Interest Payment Date on or after the
Initial Interest Reset Date, at a redemption price equal to 100% of their principal amount; and (ii)&nbsp;prior to the Initial Interest Reset Date, at a redemption price equal to 100% of their principal amount, plus the applicable
&#147;make-whole&#148; premium thereon at the time of redemption; <I>provided </I>that if the Debentures are not redeemed in whole, at least $25&nbsp;million aggregate principal amount of the Debentures, excluding any Debentures held by MetLife,
Inc. or any of its affiliates, must remain outstanding after giving effect to such redemption and all accrued and unpaid interest, including deferred interest, must be paid in full on all outstanding Debentures for all Interest Periods ending on or
before the date of redemption; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="38%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in whole, but not in part, at any time within 90 days after the occurrence of a &#147;Tax Event,&#148; a
&#147;Rating Agency Event&#148; or a &#147;Regulatory Capital Event,&#148; at a redemption price equal to (i)&nbsp;in the case of a &#147;Tax Event&#148; or a &#147;Regulatory Capital Event,&#148; 100%
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="42%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
of their principal amount or (ii)&nbsp;in the case of a &#147;Rating Agency Event,&#148; at a redemption price equal to 102% of their principal amount; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>plus</I>, in each case, accrued and unpaid interest to, but excluding, the date of redemption. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In the event the Debentures are treated as &#147;Tier 2 capital&#148; (or a substantially similar concept) under the capital rules of any &#147;capital regulator&#148; of MetLife, Inc., any redemption of Debentures will
be subject to MetLife, Inc.&#146;s receipt of any required prior approval from such capital regulator and to the satisfaction of any conditions set forth in those capital rules and any other regulations of any other capital regulator that are or
will be applicable to MetLife, Inc.&#146;s redemption of the Debentures. &#147;Capital regulator&#148; means the governmental agency or instrumentality, if any, that has group-wide oversight of MetLife, Inc.&#146;s regulatory capital.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">For more information and the definitions of &#147;Tax Event,&#148; &#147;Rating Agency Event&#148; and &#147;Regulatory Capital Event,&#148; <I>see</I> &#147;Description of the Debentures&#151;Redemption&#148; in this
prospectus supplement. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Events of Default </P></TD>
<TD>An &#147;Event of Default&#148; with respect to the Debentures shall occur only upon certain events of bankruptcy, insolvency or receivership involving MetLife, Inc. If an Event of Default occurs and continues, the principal amount of the
Debentures will automatically become due and payable without any declaration or other action on the part of the Subordinated Trustee (as defined herein) or any holder of the Debentures. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">There is no right of acceleration in the case of any payment default or other breaches of covenants under the Subordinated Indenture or the Debentures. Notwithstanding the foregoing, in the case of a default in the
payment of principal of or interest on the Debentures, including any compounded interest (and, in the case of payment of deferred interest, such failure to pay shall have continued for 30 calendar days after the conclusion of any Optional Deferral
Period), the holder of a Debenture may, or if directed by the holders of a majority in principal amount of the Debentures the Subordinated Trustee shall, subject to the conditions set forth in the Subordinated Indenture (as defined below), demand
payment of the amount then due and payable and may institute legal proceedings for the collection of such amount if MetLife, Inc. fails to make payment thereof upon demand. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Form and Denomination </P></TD>
<TD>The Debentures will be issued in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The Debentures will be represented by one or more global securities registered in the name of Cede&nbsp;&amp; Co., as nominee for The
Depository Trust Company (&#147;<I>DTC</I>&#148;). Beneficial interests in the Debentures will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC.
</TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Investors may elect to hold interests in the global securities through either DTC (in the United States), or Clearstream or Euroclear (in Europe) if they are participants in those systems, or indirectly through
organizations which are participants in those systems. MetLife, Inc. will issue certificated Debentures only in the limited circumstances described under &#147;Description of the Debentures&#151;Book-Entry System&#148; in this prospectus supplement.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture and the Subordinated Trustee </P></TD>
<TD>The Debentures will be issued pursuant to the Subordinated Indenture, dated as of June&nbsp;21, 2005 (the &#147;<I>Base Indenture</I>&#148;), between MetLife, Inc. and The Bank of New York Mellon Trust Company, N.A. (as successor in interest to
J.P. Morgan Trust Company, National Association), as Subordinated Trustee, as supplemented by a supplemental indenture, to be dated as of the closing date of this offering (the &#147;<I>Supplemental Indenture</I>&#148; and the Base Indenture as
supplemented by the Supplemented Indenture, the &#147;<I>Subordinated Indenture</I>&#148;). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Governing Law </P></TD>
<TD>The Subordinated Indenture and the Debentures will be governed by and construed in accordance with the laws of the State of New York. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk Factors </P></TD>
<TD><I>See </I>&#147;Risk Factors&#148; beginning on page S-14 of this prospectus supplement and similar sections in the 2024 Form <FONT STYLE="white-space:nowrap">10-K,</FONT> incorporated by reference herein, before buying any of the Debentures
offered hereby. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of Proceeds </P></TD>
<TD>We expect to receive proceeds, after deducting the underwriting discount and other offering expenses, of approximately $&#8195;&#8195;&#8195;&#8195;. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We intend to use the net proceeds from this offering for general corporate purposes, which may include the redemption or repurchase in whole or in part of MetLife, Inc.&#146;s 3.850% Fixed Rate Reset <FONT
STYLE="white-space:nowrap">Non-Cumulative</FONT> Preferred Stock, Series G (the &#147;<I>Series G Preferred</I>&#148;). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This prospectus supplement does not constitute a notice of redemption with respect to, or an offer to purchase, the Series G Preferred. <I>See</I> &#147;Use of Proceeds&#148; in this prospectus supplement.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Consent to Terminate the Replacement Capital Covenants </P></TD>
<TD> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By purchasing the Debentures, holders of the Debentures, as holders of the &#147;covered debt&#148; under each Replacement Capital Covenant, are
irrevocably consenting to the termination of each Replacement Capital Covenant, and represent and agree that they waive any reliance on any covenant, promise or agreement (whether express or implied) set forth in the Replacement Capital Covenants
prior to those terminations, and will not take or attempt to take any action to enforce any such covenant, promise or agreement set forth in the Replacement Capital Covenants prior to those terminations. Each current and future
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:0%; font-size:10pt; font-family:Times New Roman">
holder of the Debentures will be deemed to have consented to such terminations and made such representations and agreements and such consent, representations and agreements will be binding on all
purchasers. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_6"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in the Debentures involves a high degree of risk. In addition to the other information contained in this prospectus supplement,
the accompanying prospectus and the information incorporated by reference herein and therein, you should consider carefully the following factors relating to us and the Debentures before making an investment in the Debentures offered hereby. In
addition to the risk factors set forth below, please read the information included or incorporated by reference under &#147;Risk Factors&#148; in the accompanying prospectus and the 2024 Form <FONT STYLE="white-space:nowrap">10-K.</FONT> If any of
the following risks or those incorporated by reference actually occur, our business, results of operations, financial condition, cash flows or prospects could be materially adversely affected, which in turn could adversely affect the market for or
trading price of the Debentures. As a result, you may lose all or part of your original investment. The risks discussed below also include forward- looking statements, and our actual results may differ materially from those expressed or implied in
these forward-looking statements. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>MetLife, Inc. Has the Right to Defer Interest for Up to Five Consecutive Years. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. has the right at one or more times to defer interest on the Debentures for one or more consecutive Interest Periods that do not
exceed five years for any single Optional Deferral Period. During any such Optional Deferral Period, holders of Debentures will receive limited or no current payments on the Debentures. Holders will have no remedies against MetLife, Inc. for
nonpayment unless MetLife, Inc. fails to pay all deferred interest (including compounded interest) at the end of the five-year Optional Deferral Period, at the Maturity Date or, if applicable, at the earlier accelerated Maturity Date or redemption
date of the Debentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Deferral of Interest Payments and Other Characteristics of the Debentures Could Adversely Affect the Market Price of the
Debentures. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent a secondary market develops for the Debentures, the market price of the Debentures is likely to be
adversely affected if MetLife, Inc. defers payments of interest on the Debentures. As a result of MetLife, Inc.&#146;s deferral right or if investors perceive that there is a likelihood that MetLife, Inc. will exercise its deferral right, the market
for the Debentures may become less active or be discontinued during such an Optional Deferral Period, and the market price of the Debentures may be more volatile than the market prices of other securities that are not subject to deferral. If
MetLife, Inc. does defer interest on the Debentures and you sell your Debentures during the period of that deferral, you may not receive the same return on your investment as a holder that continues to hold its Debentures until MetLife, Inc. pays
the deferred interest at the end of the applicable Optional Deferral Period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Debentures will be Effectively Subordinated to Almost All of
MetLife, Inc.&#146;s Other Indebtedness. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s obligations under the Debentures will be subordinated and junior in
right of payment to all of its Senior Indebtedness, except any indebtedness that by its terms is subordinated to, or ranks on an equal basis with, the Debentures and certain other indebtedness, including indebtedness incurred in the ordinary course
of business. This means that MetLife, Inc. will not be able to make any payments on the Debentures if it defaults on a payment of Senior Indebtedness and does not cure the default within the applicable grace period, if the holders of the Senior
Indebtedness have the right to accelerate the maturity of the Senior Indebtedness and request that MetLife, Inc. cease payments on the Debentures or if the terms of its Senior Indebtedness otherwise restrict MetLife, Inc. from making payments to
junior creditors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024, (i) MetLife, Inc. had approximately $16.9&nbsp;billion of debt outstanding at the parent
company level (excluding intercompany liabilities), $14.4&nbsp;billion of which would be senior in priority to the Debentures, and (ii)&nbsp;MetLife, Inc.&#146;s subsidiaries had $2.3&nbsp;billion of debt outstanding (excluding intercompany
liabilities), all of which would be structurally senior in priority to the Debentures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the subordination provisions described under &#147;Description of the
Debentures&#151;Subordination,&#148; in the event of MetLife, Inc.&#146;s insolvency, funds which MetLife, Inc. would otherwise use to pay the holders of the Debentures would be used to pay the holders of Senior Indebtedness to the extent necessary
to pay the Senior Indebtedness in full. As a result of those payments, MetLife, Inc.&#146;s general creditors may recover less, ratably, than the holders of its Senior Indebtedness and these general creditors may recover more, ratably, than the
holders of the Debentures. In addition, the holders of MetLife, Inc.&#146;s Senior Indebtedness may, under certain circumstances, restrict or prohibit MetLife, Inc. from making payments on the Debentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There will be no terms in the Subordinated Indenture or the Debentures that limit MetLife, Inc.&#146;s ability to incur additional
indebtedness, and MetLife, Inc. expects from time to time to incur additional indebtedness constituting Senior Indebtedness. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Debentures Will Be
Effectively Subordinated to the Obligations of MetLife, Inc.&#146;s Subsidiaries. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s subsidiaries are separate
and distinct legal entities. Because MetLife, Inc. is a holding company, its right to participate in any distribution of assets of any of its subsidiaries, upon the subsidiary&#146;s liquidation or reorganization or otherwise, is subject to the
prior claims of the subsidiary&#146;s creditors, except to the extent that MetLife, Inc. may be recognized as a creditor of that subsidiary. The applicable insurance laws of the jurisdiction where each of MetLife, Inc.&#146;s insurance subsidiaries
is domiciled would govern any proceedings relating to that insurance subsidiary. The insurance authority of that jurisdiction would act as a liquidator or rehabilitator for the subsidiary. Both creditors and policyholders of the subsidiary would be
entitled to payment in full from the subsidiary&#146;s assets before MetLife, Inc., as a shareholder, would be entitled to receive any distribution from the subsidiary which MetLife, Inc. might apply to make payments of principal and interest on the
Debentures or other indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, MetLife, Inc.&#146;s obligations under the Debentures will be effectively subordinated to
all existing and future indebtedness and liabilities of MetLife, Inc.&#146;s subsidiaries, including liabilities under contracts of insurance and annuities written by MetLife, Inc.&#146;s insurance subsidiaries, and you, as holders of Debentures,
should look only to MetLife, Inc.&#146;s assets for payment under the Debentures. As of December&nbsp;31, 2024, MetLife, Inc.&#146;s subsidiaries had $221.4&nbsp;billion of policyholder account balances and $2.3&nbsp;billion of debt outstanding
(excluding intercompany liabilities). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>MetLife, Inc. May Redeem the Debentures Prior to Their Maturity. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may redeem the Debentures at its options for cash in whole, at any time, or in part, from time to time (i)&nbsp;on any Interest
Payment Date on or after the Initial Interest Reset Date, at a redemption price equal to 100% of their principal amount, or (ii)&nbsp;prior to the Initial Interest Reset Date, at a redemption price equal to 100% of their principal amount <I>plus</I>
a &#147;make-whole&#148; amount, in each case plus accrued and unpaid interest to, but excluding, the date of redemption. MetLife, Inc. may also redeem the Debentures in whole, but not in part, at any time within 90 days after the occurrence of a
&#147;Tax Event,&#148; a &#147;Rating Agency Event&#148; or a &#147;Regulatory Capital Event&#148; at a redemption price equal to (i)&nbsp;in the case of a &#147;Tax Event&#148; or a &#147;Regulatory Capital Event,&#148; 100% of their principal
amount plus accrued and unpaid interest to, but excluding, the date of redemption or (ii)&nbsp;in the case of a &#147;Rating Agency Event,&#148; 102% of their principal amount plus accrued and unpaid interest to, but excluding, the date of
redemption. In the event the Debentures are treated as &#147;Tier 2 capital&#148; (or a substantially similar concept) under the capital rules of any capital regulator of MetLife, Inc., any redemption of Debentures will be subject to MetLife,
Inc.&#146;s receipt of any required prior approval from such capital regulator and to the satisfaction of any conditions set forth in those capital rules and any other regulations of any other capital regulator that are or will be applicable to
MetLife, Inc.&#146;s redemption of the Debentures. If the Debentures are redeemed, the redemption may be a taxable event to you. <I>See</I> &#147;Material United States Federal Income Tax Considerations&#151;United States Holders&#151;Sale,
Exchange, Redemption or Other Taxable Disposition of Debentures&#148; in this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Events that would constitute a &#147;Tax Event,&#148; a &#147;Rating Agency Event&#148; or a
&#147;Regulatory Capital Event&#148; could occur at any time and could result in the Debentures being redeemed earlier than would otherwise be the case. In the event MetLife, Inc. chooses to redeem the Debentures, you may not be able to reinvest the
redemption proceeds in a comparable security at an effective interest rate as high as the interest rate on the Debentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If Interest Payments on
the Debentures Are Deferred, Holders of the Debentures Will Be Required to Recognize Income for U.S. Federal Income Tax Purposes, Possibly in Advance of the Receipt of Cash Attributable to Such Income. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If MetLife, Inc. were to defer interest payments on the Debentures, the Debentures would be treated as issued with original issue discount
(&#147;<I>OID</I>&#148;) at the time of such deferral, and all stated interest due after such deferral would be treated as OID. In such case, a U.S. holder would be required to include such stated interest in income as it accrues, regardless of such
U.S. holder&#146;s regular method of accounting, using a constant yield method, which may occur before such holder received any payment attributable to such income, and would not separately report the actual payments of interest on the Debentures as
taxable income. <I>See </I>&#147;Material United States Federal Income Tax Considerations&#151;United States Holders&#151;Interest Income, Original Issue Discount and Certain Contingent Payments&#148; in this prospectus supplement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A Holder of the Debentures Will Not Have Rights of Acceleration in the Case of Payment Defaults or Other Breaches of Covenants. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The only Event of Default under the Subordinated Indenture consists of specific events of bankruptcy, insolvency or receivership relating to
MetLife, Inc. There is no right of acceleration in the case of payment defaults or other breaches of covenants under the Subordinated Indenture. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Interest Rate Will Reset on the Initial Interest Reset Date and Each Subsequent Interest Reset Date, and Any Interest Payable After an Interest
Reset Date May Be Less Than an Earlier Interest Rate. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The interest rate on the Debentures for each Interest Reset Period (as
defined herein) will equal the Five-Year Treasury Rate as of the most recent Reset Interest Determination Date, plus &#8195;&#8195;%. Therefore, the interest rate after the Initial Interest Reset Date could be less than the fixed rate for the <FONT
STYLE="white-space:nowrap">initial&nbsp;10-year&nbsp;period,</FONT> and any interest payable after a subsequent Interest Reset Date may be less than the interest rate for a prior period. MetLife, Inc. has no control over the factors that may affect
U.S. Treasury rates, including geopolitical conditions and economic, financial, political, regulatory, judicial or other events. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Historical U.S.
Treasury Rates Are Not an Indication of Future U.S. Treasury Rates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the past, U.S. Treasury rates have experienced significant
fluctuations. You should note that historical levels, fluctuations and trends of U.S. Treasury rates are not necessarily indicative of future levels. Any historical upward or downward trend in U.S. Treasury rates is not an indication that U.S.
Treasury rates are more or less likely to increase or decrease at any time after the Initial Interest Reset Date, and you should not take the historical U.S. Treasury rates as an indication of future Five-Year Treasury Rates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An Active After-Market for the Debentures May Not Develop. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures do not have an established trading market. We cannot assure you that an active after-market for the Debentures will develop or
be sustained or that holders of the Debentures will be able to sell their Debentures at favorable prices or at all. Although the underwriters have indicated to us that they intend to make a market in the Debentures, as permitted by applicable laws
and regulations, they are not obligated to do so and may discontinue any such market-making at any time without notice. Accordingly, no assurance can be given as to the liquidity of, or trading markets for, the Debentures. The Debentures are not
listed and MetLife, Inc. does not plan to apply to list the Debentures on any securities exchange or to include them in any automated quotation system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If a Trading Market Does Develop, Changes in Our Credit Ratings or the Debt Markets Could Adversely
Affect the Market Price of the Debentures. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price for the Debentures depends on many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our credit ratings with major credit rating agencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prevailing interest rates being paid by other companies similar to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial condition, financial performance and future prospects; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the overall condition of the financial markets. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The condition of the financial markets and prevailing interest rates have fluctuated in the past and are likely to fluctuate in the future.
Such fluctuations could have an adverse effect on the price of the Debentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, credit rating agencies continually review
their ratings for the companies that they follow, including us. The credit rating agencies also evaluate the insurance industry as a whole and may change their credit rating for us based on their overall view of our industry. A negative change in
our rating could have an adverse effect on the price of the Debentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Credit Ratings May Not Reflect All Risks Of Your Investments In The
Debentures. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our credit ratings are an assessment by rating agencies of our ability to pay our debts when due. Consequently, real
or anticipated changes in our credit ratings will generally affect the market value of the Debentures. These credit ratings may not reflect the potential impact of risks relating to the Debentures. Agency ratings are not a recommendation to buy,
sell or hold any security, and may be revised or withdrawn at any time by the issuing organization. Each agency&#146;s rating should be evaluated independently of any other agency&#146;s rating. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to receive proceeds, after deducting the underwriting discount and other offering expenses, of approximately
$&#8195;&#8195;&#8195;&#8195;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from this offering for general corporate purposes, which may include the
redemption or repurchase in whole or in part of the Series G Preferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement does not constitute a notice of
redemption with respect to, or an offer to purchase, the Series G Preferred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_8"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our consolidated capitalization at December&nbsp;31, 2024, on an actual basis, and as adjusted to give effect
to this offering of the Debentures. This information should be read in conjunction with the 2024 Form <FONT STYLE="white-space:nowrap">10-K</FONT> and our other financial information incorporated by reference herein. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>At December&nbsp;31, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;Adjusted&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(In millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collateral financing arrangement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Junior subordinated debentures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s stockholders&#146; equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, par value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, par value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retained earnings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treasury stock, at cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(27,798</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(21,186</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total MetLife, Inc.&#146;s stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reflects $&#8195;&#8195;&#8195;&#8195;of the Debentures at a discount of approximately
$&#8195;&#8195;&#8195;&#8195;. Related debt issuance costs of $&#8195;&#8195;&#8195;&#8195; will be capitalized and amortized over the term of the Debentures. Does not reflect any redemption or repurchase of the Series G Preferred.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_9"></A>DESCRIPTION OF THE DEBENTURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>A description of the specific terms of the Debentures of MetLife, Inc. being offered is set forth below. The description is qualified in
its entirety by reference to the Indenture, dated as of June&nbsp;21, 2005 (the &#147;Base Indenture&#148;), between MetLife, Inc. and The Bank of New York Mellon Trust Company, N.A. (as successor in interest to J.P. Morgan Trust Company, National
Association), as trustee (the &#147;Subordinated Trustee&#148;), as supplemented by the Thirteenth Supplemental Indenture, to be dated as of&#8195;&#8195;, 2025 (the &#147;Supplemental Indenture&#148; and, together with the Base Indenture, the
&#147;Subordinated Indenture&#148;), between MetLife, Inc. and the Subordinated Trustee, under which the Debentures will be issued. The Subordinated Indenture has been qualified as an indenture under the Trust Indenture Act of 1939, as amended (the
&#147;Trust Indenture Act&#148;). The terms of the Subordinated Indenture are those provided in the Base Indenture, as supplemented by the Supplemental Indenture, and those made part of the Subordinated Indenture by the Trust Indenture Act. MetLife,
Inc. has filed a copy of the Base Indenture with the SEC under the Exchange Act and the Base Indenture is incorporated by reference as an exhibit to the registration statement of which this prospectus supplement forms a part. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description of certain terms of the Debentures and certain provisions of the Base Indenture, as supplemented by the
Supplemental Indenture, supplements the description under &#147;Description of Debt Securities&#148; in the accompanying prospectus. To the extent that the following description is not consistent with that contained in the accompanying prospectus
under &#147;Description of Debt Securities&#148; you should rely on this description. This description is only a summary of the material terms and does not purport to be complete. We urge you to read the Base Indenture, as supplemented by the
Supplemental Indenture, in its entirety because it, and not this description, will define your rights as a beneficial holder of the Debentures. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will initially
issue $&#8195;&#8195;&#8195;aggregate principal amount of Debentures. MetLife, Inc. may, without the consent of holders of the Debentures, increase the principal amount of the Debentures by issuing additional debentures in the future on the same
terms and conditions as the Debentures being offered hereby in all respects, except for any difference in the issue date, public offering price, interest accrued prior to the issue date of the additional debentures and first interest payment date,
and with the same CUSIP number as the Debentures offered hereby, so long as such additional debentures are fungible for U.S. federal income tax purposes with the Debentures offered hereby. The Debentures offered hereby and any such additional
debentures would rank equally and ratably in right of payment and would be treated as a single series of subordinated debt securities for all purposes under the Subordinated Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures will mature on March&nbsp;15, 2055 (the &#147;<I>Maturity Date</I>&#148;). If that day is not a Business Day, payment of
principal and interest will be postponed to the next Business Day and no interest will accrue as a result of that postponement. The Debentures will be subordinated and junior in right of payment to all of the Senior Indebtedness, as defined under
&#147;&#151;Subordination&#148; below, and&nbsp;senior to MetLife, Inc.&#146;s&nbsp;junior subordinated&nbsp;securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated
Trustee will initially serve as paying agent for the Debentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consent to Terminate the Replacement Capital Covenants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By purchasing the Debentures, holders of the Debentures, as holders of the &#147;covered debt&#148; under each Replacement Capital Covenant,
are irrevocably consenting to the termination of each Replacement Capital Covenant, and represent and agree that they waive any reliance on any covenant, promise or agreement (whether express or implied) set forth in the Replacement Capital
Covenants prior to those terminations, and will not take or attempt to take any action to enforce any such covenant, promise or agreement set forth in the Replacement Capital Covenants prior to those terminations. Each current and future holder of
the Debentures will be deemed to have consented to such terminations and made such representations and agreements and such consent, representations and agreements will be binding on all purchasers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest Rate and Interest Payment Dates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the provisions below relating to Optional Deferral, interest will accrue on the Debentures (i)&nbsp;from, and including,
&#8195;&#8195;, 2025 to, but excluding, March&nbsp;15, 2035 (the &#147;<I>Initial Interest Reset Date</I>&#148;) at an annual rate of&#8195;&#8195;&#8195;% and (ii)&nbsp;from, and including, the initial Interest Reset Date, during each Interest
Reset Period, at an annual rate equal to the Five-Year Treasury Rate as of the most recent Reset Interest Determination Date, plus&#8195;&#8195;&#8195;%. Interest on the Debentures is payable semi-annually in arrears on March&nbsp;15 and
September&nbsp;15 of each year (each, an &#147;<I>Interest Payment Date</I>&#148;), commencing on September&nbsp;15, 2025, and on the Maturity Date, subject to deferral as described under &#147;&#151;Option to Defer Interest Payments.&#148; MetLife,
Inc. refers to the period from, and including, the date the Debentures are issued to, but excluding, September&nbsp;15, 2025, and each period from, and including, each Interest Payment Date to, but excluding, the next Interest Payment Date or, if
earlier, the Maturity Date, as an &#147;<I>Interest Period</I>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest payments will be made to the persons or entities in whose
names the Debentures are registered at the close of business on March&nbsp;1 and September&nbsp;1 (in each case, whether or not a Business Day), as the case may be, immediately preceding the relevant Interest Payment Date. In the event that any
Interest Payment Date falls on a day that is not a Business Day, the interest payment due on that date will be postponed to the next day that is a Business Day, and no additional interest will accrue as a result of that postponement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of interest payable will be computed on the basis of <FONT STYLE="white-space:nowrap">a&nbsp;360-day&nbsp;year</FONT> consisting of
<FONT STYLE="white-space:nowrap">twelve&nbsp;30-day&nbsp;months.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;Business Day&#148; </I>means any day other than
(i)&nbsp;a Saturday or Sunday, (ii)&nbsp;a day on which banking institutions in The City of New York are authorized or required by law or executive order to remain closed or (iii)&nbsp;a day on which the corporate trust office of the Subordinated
Trustee is closed for business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless MetLife, Inc. has redeemed all of the outstanding Debentures as of the Initial Interest Reset
Date, MetLife, Inc. will appoint a calculation agent (the &#147;<I>Calculation Agent</I>&#148;) with respect to the Debentures prior to the Reset Interest Determination Date preceding the Initial Interest Reset Date. MetLife, Inc. or any of its
affiliates may assume the duties of the Calculation Agent. The applicable interest rate for each Interest Reset Period will be determined by the Calculation Agent as of the applicable Reset Interest Determination Date. If MetLife, Inc. or one of its
affiliates is not the Calculation Agent, the Calculation Agent will notify MetLife, Inc. of the interest rate for the relevant Interest Reset Period promptly upon such determination. MetLife, Inc. will notify the Subordinated Trustee of such
interest rate, promptly upon making or being notified of such determination. The Calculation Agent&#146;s determination of any interest rate and its calculation of the amount of interest for any Interest Reset Period beginning on or after the
Initial Interest Reset Date will be conclusive and binding absent manifest error, will be made in the Calculation Agent&#146;s sole discretion and, notwithstanding anything to the contrary in the documentation relating to the Debentures, will become
effective without consent from any other person or entity. Such determination of any interest rate and calculation of the amount of interest will be on file at MetLife, Inc.&#146;s principal offices and will be made available to any holder of the
Debentures upon request. In no event shall the Subordinated Trustee be the Calculation Agent, nor shall it have any liability for any determination made by or on behalf of such Calculation Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Five-Year Treasury Rate</I>&#148; means, as of any Reset Interest Determination Date, the average of the yields on actively traded
U.S. Treasury securities adjusted to constant maturity, for five-year maturities, for the most recent five Business Days appearing under the caption &#147;Treasury Constant Maturities&#148; in the most recent H.15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Five-Year Treasury Rate cannot be determined pursuant to the method described above, the Calculation Agent, after consulting such
sources as it deems comparable to any of the foregoing calculations, or any such source as it deems reasonable from which to estimate the Five-Year Treasury Rate, will determine the Five-Year Treasury Rate in its sole discretion, <I>provided</I>
that if the Calculation Agent determines there is an industry-accepted successor Five-Year Treasury Rate, then the Calculation Agent will use such successor rate. If </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Calculation Agent has determined a substitute or successor base rate in accordance with the foregoing, the Calculation Agent in its sole discretion may determine the Business Day convention,
the definition of Business Day and the Reset Interest Determination Date to be used and any other relevant methodology for calculating such substitute or successor base rate, including any adjustment factor needed to make such substitute or
successor base rate comparable to the Five-Year Treasury Rate, in a manner that is consistent with industry-accepted practices for such substitute or successor base rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>H.15</I>&#148; means the daily statistical release designated as such, or any successor publication as determined by the Calculation
Agent in its sole discretion, published by the Federal Reserve Board, and &#147;<I>most recent H.15</I>&#148; means the H.15 published closest in time but prior to the close of business on the applicable Reset Interest Determination Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Initial Interest Reset Date</I>&#148; means March&nbsp;15, 2035. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;Interest Reset Date</I>&#148; means the Initial Interest Reset Date and each date falling on the five-year anniversary of the
preceding Interest Reset Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Interest Reset Period</I>&#148; means the period from, and including, the Initial Interest Reset
Date to, but excluding, the next following Interest Reset Date and thereafter each period from, and including, each Interest Reset Date to, but excluding, the next following Interest Reset Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Reset Interest Determination Date</I>&#148; means, in respect of any Interest Reset Period, the day falling two Business Days prior
to the beginning of such Interest Reset Period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option to Defer Interest Payments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So long as no Event of Default with respect to the Debentures has occurred and is continuing, MetLife, Inc. may elect at one or more times to
defer payment of interest on the Debentures for one or more consecutive Interest Periods that do not exceed five years for a single Optional Deferral Period (such election, an &#147;<I>Optional Deferral</I>&#148;). MetLife, Inc. may not defer
interest beyond the Maturity Date, any earlier accelerated Maturity Date arising from an Event of Default (which, under the Subordinated Indenture, is limited to certain events of bankruptcy, insolvency or receivership involving us) or any other
earlier redemption of the Debentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During an Optional Deferral Period, interest will continue to accrue on the Debentures, and
deferred interest on the Debentures will bear additional interest at the then-applicable interest rate, compounded on each Interest Payment Date, subject to applicable law. As used in this prospectus supplement, an &#147;<I>Optional Deferral
Period</I>&#148; refers to the period beginning on an Interest Payment Date with respect to which MetLife, Inc. defers interest and ending on the earlier of (i)&nbsp;the fifth anniversary of that Interest Payment Date and (ii)&nbsp;the next Interest
Payment Date on which MetLife, Inc. has paid all deferred and unpaid amounts (including compounded interest on such deferred amounts) and all other accrued interest on the Debentures. &#147;<I>Interest</I>&#148; in this prospectus supplement refers
not only to regularly scheduled interest payments but also to interest on interest payments not paid on the applicable Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the end of five years following the commencement of an Optional Deferral Period, MetLife, Inc. must pay all accrued and unpaid deferred
interest, including compounded interest. If MetLife, Inc. has paid all deferred interest (including compounded interest thereon) on the Debentures, MetLife, Inc. can again defer interest payments on the Debentures as described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will give the holders of the Debentures and the Subordinated Trustee written notice of its election to commence or continue an
Optional Deferral Period at least one and not more than 60 Business Days before the next Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. has no
present intention to defer interest payments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend and Other Payment Stoppages During Optional Deferral Periods and Under Certain Other
Circumstances </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will agree in the Subordinated Indenture that, so long as any Debentures remain outstanding, if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc. has given notice of its election to defer interest payments on the Debentures but the related
Optional Deferral Period has not yet commenced, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an Optional Deferral Period is continuing, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then MetLife, Inc. will not, nor will MetLife, Inc. permit its subsidiaries to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">declare or pay any dividends on, make any distribution with respect to, or redeem, purchase, acquire or make a
liquidation payment with respect to, any shares of MetLife, Inc.&#146;s capital stock, other than: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any purchase, redemption or other acquisition of shares of MetLife, Inc.&#146;s capital stock in connection with
(a)&nbsp;any employment contract, employee or benefit plan or other similar arrangement, (b)&nbsp;a dividend reinvestment or stockholder purchase plan, or (c)&nbsp;the issuance of MetLife, Inc.&#146;s capital stock, or securities convertible into or
exercisable for such capital stock, as consideration in an acquisition transaction entered into prior to the applicable Optional Deferral; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any exchange, redemption or conversion of any class or series of MetLife, Inc.&#146;s capital stock, or the
capital stock of one of its subsidiaries, for any other class or series of MetLife, Inc.&#146;s capital stock, or of any class or series of its indebtedness for any class or series of MetLife, Inc.&#146;s capital stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any purchase of, or payment of cash in lieu of, fractional interests in shares of MetLife, Inc.&#146;s capital
stock pursuant to the conversion or exchange provisions of such capital stock or the securities being converted or exchanged; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any declaration of a dividend in connection with any rights plan, or the issuance of rights, stock or other
property under any rights plan, or the redemption or repurchase of rights pursuant thereto; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any dividend in the form of stock, warrants, options or other rights where the dividend stock or stock issuable
upon exercise of such warrants, options or other rights is the same stock as that on which the dividend is being paid or ranks junior to such stock; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any payment of principal, premium, if any, or interest on, or repay, purchase or redeem, any debt securities
issued by MetLife, Inc. or make any guarantee payments under any guarantees given by MetLife, Inc., in each case that rank equally with the Debentures upon MetLife, Inc.&#146;s liquidation (&#147;<I>Parity Securities</I>&#148;) or that rank junior
to the Debentures upon MetLife, Inc.&#146;s liquidation, other than any payment (including guarantee payments), permitted by the immediately following sentence. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions listed above do not apply to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any payment of current interest in respect of Parity Securities that is made ratably and in proportion to the
respective amounts of (1)&nbsp;accrued and unpaid interest on Parity Securities then outstanding, on the one hand, and (2)&nbsp;accrued and unpaid interest on the Debentures, on the other hand; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any payment of principal on, or purchase or redemption price in respect of, Parity Securities (including
guarantee payments with respect to principal) then outstanding made ratably and in proportion to the respective amounts of (1)&nbsp;the principal amount of Parity Securities then outstanding, on the one hand, and (2)&nbsp;the principal amount of
Debentures then outstanding, on the other hand; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any payment of deferred interest on Parity Securities that, if not made, would cause MetLife, Inc. to breach the
terms of the instrument governing such Parity Securities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any payment of principal in respect of Parity Securities that, if not made, would cause MetLife, Inc. to breach
the terms of the instrument governing such Parity Securities; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any purchase or acquisition of MetLife, Inc.&#146;s capital stock by any of MetLife, Inc.&#146;s separate
accounts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no Parity Securities outstanding as of the date of this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, no terms of the Debentures will restrict in any manner the ability of any of MetLife, Inc.&#146;s subsidiaries to
pay dividends or make any distributions to MetLife, Inc. or to any of its other subsidiaries. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may elect to redeem the Debentures at its option for cash: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole, at any time, or in part, from time to time (i)&nbsp;on any Interest Payment Date on or after the
Initial Interest Reset Date, at a redemption price equal to 100% of their principal amount; and (ii)&nbsp;prior to the Initial Interest Reset Date, at a redemption price equal to the greater of (1) 100% of their principal amount, and (2)(a) the sum
of the present values of the remaining scheduled payments of principal of and interest on the Debentures being redeemed discounted to the redemption date (assuming the Debentures matured on the Initial Interest Reset Date) on a semi-annual basis
(assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) at the Treasury Rate (as defined below), plus&#8195;&#8195;&#8195;basis points less (b)&nbsp;interest
accrued to the redemption date; <I>provided</I> that if the Debentures are not redeemed in whole, at least $25&nbsp;million aggregate principal amount of the Debentures, excluding any Debentures held by MetLife, Inc. or any of its affiliates, must
remain outstanding after giving effect to such redemption and all accrued and unpaid interest, including deferred interest, must be paid in full on all outstanding Debentures for all Interest Periods ending on or before the date of redemption; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole, but not in part, at any time within 90 days after the occurrence of a &#147;Tax Event,&#148; a
&#147;Rating Agency Event&#148; or a &#147;Regulatory Capital Event,&#148; at a redemption price equal to (i)&nbsp;in the case of a &#147;Tax Event&#148; or a &#147;Regulatory Capital Event,&#148; 100% of their principal amount or (ii)&nbsp;in the
case of a &#147;Rating Agency Event,&#148; at a redemption price equal to 102% of their principal amount </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>plus</I>,
in each case, accrued and unpaid interest to, but excluding, the date of redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If MetLife, Inc. does not redeem the Debentures in
whole, at least $25&nbsp;million aggregate principal amount of the Debentures, excluding any Debentures held by MetLife, Inc. or any of its affiliates, must remain outstanding after giving effect to such redemption. MetLife, Inc. may not redeem the
Debentures unless all accrued and unpaid interest, including deferred interest (and compounded interest), has been paid in full on all outstanding Debentures for all Interest Periods ending on or before the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Treasury Rate</I>&#148; means, with respect to any redemption date, the yield determined by MetLife, Inc. in accordance with the
following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Treasury Rate shall be determined by MetLife, Inc. after 4:15 p.m., New York City time (or after such time
as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the redemption date based upon the yield or yields for the most recent day that appear after such
time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected Interest Rates (Daily)&#151;H.15&#148; (or any successor designation or publication)
(&#147;<I>H.15</I>&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or heading) (&#147;<I>H.15 TCM</I>&#148;). In determining the Treasury Rate, MetLife, Inc.,
or an agent designated by MetLife, Inc., shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to March&nbsp;15, 2035 (the &#147;<I>Par Call</I>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>Date</I>&#148;) (the &#147;<I>Remaining Life</I>&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields&#151;one yield
corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life&#151;and shall interpolate to the Par Call Date on a
straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for
the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of
months or years, as applicable, of such Treasury constant maturity from the redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on the third Business Day preceding the
redemption date H.15 TCM is no longer published, MetLife, Inc., or an agent designated by MetLife, Inc., shall calculate the Treasury Rate based on the rate <I>per annum</I> equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New
York City time, on the second Business Day preceding such redemption date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable. If there is no United States Treasury security
maturing on the Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a Maturity Date preceding the Par Call Date and one with a Maturity Date following the
Par Call Date, MetLife, Inc., or an agent designated by MetLife, Inc., shall select the United States Treasury security with a Maturity Date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par
Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, MetLife, Inc., or an agent designated by MetLife, Inc., shall select from among these two or more United States Treasury securities the United
States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of
this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of
such United States Treasury security, and rounded to three decimal places. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s actions and determinations in determining
the redemption price, including those of any agent designated by MetLife, Inc., shall be conclusive and binding for all purposes, absent manifest error. The Subordinated Trustee shall have no responsibility to calculate the redemption price or
determine the Treasury Rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Rating Agency Event</I>&#148; means that any nationally recognized statistical rating organization
within the meaning of Section&nbsp;3(a)(62) under the Exchange Act that then publishes a rating for MetLife, Inc. (a &#147;<I>rating agency</I>&#148;) amends, clarifies or changes the criteria it uses to assign equity credit to securities such as
the Debentures, which amendment, clarification or change results in: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the shortening of the length of time the Debentures are assigned a particular level of equity credit by that
rating agency compared to the length of time they would have been assigned that level of equity credit by that rating agency or its predecessor on the initial issuance of the Debentures; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lowering of the equity credit (including up to a lesser amount) assigned to the Debentures by that rating
agency compared to the equity credit assigned by that rating agency or its predecessor on the initial issuance of the Debentures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Regulatory Capital Event</I>&#148; means MetLife, Inc.&#146;s good faith determination that, as a result of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any amendment to, or change in, the laws, rules or regulations of the United States or any political subdivision
of or in the United States or any other governmental agency or instrumentality as may then have group-wide oversight of MetLife, Inc.&#146;s regulatory capital that is enacted or becomes effective after the initial issuance of the Debentures;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any proposed amendment to, or change in, those laws, rules or regulations that is announced or becomes effective
after the initial issuance of the Debentures; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any official administrative decision or judicial decision or administrative action or other official
pronouncement interpreting or applying those laws, rules or regulations that is announced after the initial issuance of the Debentures; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">there is more than an insubstantial risk that the full principal amount of the Debentures outstanding from time to time would not qualify as
&#147;Tier 2 Capital&#148; (or a substantially similar concept) for purposes of the capital adequacy rules of any capital regulator to which MetLife, Inc.is or will be subject;<I>&nbsp;provided</I>&nbsp;that the proposal or adoption of any
criterion: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that is substantially the same as the corresponding criterion in the capital adequacy rules of the Board of
Governors of the Federal Reserve System applicable to bank holding companies as of the initial issuance of the Debentures; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that would result in the full principal amount of the Debentures outstanding from time to time not qualifying as
&#147;Tier 2 Capital&#148; (or a substantially similar concept) for purposes of the capital adequacy rules of the capital regulator solely because MetLife, Inc. may redeem the Debentures at its option upon the occurrence of a Rating Agency Event
will not constitute a Regulatory Capital Event. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<I>Tax Event</I>&#148; means the receipt by us of an opinion of
independent counsel experienced in such matters to the effect that, as a result of any: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amendment to or change (including any officially announced proposed change) in the laws or regulations of the
United States or any political subdivision or taxing authority of or in the United States that is enacted or effective on or after the initial issuance of the Debentures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">official administrative decision or judicial decision or administrative action or other official pronouncement
(including a private letter ruling, technical advice memorandum or other similar pronouncement) by any court, government agency or regulatory authority that reflects an amendment to, or change in, the interpretation or application of those laws or
regulations that is announced on or after the initial issuance of the Debentures; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">threatened challenge asserted in connection with an audit of MetLife, Inc., or a threatened challenge asserted in
writing against any taxpayer that has raised capital through the issuance of securities that are substantially similar to the Debentures, which challenge is asserted against MetLife, Inc. or becomes publicly known on or after the initial issuance of
the Debentures, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">there is more than an insubstantial increase in the risk that interest payable by MetLife, Inc. on the
Debentures is not, or within 90 days of the date of such opinion will not be, deductible by MetLife, Inc., in whole or in part, for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed (or, so long as the Debentures are held in the form of one or more global Debentures deposited with
DTC, otherwise transmitted in accordance with the procedures of DTC) at least 10 days but not more than 60 days before the redemption date to each holder of Debentures to be redeemed at its registered address. Unless MetLife, Inc. defaults in
payment of the redemption price and accrued interest, on and after the redemption date, interest will cease to accrue on the Debentures or portions thereof called for redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Debentures for redemption will be made by lot. No Debentures of a principal amount of
$1,000 or less will be redeemed in part. If any Debenture is to be redeemed in part only, the notice of redemption that relates to the Debenture will state the portion of the principal amount of the Debenture to be redeemed. A new Debenture in a
principal amount equal to the unredeemed portion of the Debenture will be issued in the name of the holder of the Debenture upon surrender for cancellation of the original Debenture. For so long as the Debentures are held by DTC (or another
depositary), the redemption of the Debentures and selection of the Debentures to be redeemed shall be done in accordance with the policies and procedures of the depositary, which will be made on a <I>pro rata </I>pass-through distribution of
principal basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any redemption, neither MetLife, Inc. nor the Subordinated Trustee will be
required to: issue, register the transfer of, or exchange, Debentures during a period beginning at the opening of business 15 days before the day of selection for redemption of Debentures and ending at the close of business on the day of mailing or
transmission of notice of redemption; or transfer or exchange any Debentures so selected for redemption, except, in the case of any Debentures being redeemed in part, any portion thereof not to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event the Debentures are treated as &#147;Tier 2 capital&#148; (or a substantially similar concept) under the capital rules of any
capital regulator applicable to MetLife, Inc., any redemption of Debentures will be subject to MetLife, Inc.&#146;s receipt of any required prior approval from such capital regulator and to the satisfaction of any conditions set forth in those
capital rules or any other regulations of any other capital regulator that are or will be applicable to MetLife, Inc.&#146;s redemption of the Debentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures are not subject to any sinking fund or similar provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discharge, Defeasance and Covenant Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The discharge, defeasance and covenant defeasance provisions of the Subordinated Indenture will apply to the Debentures. You should refer to
the description of these provisions under &#147;Description of Debt Securities &#151; Discharge, Defeasance and Covenant Defeasance&#148; in the accompanying prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subordination </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payment of the
principal of and interest on the Debentures is expressly subordinated, to the extent and in the manner set forth in the Subordinated Indenture, in right of payment and upon liquidation to the prior payment in full of all of MetLife, Inc.&#146;s
Senior Indebtedness. In addition, the Debentures may be fully subordinated to any interests held by the U.S. government in the event MetLife, Inc. enters into a receivership, insolvency, liquidation or similar proceeding, including a proceeding
under the &#147;orderly liquidation authority&#148; provisions of the&nbsp;Dodd-Frank Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the qualifications described below,
the term &#147;<I>Senior Indebtedness</I>&#148; is defined in the Subordinated Indenture to include principal of, premium (if any) and interest on and any other payment due pursuant to any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of MetLife, Inc.&#146;s indebtedness, whether outstanding on the issue date of the Debentures or thereafter
created, incurred or assumed, which is for money borrowed (excluding the Debentures and the Junior Subordinated Obligations) or which is evidenced by a note or similar instrument given in connection with the acquisition of any business, properties
or assets, including securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of MetLife, Inc.&#146;s obligations under leases required or permitted to be capitalized under GAAP;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any indebtedness of others of the kinds described in the first bullet point above for the payment of which
MetLife, Inc. is responsible or liable as guarantor or otherwise; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">amendments, modifications, renewals, extensions, deferrals and refundings of any of the above types of
indebtedness. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures will rank senior to all of MetLife, Inc.&#146;s equity securities, including its preferred
stock, and&nbsp;the&nbsp;Junior Subordinated&nbsp;Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Senior Indebtedness will continue to be Senior Indebtedness and
entitled to the benefits of the subordination provisions irrespective of any amendment, modification or waiver of any term of the Senior Indebtedness or extension or renewal of the Senior Indebtedness. Notwithstanding anything to the contrary in the
foregoing, Senior Indebtedness will not include (1)&nbsp;indebtedness incurred for the purchase of goods or materials </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or for services obtained in the ordinary course of business (<I>i.e</I>., trade accounts payable), which will rank junior to the Debentures and equally in right of payment and upon liquidation
with the Junior Subordinated Obligations, (2)&nbsp;indebtedness which by its terms ranks equally with or subordinated to the Debentures or the Junior Subordinated Obligations, as the case may be, in right of payment or upon liquidation,
(3)&nbsp;indebtedness owed by MetLife, Inc. to its subsidiaries, which also will rank junior to the Debentures and equally in right of payment and upon liquidation with the Junior Subordinated Obligations, and (4)&nbsp;any liability for federal,
state, local or other taxes owed or owing by MetLife, Inc. or by its subsidiaries. In addition, the rights of the holders of the Debentures will be structurally subordinated to all existing and future obligations of MetLife, Inc.&#146;s
subsidiaries. The Debentures will rank senior in right of payment upon liquidation with MetLife, Inc.&#146;s trade accounts payable and with debt that by its terms does not rank senior to or on parity with the Debentures upon MetLife, Inc.&#146;s
liquidation, including the Junior Subordinated Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024, MetLife, Inc.&#146;s short- and long-term debt
owed to third parties ranking senior to the Debentures upon liquidation, on an unconsolidated basis, totaled approximately $14.4&nbsp;billion. In addition, as of December&nbsp;31, 2024, MetLife, Inc.&#146;s short- and long-term debt owed to
subsidiaries ranking senior to the Debentures upon liquidation totaled approximately $1.4&nbsp;billion. Payments on the Debentures will also be effectively subordinated to all existing and future liabilities of MetLife, Inc.&#146;s subsidiaries to
the extent of the assets of such subsidiaries. As of December&nbsp;31, 2024, MetLife, Inc.&#146;s subsidiaries had $2.3&nbsp;billion of debt outstanding (excluding intercompany liabilities), all of which would be structurally senior in priority to
the Debentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No direct or indirect payment, in cash, property or securities, by <FONT STYLE="white-space:nowrap">set-off</FONT> or
otherwise, may be made or agreed to be made on account of the Debentures including in respect of any repayment, redemption, retirement, purchase or other acquisition of the Debentures, if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc. defaults in the payment of any principal, or premium, if any, or interest on any Senior
Indebtedness, whether at maturity or at a date fixed for prepayment or declaration or otherwise; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an event of default occurs with respect to any Senior Indebtedness permitting the holders thereof to accelerate
the maturity and written notice of such event of default, requesting that payments on the Debentures cease, is given to MetLife, Inc. by any holder of Senior Indebtedness, unless and until such event of default has been cured or waived or ceases to
exist. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All present and future Senior Indebtedness, which will include interest accruing after the commencement of any
proceeding, assignment or marshaling of assets described below, will first be paid in full before any payment, whether in cash, securities or other property, will be made by MetLife, Inc. on account of the Debentures in the event of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any insolvency, bankruptcy, receivership, liquidation, reorganization, readjustment, composition or other similar
proceeding relating to MetLife, Inc., its creditors or its property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any proceeding for MetLife, Inc.&#146;s liquidation, dissolution or other
<FONT STYLE="white-space:nowrap">winding-up,</FONT> voluntary or involuntary, whether or not involving insolvency or bankruptcy proceedings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any general assignment by MetLife, Inc. for the benefit of creditors; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other marshaling of MetLife, Inc.&#146;s assets. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In any such event, payments that would otherwise be made on the Debentures will generally be paid to the holders of Senior Indebtedness, or
their representatives, in accordance with the priorities existing among these creditors at that time until the Senior Indebtedness is paid in full. If the payments on the Debentures are in the form of MetLife, Inc.&#146;s securities or those of any
other corporation under a plan of reorganization or readjustment and are subordinated to outstanding Senior Indebtedness and to any securities issued with respect to such Senior Indebtedness under a plan of reorganization or readjustment, they will
be made first to the holders of Senior Indebtedness and then, if any amounts remain, to the holders of the Debentures. No present or future </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
holder of any Senior Indebtedness will be prejudiced in the right to enforce the subordination of the Debentures by any act or failure to act on MetLife, Inc.&#146;s part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that, notwithstanding any of the foregoing prohibitions, the Subordinated Trustee or the holders of the Debentures receive or
hold any payment on account of or in respect of the Debentures at a time when a responsible officer of the Subordinated Trustee or such holder has actual knowledge that such payment should not have been made to it, the Subordinated Trustee or such
holder, as the case may be, will hold such payment in trust for the benefit of, and, upon written request, will pay it over to, the holders of the Senior Indebtedness or their agents or representatives, for application to the payment of all
principal, premium, if any, and interest or any other amounts then payable with respect to any Senior Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Senior Indebtedness
will only be deemed to have been paid in full if the holders of such Senior Indebtedness have received cash, securities or other property which is equal to the amount of the outstanding Senior Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After payment in full of all present and future Senior Indebtedness, holders of the Debentures will be subrogated to the rights of any holders
of Senior Indebtedness to receive any further payments that are applicable to the Senior Indebtedness until all the Debentures are paid in full. In matters between holders of Debentures and any other type of MetLife, Inc.&#146;s creditors, any
payments that would otherwise be paid to holders of Senior Indebtedness and that are made to holders of the Debentures because of this subrogation will be deemed a payment by MetLife, Inc. on account of Senior Indebtedness and not on account of the
Debentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture places no limitation on the amount of additional Senior Indebtedness that MetLife, Inc. may incur.
MetLife, Inc. expects to incur from time to time additional Senior Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the contractual subordination provisions
described above, the rights of the holders of the Debentures will be structurally subordinated to all existing and future obligations of MetLife, Inc.&#146;s subsidiaries, as MetLife, Inc. is a holding company. As a result, MetLife, Inc. relies
primarily on dividends or other payments from its direct and indirect operating subsidiaries, which generally are regulated insurance companies, to pay principal and interest on its outstanding debt obligations, and to make dividend distributions on
MetLife, Inc.&#146;s capital stock. Regulatory rules will, and certain covenants contained in various debt agreements may, restrict MetLife, Inc.&#146;s ability to withdraw capital from its subsidiaries by dividends, loans or other payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the subordination provisions described above, in the event of MetLife, Inc.&#146;s insolvency, funds which MetLife, Inc. would
otherwise use to pay the holders of the Debentures would be used to pay the holders of Senior Indebtedness to the extent necessary to pay the Senior Indebtedness in full. As a result of these payments, MetLife, Inc.&#146;s general creditors may
recover less, ratably, than the holders of its Senior Indebtedness and these general creditors may recover more, ratably, than the holders of the Debentures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Denominations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures will be
issued only in registered form, without coupons, in denominations of $2,000 each and integral multiples of $1,000 in excess thereof. MetLife, Inc. expects that the Debentures will be held in book-entry form only, as described under
&#147;&#151;Book-Entry System,&#148; and will be held in the name of DTC or its nominee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger, Conveyance, Sale of Assets and Other
Transfers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of the Subordinated Indenture relating to our possible consolidation, merger, conveyance, sale of assets and
other transfers will apply to the Debentures. You should refer to the description of these provisions under &#147;Description of Debt Securities &#151; Restrictive Covenants&#148; and &#147;Description of Debt Securities &#151; Consolidation,
Merger, Sale of Assets and Other Transactions&#148; in the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default; Waiver and Notice </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An &#147;<I>Event of Default</I>&#148; with respect to the Debentures shall occur only upon certain events of bankruptcy, insolvency or
receivership involving MetLife, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture refers to breaches that are not &#147;<I>Events of Default</I>&#148; as
&#147;<I>defaults</I>.&#148; They include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure to pay interest, including compounded interest, in full on any Debentures for a period of 30 days
after the conclusion of a five-year period following the commencement of any Optional Deferral Period if such Optional Deferral Period has not ended prior to the conclusion of such five-year period; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure to pay principal of or premium, if any, on the Debentures when due; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the failure to comply with MetLife, Inc.&#146;s covenants under the Subordinated Indenture.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#147;<I>default</I>&#148; also includes, for example, a failure to pay interest when due if MetLife, Inc. does not
give a timely written notice of its election to commence or continue an Optional Deferral Period. If MetLife, Inc. does not give a timely written notice of its election to commence or continue an Optional Deferral Period and fail to pay interest
when due, any holder of Debentures may seek to enforce MetLife, Inc.&#146;s obligation to make the missed interest payment, including through legal process. However, there is no right of acceleration except upon the occurrence of an Event of Default
as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If MetLife, Inc. does give a timely written notice of its election to commence or continue an Optional Deferral
Period on any Interest Payment Date (and, if such notice continues an Optional Deferral Period, the Optional Deferral Period has not continued for five years), then no &#147;<I>default</I>&#148; arises from MetLife, Inc.&#146;s <FONT
STYLE="white-space:nowrap">non-payment</FONT> of interest on such Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture provides that the
Subordinated Trustee must give holders notice of all defaults or Events of Default within 90 days after a responsible officer of the Subordinated Trustee receives written notice of such default or Event of Default. However, except in the case of a
default in payment on the Debentures, the Subordinated Trustee will be protected in withholding the notice if its responsible officers determine that withholding of the notice is in the interest of such holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default under the Subordinated Indenture occurs, the entire principal amount of the Debentures will automatically become due
and payable without any declaration or other action on the part of the Subordinated Trustee or any holder of the Debentures. There is no right of acceleration in the case of any payment default or other breaches of covenants under the Subordinated
Indenture or the Debentures. Notwithstanding the foregoing, in the case of a default in the payment of principal of or interest on the Debentures, including any compound interest (and, in the case of payment of deferred interest, such failure to pay
shall have continued for 30 calendar days after the conclusion of the Optional Deferral Period), the holder of a Debenture may, or if directed by the holders of a majority in principal amount of the Debentures, the Subordinated Trustee shall,
subject to the conditions set forth in the Subordinated Indenture, demand payment of the amount then due and payable and may institute legal proceedings for the collection of such amount if MetLife, Inc. fails to make payment thereof upon demand.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of a majority in aggregate principal amount of the outstanding Debentures may waive any past default, except: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a default in payment of principal or interest; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a default under any provision of the Subordinated Indenture that itself cannot be modified or amended without the
consent of the holders of all outstanding Debentures. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of a majority in principal amount of the Debentures
will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Subordinated Trustee, subject to the provisions of the Subordinated Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. is required to file an officers&#146; certificate with the Subordinated
Trustee each year that states, to the knowledge of the certifying officers, whether MetLife, Inc. has complied with all conditions and covenants under the terms of the Subordinated Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Trustee shall have no right or obligation under the Subordinated Indenture or otherwise to exercise any remedies on behalf of
any holders of the Debentures pursuant to the Subordinated Indenture in connection with any &#147;default,&#148; unless such remedies are available under the Subordinated Indenture and the Subordinated Trustee is directed to exercise such remedies
by the holders of a majority in principal amount of the Debentures pursuant to and subject to the conditions of the Subordinated Indenture. In connection with any such exercise of remedies the Subordinated Trustee shall be entitled to the same
immunities and protections and remedial rights (other than acceleration) as if such &#147;<I>default</I>&#148; were an &#147;<I>Event of Default</I>.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Actions Not Restricted by the Subordinated Indenture </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture does not contain restrictions on MetLife, Inc.&#146;s ability to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur, assume or become liable for any type of debt or other obligation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">create liens on its property for any purpose; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pay dividends or make distributions on its capital stock or purchase or redeem its capital stock, except as set
forth under &#147;&#151;Dividend and Other Payment Stoppages During Optional Deferral Periods and Under Certain Other Circumstances&#148; above, or make debt payments on, or purchase, redeem or retire, any Senior Indebtedness. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture does not require the maintenance of any financial ratios or specified levels of net worth or liquidity. In
addition, the Subordinated Indenture does not contain any provisions that would require MetLife, Inc. to repurchase or redeem or modify the terms of any of the Debentures upon a change of control or other event involving MetLife, Inc. that may
adversely affect the creditworthiness of the Debentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification of the Subordinated Indenture </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The modification provisions of the Subordinated Indenture will apply to Debentures. You should refer to the description of these provisions
under &#147;Description of Debt Securities &#151; Modification and Waiver&#148; in the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, MetLife,
Inc. will be permitted to modify, without consent of holders of the Debentures; <I>provided</I> that (i)&nbsp;MetLife, Inc. has determined, in good faith, that such modification is not materially adverse to such holders and (ii)&nbsp;the Rating
Agencies then rating the Debentures confirm the then current ratings of the Debentures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-Entry System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DTC, to which MetLife, Inc.&#146;s refer along with its successors in this capacity as the depositary, will act as securities depositary for
the Debentures. The Debentures will be issued only as fully registered securities registered in the name of Cede&nbsp;&amp; Co. (&#147;<I>Cede</I>&#148;), the depositary&#146;s nominee. One or more fully registered global security certificates,
representing the total aggregate principal amount of the Debentures, will be issued and will be deposited with the depositary or its custodian and will bear a legend regarding the restrictions on exchanges and registration of transfer of the global
securities. So long as Cede, as the nominee of DTC, is the registered owner of any global security, Cede for all purposes will be considered the sole holder of that global security. Except as provided below, owners of beneficial interests in a
global security will not be entitled to have certificates registered in their names, will not receive physical delivery of certificates in definitive form and will not be considered the holders thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The laws of some jurisdictions may require that some purchasers of securities take physical
delivery of securities in definitive form. These laws may impair the ability to transfer beneficial interests in the Debentures so long as the Debentures are represented by global security certificates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investors may elect to hold interests in the Debentures in global form through DTC in the United States or through Clearstream or Euroclear in
Europe, if they are participants in those systems, or indirectly through organizations that are participants in those systems. Clearstream and Euroclear will hold interests on behalf of their participants through customers&#146; securities accounts
in Clearstream&#146;s and Euroclear&#146;s names on the books of their respective depositaries, which in turn will hold such interests in customers&#146; securities accounts in the depositaries&#146; names on the books of DTC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initial settlement for the Debentures will be made in immediately available funds. Secondary market trading between DTC participants will
occur in the ordinary way in accordance with DTC rules and will be settled in immediately available funds. Secondary market trading between Clearstream participants and/or Euroclear participants will occur in the ordinary way in accordance with the
applicable rules and operating procedures of Clearstream and the Euroclear System, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cross-market transfers between DTC, on
the one hand, and directly or indirectly through Euroclear or Clearstream participants, on the other, will be effected in DTC in accordance with DTC rules on behalf of Euroclear or Clearstream, as the case may be, by its respective depositary;
however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with its rules and procedures and within its established deadlines. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Euroclear or Clearstream will, if the transaction meets its settlement requirements, deliver instructions to its respective depositary to take
action to effect final settlement on its behalf by delivering or receiving beneficial interests in the relevant global security in DTC, and making or receiving payment in accordance with normal procedures
<FONT STYLE="white-space:nowrap">for&nbsp;same-day&nbsp;funds</FONT> settlement applicable to DTC. Euroclear participants and Clearstream participants may not deliver instructions directly to the depositaries for Euroclear or Clearstream. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of time zone differences, the securities account of a Euroclear participant or Clearstream participant purchasing a beneficial
interest in a global security from a participant will be credited during the securities settlement processing day immediately following the DTC settlement date and such credit of any transactions in beneficial interests in such global security
settled during such processing will be reported to the relevant Euroclear participant or Clearstream participant on that Business Day. Cash received in Euroclear or Clearstream as a result of sales of beneficial interests in a global security by or
through a Euroclear participant or Clearstream participant to a participant will be received with value on the DTC settlement date but will be available in the relevant Euroclear or Clearstream cash account only as of the Business Day following
settlement in DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither MetLife, Inc. nor the Subordinated Trustee (or any registrar or paying agent) will have any responsibility for
the performance by DTC, Euroclear or Clearstream or any of the participants or indirect participants of DTC, Euroclear or Clearstream of their respective obligations under the rules and procedures governing their operations. DTC has advised us that
it will take any action permitted to be taken by a holder of Debentures only at the direction of one or more participants whose DTC accounts are credited with interests in a global security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DTC has informed us that it is a limited-purpose trust company organized under the New York Banking Law, a &#147;banking organization&#148;
within the meaning of the New York Banking Law, a member of the Federal Reserve System, a &#147;clearing corporation&#148; within the meaning of the New York Uniform Commercial Code, and a &#147;clearing agency&#148; registered pursuant to the
provisions of Section&nbsp;17A of the Exchange Act. DTC holds and provides asset servicing for securities that DTC&#146;s participants (&#147;<I>direct participants</I>&#148;) deposit with it. DTC also facilitates the post-trade settlement among
direct participants of sales and other securities transactions in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
deposited securities, through electronic computerized book-entry transfers and pledges between direct participants&#146; accounts. This eliminates the need for physical movement of securities
certificates. Direct participants include both U.S. <FONT STYLE="white-space:nowrap">and&nbsp;non-U.S.&nbsp;securities</FONT> brokers and dealers, banks, trust companies, clearing corporations, and certain other organizations. DTC is a wholly-owned
subsidiary of The Depository Trust&nbsp;&amp; Clearing Corporation (&#147;<I>DTCC</I>&#148;). DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing
agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others such as both U.S. <FONT STYLE="white-space:nowrap">and&nbsp;non-U.S.&nbsp;securities</FONT> brokers and dealers, banks, trust
companies, and clearing corporations that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly (&#147;<I>indirect participants</I>&#148; and, together with direct participants,
&#147;<I>participants</I>&#148;). The DTC Rules applicable to its participants are on file with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases of Debentures under
the DTC system must be made by or through direct participants, which will receive a credit for the Debentures on DTC&#146;s records. The ownership interest of each actual purchaser of each Debenture (&#147;<I>beneficial owner</I>&#148;) is in turn
to be recorded on the direct and indirect participants&#146; records. Beneficial owners will not receive written confirmation from DTC of their purchase. Beneficial owners are, however, expected to receive written confirmations providing details of
the transaction, as well as periodic statements of their holdings, from the direct or indirect participant through which the beneficial owner entered into the transaction. Transfers of ownership interests in the Debentures are to be accomplished by
entries made on the books of direct and indirect participants acting on behalf of beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in the Debentures, except in the limited circumstances
described below in which a global security will become exchangeable for Debenture certificates registered in the manner described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To facilitate subsequent transfers, all securities deposited by direct participants with DTC are registered in the name of DTC&#146;s
partnership nominee, Cede, or such other name as may be requested by an authorized representative of DTC. The deposit of the Debentures with DTC and their registration in the name of Cede or such other DTC nominee do not effect any change in their
beneficial ownership. DTC has no knowledge of the actual beneficial owners of the Debentures; DTC&#146;s records reflect only the identity of the direct participants to whose accounts such Debentures are credited, which may or may not be the
beneficial owners. The participants will remain responsible for keeping account of their holdings on behalf of their customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants, and by
participants to beneficial owners will be governed by arrangements among them, subject to any statutory or regulatory requirements as may be in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Redemption proceeds, principal and interest payments on the Debentures will be made to Cede, or such other nominee as may be requested by an
authorized representative of DTC. DTC&#146;s practice is to credit direct participants&#146; accounts upon DTC&#146;s receipt of funds, and corresponding detail information from the issuer or paying agent, on the payable date in accordance with
their respective holdings shown on DTC&#146;s records. Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities held for the accounts of customers in bearer form
or registered in &#147;street name,&#148; and will be the responsibility of such participant and not of DTC, the paying agent or us, subject to any statutory or regulatory requirements as may be in effect from time to time. Payment of redemption
proceeds, principal and interest payments to Cede (or such other nominee as may be requested by an authorized representative of DTC) is the responsibility of the issuer or paying agent, disbursement of such payments to direct participants will be
the responsibility of DTC, and disbursement of such payments to the beneficial owners will be the responsibility of participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither
MetLife, Inc. nor the Subordinated Trustee (or any registrar or paying agent) will have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests in the global securities
or for maintaining, supervising or reviewing any records relating to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
those beneficial ownership interests. The information in this section concerning DTC and DTC&#146;s book-entry system has been obtained from sources that MetLife, Inc. believes to be reliable,
but MetLife, Inc. takes no responsibility for the accuracy thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">DTC may discontinue providing its services as securities depositary
with respect to the Debentures at any time by giving reasonable notice to MetLife, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The global security will terminate and interests
in it will be exchanged for physical certificates representing the Debentures only in the following situations: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC or any successor depositary notifies us that it is unwilling or unable to continue as depositary for global
securities or ceases to be a &#147;clearing agency&#148; registered under the Exchange Act and MetLife, Inc. notify the Subordinated Trustee that we are unable to locate a qualified successor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an Event of Default, as described under &#147;Description of the Debentures&#151;Events of Default; Waiver and
Notice&#148; in this prospectus supplement, under the Debentures has occurred and is continuing; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc., in its sole discretion and subject to the procedures of the depositary, determine that any or all
of the Debentures will no longer be represented by global securities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In those situations, the Debentures represented
by a global security that is exchangeable pursuant to this paragraph will be exchangeable for Debenture certificates registered in the names directed by the depositary, with the same terms and in authorized denominations. MetLife, Inc. expects that
these instructions will be based upon directions received by the depositary from its participants with respect to ownership of beneficial interests in the global security certificates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Subordinated Indenture
and the Debentures will be governed by, and construed in accordance with, the laws of the State of New York, without regard to its principles of conflicts of laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Subordinated Trustee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Subordinated Trustee will have all of the duties and responsibilities specified under the&nbsp;Trust Indenture Act of 1939, as amended. Other than its duties in a case of default, the Subordinated Trustee is under no obligation to exercise any of
the powers under the Subordinated Indenture at the request, order or direction of any holders of Debentures unless offered reasonable indemnification. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Miscellaneous </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. or any of
its affiliates may from time to time purchase any of the Debentures that are then outstanding by tender, in the open market or by private agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_10"></A>CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general discussion of the material U.S. federal income tax considerations relating to the purchase, ownership and
disposition of the Debentures. This discussion is the opinion of Willkie Farr&nbsp;&amp; Gallagher LLP, our counsel. This discussion is based upon the provisions of the U.S. Internal Revenue Code of 1986, as amended (the &#147;<I>Code</I>&#148;),
Treasury regulations promulgated thereunder and administrative and judicial interpretations thereof, all as in effect on the date hereof, and all of which are subject to change, possibly with retroactive effect, or to different interpretations. This
discussion applies only to Debentures that are held as &#147;capital assets,&#148; within the meaning of the Code, by a holder (as defined below) who purchases Debentures in the initial offering at their &#147;issue price&#148; (<I>i.e</I>., the
first price at which a substantial amount of the Debentures is sold to the public, excluding sales to bond houses and brokers). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
discussion is for general information only and does not address all of the material tax considerations that may be relevant to a holder in light of its particular circumstances or to holders subject to special treatment under U.S. federal income tax
laws (such as banks, insurance <FONT STYLE="white-space:nowrap">companies,&nbsp;tax-exempt&nbsp;entities,</FONT> retirement plans, dealers in securities, real estate investment trusts, regulated investment companies, persons holding the Debentures
as part of a &#147;straddle,&#148; &#147;hedge,&#148; &#147;conversion&#148; or other integrated transaction, United States holders (as defined below) whose functional currency is not the U.S. dollar, former citizens or residents of the United
States, nonresident alien individuals present in the United States for more than 182 days in a taxable year, holders who mark securities to market for U.S. federal income tax purposes, or taxpayers that purchase or sell Debentures as part of a wash
sale for tax purposes). This discussion addresses only U.S. federal income taxation and does not discuss all of the tax consequences that may be relevant to a holder in light of their individual circumstances, including foreign, state or local tax
consequences, tax consequences arising under the Medicare contribution tax on net investment income, any U.S. federal estate, gift or alternative minimum tax consequences, or the potential application of the income accrual rules set forth in
Section&nbsp;451(b) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes holds
the Debentures, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner and the tax treatment of the partnership. A partner in such a partnership holding the Debentures should consult its tax advisor
with regard to the U.S. federal income tax treatment of an investment in the Debentures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a
&#147;<I>United States holder</I>&#148; is a beneficial owner of a Debenture that is, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation created or organized in or under the laws of the United States, any state thereof or the District
of Columbia, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate whose income is subject to U.S. federal income tax regardless of its source, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if (a)&nbsp;a U.S. court can exercise primary supervision over the trust&#146;s administration and one or
more United States persons are authorized to control all substantial decisions of the trust or (b)&nbsp;it has a valid election in effect under applicable Treasury regulations to be treated as a domestic trust. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a &#147;<I><FONT STYLE="white-space:nowrap">non-United</FONT></I><I></I><I>&nbsp;States holder</I>&#148; is a
beneficial owner of a Debenture (other than a partnership or an entity or arrangement classified as a partnership for U.S. federal income tax purposes) that is not a &#147;<I>United States holder</I>,&#148; and &#147;<I>holders</I>&#148; refers to
United States holders <FONT STYLE="white-space:nowrap">and&nbsp;non-United&nbsp;States</FONT> holders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Persons considering the purchase of the Debentures should consult their tax advisers with
respect to the U.S. federal tax considerations relating to the purchase, ownership and disposition of the Debentures in light of their own particular circumstances, as well as the effect of any state, local, foreign and other tax laws. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Classification of the Debentures </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
determination of whether a security should be classified as indebtedness or equity for U.S. federal income tax purposes requires a judgment based on all relevant facts and circumstances. There is no statutory, judicial or administrative authority
that directly addresses the U.S. federal income tax treatment of securities similar to the Debentures. Based upon an analysis of the relevant facts and circumstances, under applicable law as of the issue date of the Debentures, the Debentures will
be treated as indebtedness for U.S. federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, there can be no assurance that the Internal Revenue Service
(&#147;<I>IRS</I>&#148;) or a court will agree with our determination. No ruling is being sought from the IRS on any of the issues discussed herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. agrees, and by acquiring an interest in a Debenture each beneficial owner of a Debenture agrees, to treat the Debentures as
indebtedness for U.S. federal income tax purposes, and the remainder of this discussion assumes such treatment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>United States Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Income, Original Issue Discount and Certain Contingent Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is expected, and assumed for purposes of this discussion that, subject to the discussion below, the Debentures will be treated as variable
rate debt instruments, and will not be issued with original issue discount (&#147;<I>OID</I>&#148;) for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treasury regulations provide that the possibility that interest on the Debentures might be deferred could result in the Debentures being
treated as issued with OID, unless the likelihood of such deferral is remote. Similarly, Treasury regulations provide that the possibility that the Debentures might be redeemed at a premium following a &#147;Rating Agency Event&#148; could subject
the Debentures to special rules that apply to contingent payment debt instruments, unless the likelihood of such redemption is remote or incidental. MetLife, Inc. believes that the likelihood of interest deferral or redemption at a premium following
a &#147;Rating Agency Event&#148; is remote and therefore that the possibility of such deferral or redemption will not result in the Debentures being treated as issued with OID or being subject to the rules that apply to contingent payment debt
instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, interest paid on the Debentures should be taxable to a United States holder as ordinary interest income at the
time it accrues or is received in accordance with such United States holder&#146;s method of accounting for U.S. federal income tax purposes. However, no rulings or other interpretations have been issued by the IRS that address the meaning of the
term &#147;remote,&#148; as used in the applicable Treasury regulations, and there can be no assurance that the IRS or a court will agree with our position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the possibility of interest deferral were determined not to be remote, or if interest were in fact deferred, the Debentures would be
treated as issued with OID at the time of issuance, or at the time of such deferral, as the case may be, and all stated interest, or if interest is in fact deferred all stated interest due after such deferral, would be treated as OID. The Debentures
would also be treated as issued with OID at the time of issuance if the Debentures were not variable rate debt instruments for U.S. federal income tax purposes, or were otherwise treated as issued with OID under the rules that apply to variable rate
debt instruments. In such case, a United States holder would be required to include some or all of the interest in income as it accrued, regardless of the holder&#146;s regular method of accounting, using <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">the&nbsp;constant-yield-to-maturity&nbsp;method</FONT></FONT> of accrual, which may occur before such United States holder received any payment attributable to such income, and would not separately
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
report the actual cash payments of interest on the Debentures as taxable income other than payments (if any) of &#147;qualified stated interest&#148; for U.S. federal income tax purposes.
Similarly, if the possibility of redemption at a premium following a &#147;Rating Agency Event&#148; were determined not to be remote or incidental, a United States holder would generally be required to accrue interest income at a rate higher than
the stated interest rate on the Debentures and to treat as interest income (rather than capital gain) any gain recognized on a sale, exchange, redemption or other disposition of the Debentures before the resolution of the contingencies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale, Exchange, Redemption or Other Taxable Disposition of Debentures </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the sale, exchange, redemption or other taxable disposition of a Debenture, a United States holder will generally recognize gain or loss
equal to the difference between the amount realized (less any accrued interest not previously included in the United States holder&#146;s income, which will be taxable as ordinary income) on the sale, exchange, redemption or other taxable
disposition and such United States holder&#146;s adjusted tax basis in the Debenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming that interest payments on the Debentures
are not deferred and that the Debentures are not treated as issued with OID, a United States holder&#146;s adjusted tax basis in a Debenture generally will be its initial purchase price. If the Debentures are treated as issued with OID, a United
States holder&#146;s adjusted tax basis in a Debenture generally will be its initial purchase price, increased by OID previously includible in such United States holder&#146;s gross income to the date of disposition and decreased by payments
received on the Debenture since and including the date that the Debenture was treated as issued with OID (other than payments of qualified stated interest, if any). Gain or loss recognized by a United States holder generally will be long-term
capital gain or loss if the United States holder has held the Debenture for more than one year at the time of disposition. A United States holder that is an individual is generally entitled to preferential treatment for net long-term capital gains.
The ability of a United States holder to deduct capital losses is limited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-United&nbsp;States</FONT> Holders
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below concerning FATCA withholding and backup withholding, the following is a discussion of U.S. federal
income tax and withholding tax considerations generally applicable <FONT STYLE="white-space:nowrap">to&nbsp;non-United&nbsp;States</FONT> holders: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Payments of principal and interest (including OID, if applicable) with respect to a Debenture held by or for a <FONT
STYLE="white-space:nowrap">non-United</FONT> States holder will not be subject to U.S. federal income or withholding tax, provided that, in the case of amounts treated as interest, (a)&nbsp;such <FONT STYLE="white-space:nowrap">non-United</FONT>
States holder does not own, actually or constructively, 10% or more of the total combined voting power of all classes of MetLife, Inc. stock entitled to vote, (b)&nbsp;such <FONT STYLE="white-space:nowrap">non-United</FONT> States holder is not a
controlled foreign corporation, within the meaning of Section&nbsp;957(a) of the Code, that is related, actually or constructively, to MetLife, Inc. through stock ownership and (c)&nbsp;such <FONT STYLE="white-space:nowrap">non-United</FONT> States
holder complies with applicable certification requirements related to its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status including, in general, furnishing an IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or other applicable Form <FONT STYLE="white-space:nowrap">W-8.</FONT> A <FONT STYLE="white-space:nowrap">non-United</FONT> States holder will also generally not be
subject to U.S. federal withholding tax on payments of principal and interest (including OID, if applicable) effectively connected to such holder&#146;s U.S. trade or business if such <FONT STYLE="white-space:nowrap">non-United</FONT> States holder
provides the appropriate documentation (generally, IRS Form <FONT STYLE="white-space:nowrap">W-8ECI)</FONT> to the applicable withholding agent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A <FONT STYLE="white-space:nowrap">non-United</FONT> States holder will generally not be subject to U.S.
federal income or withholding tax on amounts treated as gain realized on the sale, exchange, redemption or other disposition of a Debenture unless such gain is effectively connected with the conduct of a trade or business in the United States by
such <FONT STYLE="white-space:nowrap">non-United</FONT> States holder, in which event such gain generally will be subject to U.S. federal income tax in the manner described in (iii)&nbsp;below. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a <FONT STYLE="white-space:nowrap">non-United</FONT> States holder is engaged in the conduct of a trade or
business in the United States (or, if an applicable income tax treaty applies, has a U.S. permanent establishment), and if </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
amounts treated as interest on a Debenture (including OID, if applicable) or gain recognized on the sale, exchange, redemption or other disposition of a Debenture are effectively connected with
such U.S. trade or business (or, if an applicable income tax treaty applies, are attributable to a U.S. permanent establishment), such <FONT STYLE="white-space:nowrap">non-United</FONT> States holder generally will not be subject to the 30% U.S.
federal withholding tax on such interest or gain described above; provided that, in the case of the above-described withholding tax on amounts treated as interest, such <FONT STYLE="white-space:nowrap">non-United</FONT> States holder provides the
appropriate documentation (generally, IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI)&nbsp;to</FONT> the applicable withholding agent. Instead, <FONT STYLE="white-space:nowrap">such&nbsp;non-United&nbsp;States</FONT> holder generally will be
subject to U.S. federal income tax on such interest or gain in substantially the same manner as a United States holder </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(except as provided by an applicable income tax treaty). In addition, <FONT STYLE="white-space:nowrap">a&nbsp;non-United&nbsp;States</FONT>
holder that is treated as a corporation for U.S. federal income tax purposes may be subject to a branch profits tax at a rate of 30% (or a lower rate if provided by an applicable income tax treaty) on its effectively connected income for the taxable
year, subject to certain adjustments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FATCA Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Sections 1471 through 1474 of the Code, commonly known as the Foreign Account Tax Compliance Act (&#147;<I>FATCA</I>&#148;), a 30%
withholding tax (&#147;<I>FATCA withholding</I>&#148;) may be imposed on certain payments to <FONT STYLE="white-space:nowrap">a&nbsp;non-United&nbsp;States</FONT> holder or to certain foreign financial institutions, investment funds and <FONT
STYLE="white-space:nowrap">other&nbsp;non-United&nbsp;States</FONT> persons receiving payments on a holder&#146;s behalf if <FONT STYLE="white-space:nowrap">such&nbsp;non-United&nbsp;States</FONT> holder or such persons fail to comply with certain
information reporting requirements. Payments of interest that <FONT STYLE="white-space:nowrap">a&nbsp;non-United&nbsp;States</FONT> holder receives in respect of the Debentures could be affected by this withholding if
<FONT STYLE="white-space:nowrap">such&nbsp;non-United&nbsp;States</FONT> holder is subject to the FATCA information reporting requirements and fails to comply with them or if a holder holds Debentures through
<FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;person</FONT> (e.g., a foreign bank or broker) that fails to comply with these requirements (even if payments to such holder would not otherwise have been subject to FATCA withholding). Holders
should consult their own tax advisors regarding the relevant U.S. law and other official guidance on FATCA withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depending on its
circumstances, a holder may be entitled to a refund or credit in respect of some or all of this withholding. However, even if a holder is entitled to have any such withholding refunded, the required procedures could be cumbersome and significantly
delay the holder&#146;s receipt of any amounts withheld. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Current provisions of the Code and Treasury regulations that govern FATCA treat
gross proceeds from the sale or other disposition of debt obligations that can produce U.S.-source interest (such as the Debentures) as subject to FATCA withholding. However, under proposed Treasury regulations (the preamble to which specifies that
taxpayers are permitted to rely on them pending finalization), such gross proceeds are not subject to FATCA withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Documentation
that holders provide in order to be treated as FATCA compliant may be reported to the IRS and other tax authorities, including information about a holder&#146;s identity, its FATCA status, and if applicable, its direct and indirect U.S. owners.
Prospective investors should consult their own tax advisers about how information reporting and the possible imposition of withholding tax under FATCA may apply to their investment in the Debentures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Backup Withholding and Information Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding and information reporting requirements generally apply to interest and principal payments (including payments of OID, if
applicable) made to, and to the proceeds of sales by, certain <FONT STYLE="white-space:nowrap">non-corporate</FONT> United States holders. A United States holder not otherwise exempt from backup withholding generally can avoid backup withholding by
providing IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-9.</FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of <FONT STYLE="white-space:nowrap">a&nbsp;non-United&nbsp;States</FONT> holder,
backup withholding and information reporting will not apply to payments on, or proceeds from the sale, exchange, redemption or other disposition of, a Debenture if the certification referred to in clause (i)(c) of the paragraph under the <FONT
STYLE="white-space:nowrap">heading&nbsp;&#147;&#151;Non-United&nbsp;States</FONT> Holders&#148; has been received. Withholding agents must nevertheless report to the IRS and to <FONT STYLE="white-space:nowrap">each&nbsp;non-United&nbsp;States</FONT>
holder the amount of interest (including OID, if applicable) paid with respect to the Debentures held by <FONT STYLE="white-space:nowrap">such&nbsp;non-United&nbsp;States</FONT> holder and the rate of withholding (if any) applicable to <FONT
STYLE="white-space:nowrap">such&nbsp;non-United&nbsp;States</FONT> holder, unless <FONT STYLE="white-space:nowrap">such&nbsp;non-United&nbsp;States</FONT> holder is an &#147;exempt recipient&#148; or otherwise establishes an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any amounts withheld under the backup withholding rules will be allowed as a refund or a credit against the holder&#146;s U.S. federal income
tax liability,<I>&nbsp;provided</I>&nbsp;the required information is timely furnished to the IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_11"></A>CERTAIN ERISA CONSIDERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A fiduciary of a pension, profit-sharing or other employee benefit plan subject to the Employee Retirement Income Security Act of 1974, as
amended (&#147;<I>ERISA</I>,&#148; and each such plan and any entity or account holding the &#147;plan assets&#148; of such plan, a &#147;<I>plan</I>&#148;), should consider the fiduciary standards of ERISA in the context of the plan&#146;s
particular circumstances before authorizing an investment in the Debentures. Among other factors, the fiduciary should consider whether the investment would satisfy the prudence and diversification requirements of ERISA and would be consistent with
the documents and instruments governing the plan, and whether the investment would involve a prohibited transaction under ERISA or the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;406 of ERISA and Section&nbsp;4975 of the Code prohibit plans, as well as individual retirement accounts
(&#147;<I>IRAs</I>&#148;), Keogh plans, any other plans that are subject to Section&nbsp;4975 of the Code and any entities or accounts holding the &#147;plan assets&#148; of the foregoing (also &#147;<I>plans</I>&#148;), from engaging in certain
transactions involving &#147;plan assets&#148; with persons who are &#147;parties in interest&#148; under ERISA or &#147;disqualified persons&#148; under the Code with respect to the plan. A violation of these prohibited transaction rules may result
in excise tax or other liabilities under ERISA or the Code for those persons, unless exemptive relief is available under an applicable statutory, regulatory or administrative exemption. Employee benefit plans that are governmental plans (as defined
in Section&nbsp;3(32) of ERISA), certain church plans (as defined in Section&nbsp;3(33) of ERISA) <FONT STYLE="white-space:nowrap">and&nbsp;non-U.S.&nbsp;plans</FONT> (as described in Section&nbsp;4(b)(4) of ERISA) (&#147;<I><FONT
STYLE="white-space:nowrap">non-ERISA</FONT></I><I></I><I>&nbsp;arrangements</I>&#148;) are not subject to the requirements of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code but may be subject to similar provisions under applicable
federal, state, <FONT STYLE="white-space:nowrap">local,&nbsp;non-U.S.&nbsp;or</FONT> other laws (&#147;<I>similar laws</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. and certain of its affiliates may each be considered a party in interest and a disqualified person with respect to many plans.
The acquisition, holding or disposition of the Debentures by a plan with respect to which MetLife, Inc., the underwriters or any of their respective affiliates is or becomes a party in interest or disqualified person may result in a prohibited
transaction under ERISA or Section&nbsp;4975 of the Code, unless the Debentures are acquired, held or disposed of pursuant to an applicable exemption. The U.S. Department of Labor has issued several prohibited transaction class exemptions, or
&#147;<I>PTCEs</I>,&#148; that may provide exemptive relief if required for direct or indirect prohibited transactions that may arise from the acquisition, holding or disposition of the Debentures. These exemptions include <FONT
STYLE="white-space:nowrap">PTCE&nbsp;84-14&nbsp;(for</FONT> certain transactions determined by independent qualified professional asset managers), <FONT STYLE="white-space:nowrap">PTCE&nbsp;90-1&nbsp;(for</FONT> certain transactions involving
insurance company pooled separate accounts), <FONT STYLE="white-space:nowrap">PTCE&nbsp;91-38&nbsp;(for</FONT> certain transactions involving bank collective investment funds), <FONT STYLE="white-space:nowrap">PTCE&nbsp;95-60&nbsp;(for</FONT>
transactions involving certain insurance company general accounts) and <FONT STYLE="white-space:nowrap">PTCE&nbsp;96-23&nbsp;(for</FONT> transactions managed <FONT STYLE="white-space:nowrap">by&nbsp;in-house&nbsp;asset</FONT> managers). In addition,
ERISA Section&nbsp;408(b)(17) and Section&nbsp;4975(d)(20) of the Code may provide an exemption for the acquisition and disposition of the Debentures,<I>&nbsp;provided</I><I></I>&nbsp;that neither MetLife, Inc. nor any of its affiliates have or
exercise any discretionary authority or control or render any investment advice with respect to the assets of any plan involved in the transaction, and<I>&nbsp;provided</I><I></I>&nbsp;further that the plan pays no more and receives no less than
&#147;adequate consideration&#148; in connection with the transaction (the &#147;<I>service provider exemption</I>&#148;). There can be no assurance that all of the conditions of any such exemptions will be satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the foregoing, the Debentures should not be acquired or held by any person investing &#147;plan assets&#148; of any plan <FONT
STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement,</FONT> unless such acquisition and holding will not constitute <FONT STYLE="white-space:nowrap">a&nbsp;non-exempt&nbsp;prohibited</FONT> transaction under ERISA and the Code or a similar
violation of any applicable similar laws. Neither this discussion nor anything in this prospectus supplement is or is intended to be investment advice directed at any potential acquiror or holder that is a plan
<FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement,</FONT> or at such acquirors or holders generally, and such acquirors and holders should consult and rely on their counsel and advisors as to whether an investment in the Debentures
is suitable and consistent with ERISA, the Code and any similar laws, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any acquiror or holder of the Debentures or any
interest therein will be deemed to have represented by its acquisition and holding of the Debentures or any interest therein that it either (1)&nbsp;is not a plan or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">a&nbsp;non-ERISA&nbsp;arrangement</FONT> and is not acquiring or holding the Debentures on behalf of or with the assets of any plan
<FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement</FONT> or (2)&nbsp;the acquisition, holding and disposition of the Debentures will not constitute <FONT STYLE="white-space:nowrap">a&nbsp;non-exempt&nbsp;prohibited</FONT>
transaction or a similar violation under any applicable similar laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the complexity of these rules and the penalties that may be
imposed upon persons involved in nonexempt prohibited transactions, it is important that fiduciaries or other persons considering acquiring the Debentures on behalf of or with the assets of any plan
<FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement</FONT> consult with their counsel regarding the availability of exemptive relief under any of the PTCEs listed above or the service provider exemption or the potential consequences
of any acquisition, holding or disposition under similar laws, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acquirors of the Debentures have exclusive responsibility
for ensuring that their acquisition, holding and disposition of the Debentures do not violate the fiduciary or prohibited transaction rules of ERISA or the Code or any similar provisions of similar laws. The transfer of any Debentures to a plan <FONT
STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement</FONT> is in no respect a representation by MetLife, Inc. or any of its affiliates or representatives that an investment in the Debentures meets all relevant legal requirements with
respect to investments by any such plans <FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangements</FONT> generally or any particular plan <FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement</FONT> or that such investment
is appropriate for such plans <FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangements</FONT> generally or any particular plan <FONT STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement.</FONT> None of the MetLife, Inc., the
underwriters or any of their respective affiliates has provided (or will provide) any investment advice or make any recommendation, including, without limitation, in a fiduciary capacity, with respect to the investment in the Debentures by any plan <FONT
STYLE="white-space:nowrap">or&nbsp;non-ERISA&nbsp;arrangement.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_12"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions of the Underwriting Agreement, dated&#8195;&#8195;&#8195;, 2025 (the &#147;<I>Underwriting
Agreement</I>&#148;), and the Pricing Agreement, dated&#8195;&#8195;&#8195;, 2025, MetLife, Inc. has agreed to sell to each of the underwriters named below, severally, and each of the underwriters has severally agreed to purchase, the principal
amount of the Debentures set forth opposite its name below. BNP Paribas Securities Corp., BofA Securities, Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Morgan Stanley&nbsp;&amp; Co. LLC and TD Securities (USA) LLC will act as
joint bookrunners for the offering and are the representatives of the underwriters. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount&nbsp;of<BR>Debentures</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deutsche Bank Securities Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement provides that the obligations of the several underwriters to purchase the
Debentures offered hereby are subject to approval of certain legal matters by counsel and to certain other conditions. The underwriters are committed to take and pay for all of the Debentures being offered, if any Debentures are taken. In the event
of default by any underwriter, the Underwriting Agreement provides that, in certain circumstances, the purchase commitments of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may be increased, or the Underwriting Agreement
may be terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters initially propose to offer the Debentures to the public at the price to the public set forth on the
cover page of this prospectus supplement. The offering of the Debentures by the underwriters is subject to receipt and acceptance, and the underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in
whole or in part. Any Debentures sold by the underwriters to securities dealers may be sold at a discount of up to&#8195;&#8195;&#8195;% of the principal amount of the Debentures from the price to the public. Any such securities dealers may resell
any Debentures purchased from the underwriters to certain other brokers or dealers at a discount of up to&#8195;&#8195;&#8195;% of the principal amount of the Debentures from the initial public offering price. After the initial offering of the
Debentures to the public, the offering price and the other selling terms may be varied from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures are a new issue
of securities with no established trading market and will not be listed on any national securities exchange. The underwriters have advised us that they intend to make a market for the Debentures, but they have no obligation to do so and may
discontinue market making at any time without providing any notice. No assurance can be given as to the liquidity of any trading market for the Debentures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the underwriting discount, MetLife, Inc. estimates that its expenses for the offering of the Debentures will be approximately
$2.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. has agreed to indemnify the underwriters against certain liabilities, including liabilities under the
Securities Act of 1933, as amended, or to contribute to payments which the underwriters may be required to make in respect of any such liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the representatives may engage in transactions that stabilize, maintain or otherwise affect the price of the
Debentures. Specifically, the representatives may overallot in connection with the offering, creating a syndicate short position. In addition, the representatives may bid for, and purchase, Debentures in the open market to cover syndicate short
positions or to stabilize the price of the Debentures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Finally, the representatives may reclaim selling concessions allowed for distributing the Debentures in the offering, if the representatives repurchase previously distributed Debentures in
syndicate covering transactions, stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the Debentures above independent market levels. The representatives are not required to engage in any of
these activities, may end any of them at any time, and must bring them to an end after a limited period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters and their
respective affiliates are full service financial institutions engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging,
market making, brokerage and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities and services. In the ordinary course of their respective businesses, the underwriters and their affiliates have engaged, and may in the
future engage, in commercial, investment or retail banking transactions with MetLife, Inc. and its affiliates for which they have in the past received, and may in the future receive, customary fees and commissions for these transactions. Certain of
the underwriters or their affiliates are lenders under MetLife&#146;s credit agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business
activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their
own account and for the accounts of their customers. Such investment and securities activities may involve securities and/or instruments of MetLife, Inc. or its affiliates. If any of the underwriters or their affiliates have a lending relationship
with us, certain of those underwriters or their affiliates routinely hedge, and certain other of those underwriters may hedge, their credit exposure to us consistent with their customary risk management policies. Typically, these underwriters and
their affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit default swaps or the creation of short positions in our securities, including potentially the Debentures offered hereby. Any such
credit default swaps or short positions could adversely affect future trading prices of the Debentures offered hereby. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent
research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Alternative Settlement Cycle </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is
expected that delivery of the Debentures will be made to investors on or about&#8195;&#8195;&#8195;, 2025, which is the&#8195;&#8195;&#8195;business day following the date of this prospectus supplement (such settlement being referred to as
&#147;<I>T+</I><I></I><I>&#8195;</I><I>&#8195;</I><I>&#8195;</I>&#148; ). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Exchange Act, trades in the secondary market are required to settle in one business day, unless the parties
to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade their Debentures more than one business day prior to the settlement date will be required, by virtue of the fact that the Debentures initially will settle
T+&#8195;, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement, and so should consult their own advisors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Offering Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>European
Economic Area </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area (&#147;<I>EEA</I>&#148;), no Debentures, which are
the subject of the offering contemplated by this prospectus supplement and the accompanying prospectus have been offered, sold or otherwise made available or will be offered, sold or otherwise made available to any retail investor in the EEA. For
the purposes of this provision: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;<I>retail investor</I>&#148; means a person who is one (or more) of the following:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended,
&#147;<I>MiFID II</I>&#148;); or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a customer within the meaning of the Directive (EU) 2016/97 (as amended, the &#147;<I>Insurance Distribution
Directive</I>&#148;), where that customer would not qualify as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not a qualified investor as defined in Regulation (EU) 2017/1129 (the &#147;<I>Prospectus
Regulation</I>&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;<I>offer</I>&#148; includes the communication in any form and by any means of sufficient
information on the terms of the offer and the Debentures to be offered so as to enable an investor to decide to purchase or subscribe for the Debentures. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>United Kingdom </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No
Debentures, which are the subject of the offering contemplated by this prospectus supplement and the accompanying prospectus have been offered, sold or otherwise made available or will be offered, sold or otherwise made available to any retail
investor in the United Kingdom (the &#147;<I>UK</I>&#148;). For the purposes of this provision: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;<I>retail investor</I>&#148; means a person who is one (or more) of the following:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a retail client as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it forms part of
domestic law by virtue of the European Union (Withdrawal) Act 2018 (&#147;<I>EUWA</I>&#148;); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (as amended, the
&#147;<I>FSMA</I>&#148;) and any rules or regulations made under the FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client, as defined in point (8)&nbsp;of Article 2(1) of Regulation
(EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">not a qualified investor as defined in the Prospectus Regulation as it forms part of domestic law by virtue of
the EUWA (the &#147;<I>UK Prospectus Regulation</I>&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;<I>offer</I>&#148; includes the communication in any form and by any means of sufficient
information on the terms of the offer and the Debentures to be offered so as to enable an investor to decide to purchase or subscribe for the Debentures. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has represented and agreed that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has only communicated or caused to be communicated and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the FSMA) received by it in connection with the issue or sale of the Debentures which are the subject of the offering contemplated by this prospectus
supplement and the accompanying prospectus in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to MetLife, Inc.; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it
in relation to the Debentures in, from or otherwise involving the UK. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This prospectus supplement and the accompanying prospectus are only being distributed to, and are only directed
at (i)&nbsp;persons outside the UK, or (ii)&nbsp;in the UK, persons (A)&nbsp;who are &#147;<I>qualified investors</I>&#148; (as defined in the UK Prospectus Regulation), (B) who have professional experience in matters relating to investments falling
within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the &#147;<I>Order</I>&#148;), (C) who are high net worth entities falling within Article 49(2)(a) to (D)&nbsp;of the Order, or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other persons to whom it may lawfully be communicated (all such persons together being referred to as
&#147;<I>relevant persons</I>&#148;). Accordingly, such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the UK. This prospectus supplement and the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
accompanying prospectus must not be acted on or relied on in the UK by persons who are not relevant persons. In the UK, any investment or investment activity to which this prospectus supplement
and the accompanying prospectus relate are only available to, and will be engaged in with, relevant persons only. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Canada </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Debentures may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection
73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument <FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the
Debentures must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this
prospectus supplement and the accompanying prospectus contains a misrepresentation, <I>provided </I>that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the
purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (&#147;<I>NI <FONT
STYLE="white-space:nowrap">33-105</FONT></I>&#148;), the underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with
this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Debentures may not be offered or sold by means of any document other than (i)&nbsp;in circumstances which do not constitute an offer to the
public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.32, Laws of Hong Kong) or (ii)&nbsp;to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap.571, Laws
of Hong Kong) and any rules made thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap.32,
Laws of Hong Kong), and no advertisement, invitation or document relating to the Debentures may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or
the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to Debentures which are or are intended to be disposed of only to persons outside
Hong Kong or only to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Debentures have not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No.&nbsp;25 of 1948, as amended; the &#147;<I>Financial Instruments and Exchange Act</I>&#148;) and each underwriter has agreed that
it will not offer or sell any Debentures, directly or indirectly, in Japan or to, or for the benefit of, any &#147;<I>resident</I>&#148; of Japan (which term as used herein means any person resident in Japan, including any corporation or other
entity organized under the laws of Japan), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to, or for the benefit of, a resident of Japan, except pursuant to an exemption from the
registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has acknowledged that this prospectus supplement has not been registered as a prospectus with the Monetary Authority of
Singapore. Accordingly, each underwriter has represented, warranted and agreed that it has not offered or sold any Debentures or caused the Debentures to be made the subject of an invitation for subscription or purchase and will not offer or sell
any Debentures or cause the Debentures to be made the subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this prospectus supplement or any other document or material in
connection with the offer or sale, or invitation for subscription or purchase, of the Debentures, whether directly or indirectly, to any person in Singapore other than (i)&nbsp;to an institutional investor (as defined in Section&nbsp;4A of the
Securities and Futures Act 2001 of Singapore, as modified or amended from time to time (the &#147;<I>SFA</I>&#148;)) pursuant to Section&nbsp;274 of the SFA or (ii)&nbsp;to an accredited investor (as defined in Section&nbsp;4A of the SFA) pursuant
to and in accordance with the conditions specified in Section&nbsp;275 of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Singapore SFA Product Classification &#150; In
connection with Section&nbsp;309B of the SFA and the CMP Regulations 2018, unless otherwise specified before an offer of Debentures, MetLife, Inc. has determined, and hereby notifies all relevant persons (as defined in Section&nbsp;309A(1) of the
SFA) that the Debentures are &#147;prescribed capital markets products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale
of Investment Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>South Korea </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Debentures may not be offered, sold and delivered directly or indirectly, or offered or sold to any person for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in South Korea or to any resident of South Korea
except pursuant to the applicable laws and regulations of South Korea, including the Financial Investment Services and Capital Markets Act and the Foreign Exchange Transaction Law and the decrees and regulations thereunder. The Debentures have not
been registered with the Financial Services Commission of South Korea for public offering in South Korea. Furthermore, the Debentures may not be <FONT STYLE="white-space:nowrap">re-sold</FONT> to South Korean residents unless the purchaser of the
Debentures complies with all applicable regulatory requirements (including but not limited to government approval requirements under the Foreign Exchange Transaction Law and its subordinate decrees and regulations) in connection with their purchase.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Switzerland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement is not intended to constitute an offer or solicitation to purchase or invest in the Debentures. The Debentures may
not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act (&#147;<I>FinSA</I>&#148;) and no application has or will be made to admit the Debentures to trading on any trading venue
(exchange or multilateral trading facility) in Switzerland. Neither this prospectus supplement nor any other offering or marketing material relating to the Debentures constitutes a prospectus pursuant to the FinSA, and neither this prospectus
supplement nor any other offering or marketing material relating to the Debentures may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Taiwan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Debentures have not been and will not be registered or filed with, or approved by, the Financial Supervisory Commission of Taiwan and/or any other regulatory authority of Taiwan pursuant to relevant securities laws and regulations and may not be
sold, issued or offered within Taiwan through a public offering or in circumstances which constitute an offer within the meaning of the Securities and Exchange Act of Taiwan or relevant laws and regulations that requires registration with or
approval of the Financial Supervisory Commission of Taiwan and/or other regulatory authority of Taiwan. No person or entity in Taiwan has been authorized to offer, sell, distribute, give advice regarding or otherwise intermediate the offering and
sale of the Debentures in Taiwan or the provision of information relating to this prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By accepting this prospectus supplement and the accompanying prospectus or by subscribing to
the Debentures, investors are deemed to have acknowledged and agreed to abide by these restrictions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_13"></A>LEGAL OPINIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain legal matters will be passed upon for MetLife, Inc. by Timothy J. Ring, Senior Vice President&nbsp;&amp; Secretary of MetLife Group,
Inc., an affiliate of MetLife, Inc. Timothy J. Ring is paid a salary by an affiliate of MetLife, Inc., is a participant in various employee benefit plans offered by MetLife, Inc. and its affiliates to employees generally, is paid equity-based
compensation in accordance with MetLife&#146;s compensation programs and owns MetLife, Inc. common stock. Certain legal matters, including the validity of the Debentures, will be passed upon by Willkie Farr&nbsp;&amp; Gallagher LLP, New York, New
York. Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP, New York, New York is acting as counsel to the underwriters. Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP has in the past provided, and continues to provide, legal services to MetLife.
Willkie Farr&nbsp;&amp; Gallagher LLP and Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP each maintain various group insurance policies with Metropolitan Life Insurance Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supptx939353_14"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements of MetLife, Inc., as of December&nbsp;31, 2024 and 2023, and for each of the three years in the period ended
December&nbsp;31, 2024, incorporated by reference in this prospectus supplement by reference to MetLife, Inc.&#146;s annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024, and the effectiveness
of MetLife, Inc.&#146;s internal control over financial reporting have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by
reference in reliance upon the reports of such firm given their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>METLIFE, INC. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt
Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Preferred Stock </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Depositary Shares </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common
Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Purchase Contracts </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units
</B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may offer these securities, or any combination thereof, from time to time in amounts, at prices and on other terms to be
determined at the time of the offering. MetLife, Inc. will provide the specific terms of these securities in supplements to this prospectus. You should read this prospectus and the accompanying prospectus supplement carefully before you make your
investment decision. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS PROSPECTUS MAY NOT BE USED TO SELL SECURITIES UNLESS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may offer securities through underwriting syndicates managed or <FONT STYLE="white-space:nowrap">co-managed</FONT> by one or
more underwriters, through agents, or directly to purchasers. The prospectus supplement for each offering of securities will describe in detail the plan of distribution for that offering. For general information about the distribution of securities
offered, please see &#147;Plan of Distribution&#148; in this prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s common stock is listed on the New York
Stock Exchange under the trading symbol &#147;MET.&#148; Unless otherwise stated in this prospectus or an accompanying prospectus supplement, none of these securities will be listed on a securities exchange, other than MetLife, Inc.&#146;s common
stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. or any of its affiliates may use this prospectus and the applicable prospectus supplement in a remarketing or other
resale transaction involving the securities after their initial sale. These transactions may be executed at negotiated prices that are related to market prices at the time of purchase or sale, or at other prices, as determined from time to time.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in MetLife, Inc.&#146;s securities involves risks. See &#147;<A HREF="#rom939353_2">Risk Factors</A>&#148; on page&nbsp;1 of
this prospectus. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>None of the Securities and Exchange Commission, any state securities commission, the New York Superintendent of
Financial Services or any other regulatory body has approved or disapproved of these securities or determined if this prospectus or the accompanying prospectus supplement is truthful or complete. They have not made, nor will they make, any
determination as to whether anyone should buy these securities. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date
of this prospectus is November&nbsp;17, 2022 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc1"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_2">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_3">SPECIAL NOTE&nbsp;REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_4">NOTE REGARDING RELIANCE ON STATEMENTS IN OUR CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_5">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_6">METLIFE, INC.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_7">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_8">DESCRIPTION OF SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_9">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_10">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_11">DESCRIPTION OF DEPOSITARY SHARES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_12">DESCRIPTION OF WARRANTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_13">DESCRIPTION OF PURCHASE CONTRACTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_14">DESCRIPTION OF UNITS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_15">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_16">LEGAL OPINION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom939353_17">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise stated or the context otherwise requires, references in this prospectus to &#147;MetLife,&#148; &#147;we,&#148;
&#147;our,&#148; &#147;us,&#148; or &#147;the Company&#148; refer to MetLife, Inc., a Delaware corporation incorporated in 1999, together with its subsidiaries and affiliates, while references to &#147;MetLife, Inc.&#148; refer only to the holding
company on an unconsolidated basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that MetLife, Inc. filed with the
U.S.&nbsp;Securities and Exchange Commission (the &#147;<I>SEC</I>&#148;) using a &#147;shelf&#148; registration process. Under this shelf process, MetLife, Inc. may, from time to time, sell any combination of debt securities, preferred stock,
depositary shares, common stock, warrants, purchase contracts and units in one or more offerings in one or more currencies, currency units or composite currencies. This prospectus provides you with a general description of the securities MetLife,
Inc. may offer. Each time that securities are sold, a prospectus supplement that will contain specific information about the terms of that offering will be provided. The prospectus supplement may also add, update or change information contained in
this prospectus. You should read both this prospectus and any prospectus supplement together with additional information described under the heading &#147;Where You Can Find More Information.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should rely on the information contained or incorporated by reference in this prospectus. MetLife, Inc. has not authorized anyone to
provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. MetLife, Inc. is not making an offer to sell these securities in any jurisdiction where the offer or sale is not
permitted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should assume that the information in this prospectus is accurate as of the date of the prospectus. Our business,
financial condition, results of operations and prospects may have changed since that date. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_2"></A>RISK FACTORS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in MetLife, Inc.&#146;s securities involves risks. We urge you to carefully consider the risk factors described in our
filings with the SEC that are incorporated by reference in this prospectus and in any prospectus supplement, pricing supplement or free writing prospectus used in connection with an offering of our securities, as well as the information relating to
us identified herein in &#147;Special Note Regarding Forward-Looking Statements,&#148; before making an investment decision. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_3"></A>SPECIAL NOTE&nbsp;REGARDING FORWARD-LOOKING STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus and the accompanying prospectus supplement may contain or
incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events and
do not relate strictly to historical or current facts. They use words and terms such as &#147;anticipate,&#148; &#147;assume,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148;
&#147;if,&#148; &#147;intend,&#148; &#147;likely,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;project,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would&#148; and other words and terms of similar meaning or that are
otherwise tied to future periods or future performance, in each case in all derivative forms. They include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or
products, future sales efforts, future expenses, the outcome of contingencies such as legal proceedings, and future trends in operations and financial results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many factors determine MetLife&#146;s results, and they involve unpredictable risks and uncertainties. Our forward-looking statements depend
on our assumptions, our expectations, and our understanding of the economic environment, but they may be inaccurate and may change. We do not guarantee any future performance. Our results could differ materially from those we express or imply in
forward-looking statements. The risks, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
uncertainties and other factors, including those relating to the COVID-19 pandemic, identified in MetLife, Inc.&#146;s filings with the SEC, and others, may cause such differences. These factors
include: (1)&nbsp;economic condition difficulties, including risks relating to public health, interest rates, credit spreads, equity, real estate, obligors and counterparties, currency exchange rates, derivatives, and terrorism and security;
(2)&nbsp;global capital and credit market adversity; (3)&nbsp;credit facility inaccessibility; (4)&nbsp;financial strength or credit ratings downgrades; (5)&nbsp;unavailability, unaffordability, or inadequate reinsurance; (6)&nbsp;statutory life
insurance reserve financing costs or limited market capacity; (7)&nbsp;legal, regulatory, and supervisory and enforcement policy changes; (8)&nbsp;changes in tax rates, tax laws or interpretations; (9)&nbsp;litigation and regulatory investigations;
(10)&nbsp;London Interbank Offered Rate discontinuation and transition to alternative reference rates; (11)&nbsp;unsuccessful efforts to meet all environmental, social, and governance standards or to enhance our sustainability; (12)&nbsp;MetLife,
Inc.&#146;s inability to pay dividends and repurchase common stock; (13)&nbsp;MetLife, Inc.&#146;s subsidiaries&#146; inability to pay it dividends; (14)&nbsp;investment defaults, downgrades, or volatility; (15)&nbsp;investment sales or lending
difficulties; (16)&nbsp;collateral or derivative-related payments; (17)&nbsp;investment valuations, allowances, or impairments changes; (18)&nbsp;claims or other results that differ from our estimates, assumptions, or models; (19)&nbsp;global
political, legal, or operational risks; (20)&nbsp;business competition; (21)&nbsp;technological changes; (22)&nbsp;catastrophes; (23) climate changes or responses to it; (24) deficiencies in our closed block; (25) goodwill or other asset impairment,
or deferred income tax asset allowance; (26) acceleration of amortization of deferred policy acquisition costs, deferred sales inducements, value of business acquired, value of distribution agreements acquired or value of customer relationships
acquired; (27)&nbsp;product guarantee volatility, costs, and counterparty risks; (28) risk management failures; (29) insufficient protection from operational risks; (30)&nbsp;failure to protect confidentiality and integrity of data or other
cybersecurity or disaster recovery failures; (31) accounting standards changes; (32) excessive risk-taking; (33) marketing and distribution difficulties; (34) pension and other postretirement benefit assumption changes; (35)&nbsp;inability to
protect our intellectual property or avoid infringement claims; (36) acquisition, integration, growth, disposition, or reorganization difficulties; (37) Brighthouse Financial, Inc. separation risks; (38) MetLife, Inc.&#146;s Board of Directors
influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and (39)&nbsp;legal- and corporate governance-related effects on business combinations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes
aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in reports to the SEC. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_4"></A>NOTE REGARDING RELIANCE ON STATEMENTS IN OUR CONTRACTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In reviewing the agreements included as exhibits to any of the documents incorporated by reference into this prospectus and any prospectus
supplement, please remember that they are included to provide you with information regarding their terms and are not intended to provide any other factual or disclosure information about MetLife, Inc., its subsidiaries or affiliates, or the other
parties to the agreements. The agreements contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable
agreement and: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the
risk to one of the parties if those statements prove to be inaccurate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have been qualified by disclosures that were made to the other party in connection with the negotiation of the
applicable agreement, which disclosures are not necessarily reflected in the agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may apply standards of materiality in a way that is different from what may be viewed as material to
investors;&nbsp;and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">were made only as of the date of the applicable agreement or such other date or dates as may be specified in the
agreement and are subject to more recent developments. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, these representations and warranties may not describe the actual state of affairs as of the
date they were made or at any other time. Additional information about MetLife, Inc. and its subsidiaries and affiliates may be found elsewhere in this prospectus and the accompanying prospectus supplement, as well as MetLife, Inc.&#146;s other
public filings, which are available without charge through the SEC website at www.sec.gov. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_5"></A>WHERE YOU CAN FIND
MORE INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. files reports, proxy statements and other information with the SEC. The SEC maintains an internet site
at www.sec.gov that contains reports, proxy and information statements and other information regarding companies that file electronically with the SEC, including MetLife, Inc. MetLife, Inc.&#146;s common stock is listed and traded on the New York
Stock Exchange under the symbol &#147;MET.&#148; These reports, proxy statements and other information can also be read at the offices of the New York Stock Exchange, 11 Wall Street, New York, New&nbsp;York 10005. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows &#147;incorporation by reference&#148; into this prospectus of information that MetLife, Inc. files with the SEC. This permits
MetLife, Inc. to disclose important information to you by referencing these filed documents. Any information referenced this way is considered part of this prospectus, and any information filed with the SEC subsequent to the date of this prospectus
will automatically be deemed to update and supersede this information. Information furnished under Item&nbsp;2.02 and Item&nbsp;7.01 of MetLife, Inc.&#146;s Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> is not incorporated
by reference in this registration statement and prospectus. MetLife, Inc. incorporates by reference the following documents which have been filed with the SEC: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000014/met-20211231.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></A> for the year ended December&nbsp;31, 2021 (the &#147;<I>2021 Annual Report</I>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;
10-Q</FONT> for the quarters ended <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000108/met-20220331.htm">March&nbsp;31, 2022</A> (the &#147;<I>First Quarter Form <FONT
STYLE="white-space:nowrap">10-Q</FONT></I>&#148;), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000116/met-20220630.htm">June<U></U>&nbsp;30, 2022</A> (the &#147;<I>Second Quarter Form <FONT
STYLE="white-space:nowrap">10-Q</FONT></I>&#148;) and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000174/met-20220930.htm">September&nbsp;30, 2022</A> (the &#147;<I>Third Quarter Form <FONT
STYLE="white-space:nowrap">10-Q</FONT></I>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Registration Statement on <FONT STYLE="white-space:nowrap">Form&nbsp;
8-A,</FONT> dated <A HREF="http://www.sec.gov/Archives/edgar/data/1099219/000095012300003181/0000950123-00-003181.txt">March<U></U>&nbsp;31, 2000</A>, relating to registration of shares of MetLife, Inc.&#146;s common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The portions of MetLife, Inc.&#146;s Definitive Proxy Statement filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1099219/000114036122016708/ny20001550x1_def14a.htm">April
<U></U>&nbsp;29, 2022</A> for MetLife,&nbsp;Inc.&#146;s Annual Meeting of Stockholders incorporated by reference into the 2021 Annual Report;&nbsp;and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000003/met-20220202.htm">February
 2, 2022</A> (only with respect to Item 8.01 information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000006/met-20220208.htm">February 8, 2022</A> (only with respect to Item 8.01
information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000011/met-20220215.htm">February<U></U>&nbsp;
15, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000059/met-20220307.htm">March 7, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000081/met-20220404.htm">April
 4, 2022</A> as amended by the Form 8-K/A filed <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312522175577/d327708d8ka.htm">June 16, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000106/met-20220504.htm">May
 4, 2022</A> (only with respect to Item 8.01 information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000110/met-20220509.htm">May<U></U>&nbsp;9, 2022</A> (only with respect to Item 8.01
information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312522151787/d288814d8k.htm">May 16, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312522181566/d727999d8k.htm">June&nbsp;24,
 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312522191281/d375895d8k.htm">July 11, 2022</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000118/met-20220808.htm">August
<U></U>&nbsp;
8, 2022</A> (only with respect to Item 8.01 information), <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312522221281/d361772d8k.htm">August 15, 2022</A><B></B>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000109921922000176/met-20221107.htm">November&nbsp;7,
 2022</A> (only with respect to Item 8.01 information) and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1099219/000119312522285799/d404514d8k.htm">November 15, 2022</A>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. incorporates by reference the documents listed above and any future filings made with the SEC in accordance with
Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;<I>Exchange Act</I>&#148;), other than information furnished under Item&nbsp;2.02 or Item&nbsp;7.01 of MetLife, Inc.&#146;s Current Reports on Form
<FONT STYLE="white-space:nowrap">8-K,</FONT> until MetLife, Inc. files a post-effective amendment which indicates the termination or completion of the offering of the securities made by this prospectus. Any such reports filed by MetLife, Inc. with
the SEC, other than information furnished under Item&nbsp;2.02 or Item&nbsp;7.01 of MetLife, Inc.&#146;s Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> on or after the date of this prospectus and before the date that the
offering of the securities by means of this prospectus is terminated or completed will automatically update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will provide without charge upon written or oral request, a copy of any or all of the documents that are incorporated by
reference into this prospectus, other than exhibits to those documents, unless those </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exhibits are specifically incorporated by reference into those documents. Requests should be directed to Investor Relations, MetLife, Inc., 200 Park Avenue, New York, New York 10166 by electronic
mail (metir@metlife.com), or by telephone <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(212-578-9500).</FONT></FONT> You may also obtain the documents incorporated by reference into this prospectus at MetLife&#146;s website,
www.metlife.com. All other information contained on MetLife&#146;s website is not a part of this prospectus, and any references to MetLife&#146;s website are intended to be inactive textual references only. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_6"></A>METLIFE, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife is one of the world&#146;s leading financial services companies, providing insurance, annuities, employee benefits and asset
management. MetLife holds leading market positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife
is also one of the largest institutional investors in the United States with a general account portfolio invested primarily in fixed income securities (corporate, structured products, municipals, and government and agency) and mortgage loans, as
well as real estate, real estate joint ventures, other limited partnerships and equity securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife&#146;s well-recognized brand,
globally diversified and market leading market positions, competitive and innovative product offerings and financial strength and expertise should help drive future growth and enhance shareholder value. The Company will continue to execute on its
Next Horizon strategy, creating value focusing on the following three pillars: focus, simplify and differentiate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife is organized
into five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. In addition, the Company reports certain of its results of operations in Corporate&nbsp;&amp; Other.<I>&nbsp;See</I>&nbsp;&#147;Business &#151;
Segments and Corporate&nbsp;&amp; Other&#148; and Note 2 of the Notes to the Consolidated Financial Statements in the 2021 Annual Report&nbsp;incorporated by reference herein and Note 2 of the Notes to the Interim Condensed Consolidated Financial
Statements in the First, Second and Third Quarter <FONT STYLE="white-space:nowrap">Forms&nbsp;10-Q&nbsp;incorporated</FONT> by reference herein for further information on MetLife&#146;s segments and Corporate&nbsp;&amp; Other. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. is a holding company for its insurance and financial subsidiaries and does not have any significant operations of its own.
Dividends from its subsidiaries and permitted payments to it under its tax sharing arrangements with its subsidiaries are its principal sources of cash to meet its obligations and to pay preferred and common stock dividends. MetLife, Inc.&#146;s
insurance subsidiaries are subject to regulatory restrictions on the payment of dividends imposed by the regulators of their respective domiciles. The dividend limitation for U.S.&nbsp;insurance subsidiaries is based on the surplus to policyholders
at the end of the immediately preceding calendar year and statutory net gain from operations of the immediately preceding calendar year. Statutory accounting practices, as prescribed by insurance regulators of various states in which we conduct
business, differ in certain respects from accounting principles used in financial statements prepared in conformity with accounting principles generally accepted in the United States of America (&#147;<I>GAAP</I>&#148;). The significant differences
relate to the treatment of deferred policy acquisition costs, certain deferred income tax, required investment liabilities, statutory reserve calculation assumptions, goodwill and surplus notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. is incorporated under the laws of the State of Delaware. MetLife, Inc.&#146;s principal executive offices are located at 200
Park Avenue, New York, New York 10166-0188, its telephone number is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-578-9500</FONT></FONT> and its internet address is www.metlife.com. Information contained on MetLife&#146;s
website does not constitute part of this prospectus. This website address is an inactive textual reference and is not intended to be an actual link to the website. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_7"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may use the proceeds of securities sold or <FONT STYLE="white-space:nowrap">re-sold</FONT> under this registration statement for, among
other things, general corporate purposes. The prospectus supplement for each offering of securities will specify the intended use of the proceeds of that offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_8"></A>DESCRIPTION OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains summary descriptions of the debt securities, preferred stock, depositary shares, common stock, warrants, purchase
contracts and units that MetLife, Inc. may sell from time to time. These summary descriptions are not meant to be complete descriptions of each security. However, this prospectus and the applicable prospectus supplement together contain the material
terms of the securities being offered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_9"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this prospectus, debt securities means the debentures, notes, bonds and other evidences of indebtedness that MetLife, Inc. may
issue from time to time. The debt securities will either be senior debt securities or subordinated debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the applicable
prospectus supplement states otherwise, senior debt securities will be issued under the Senior Indenture, dated as of November&nbsp;9, 2001 (the &#147;<I>Senior Indenture</I>&#148;), between MetLife, Inc. and The Bank of New York Mellon Trust
Company, N.A. (as successor in interest to J.P. Morgan Trust Company, National Association (as successor to Bank One Trust Company, N.A.)), as trustee, and subordinated debt securities will be issued under the Subordinated Indenture, dated as of
June&nbsp;21, 2005 (the &#147;<I>Subordinated Indenture</I>&#148;), between MetLife, Inc. and The Bank of New York Mellon Trust Company, N.A. (as successor in interest to J.P. Morgan Trust Company, National Association), as trustee. This prospectus
sometimes refers to the Senior Indenture and the Subordinated Indenture collectively as the &#147;<I>Indentures</I>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Senior
Indenture and the Subordinated Indenture are incorporated by reference as exhibits to the registration statement of which this prospectus forms a part. The statements and descriptions in this prospectus or in any prospectus supplement regarding
provisions of the Indentures and debt securities are summaries thereof, do not purport to be complete and are subject to, and are qualified in their entirety by reference to, all of the provisions of the Indentures and the debt securities, including
the definitions therein of certain terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The debt securities will be direct unsecured obligations of MetLife, Inc. The senior debt securities will rank equally with all of MetLife,
Inc.&#146;s other senior and unsubordinated debt. The subordinated debt securities will be subordinate and junior in right of payment to all of MetLife, Inc.&#146;s present and future senior indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because MetLife, Inc. is principally a holding company, its right to participate in any distribution of assets of any subsidiary, including
Metropolitan Life Insurance Company, upon the subsidiary&#146;s liquidation or reorganization or otherwise, is subject to the prior claims of creditors of the subsidiary, except to the extent MetLife, Inc. may be recognized as a creditor of that
subsidiary. Accordingly, MetLife, Inc.&#146;s obligations under the debt securities will be effectively subordinated to all existing and future indebtedness and liabilities of its subsidiaries, including liabilities under contracts of insurance and
annuities written by MetLife, Inc.&#146;s insurance subsidiaries, and holders of debt securities should look only to MetLife, Inc.&#146;s assets for payment thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indentures do not limit the aggregate principal amount of debt securities that MetLife, Inc. may issue and provide that MetLife, Inc. may
issue debt securities from time to time in one or more series, in each case with the same or various maturities, at par or at a discount. MetLife, Inc. may issue additional debt securities of a particular series without the consent of the holders of
the debt securities of such series outstanding at the time of the issuance. Any such additional debt securities, together with all other outstanding debt securities of that series, will constitute a single series of debt securities under the
applicable Indenture. None of the Indentures limit our ability to incur other debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each prospectus supplement will describe the terms
relating to the specific series of debt securities being offered. These terms will include some or all of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of debt securities and whether they are subordinated debt securities or senior debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices at which MetLife, Inc. will sell the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the maturity date or dates of the debt securities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates of interest, if any, which may be fixed or variable, per annum at which the debt securities
will bear interest, or the method of determining such rate or rates, if any; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates from which any interest will accrue, the dates on which interest will be payable, or the method
by which such date or dates will be determined; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the right, if any, to extend the interest payment periods and the duration of any such deferral period, including
the maximum consecutive period during which interest payment periods may be extended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the amount of payments of principal of (and premium, if any) or interest on the debt securities may be
determined with reference to any index, formula or other method, such as one or more currencies, commodities, equity indices or other indices, and the manner of determining the amount of such payments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which MetLife, Inc. will pay interest on the debt securities and the regular record date for
determining who is entitled to the interest payable on any interest payment date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where the principal of (and premium, if any) and interest on the debt securities will be
payable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if MetLife, Inc. possesses the option to do so, the periods within which and the prices at which MetLife, Inc.
may redeem the debt securities, in whole or in part, pursuant to optional redemption provisions, and the other terms and conditions of any such provisions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc.&#146;s obligation, if any, to redeem, repay or purchase debt securities by making periodic payments
to a sinking fund or through an analogous provision or at the option of holders of the debt securities, and the period or periods within which and the price or prices at which MetLife, Inc. will redeem, repay or purchase the debt securities, in
whole or in part, pursuant to such obligation, and the other terms and conditions of such obligation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and integral
multiples of $1,000; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion, or methods of determining the portion, of the principal amount of the debt securities which MetLife,
Inc. must pay upon the acceleration of the maturity of the debt securities in connection with an Event of Default (as described below), if other than the full principal amount; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency, currencies or currency unit in which MetLife, Inc. will pay the principal of (and premium, if any)
or interest, if any, on the debt securities, if not U.S. dollars and the manner of determining the equivalent thereof in U.S. dollars; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provisions, if any, granting special rights to holders of the debt securities upon the occurrence of specified
events; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any deletions from, modifications of or additions to the Events of Default or MetLife, Inc.&#146;s covenants with
respect to the applicable series of debt securities, and whether or not such Events of Default or covenants are consistent with those contained in the applicable Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the application, if any, of the terms of the Indenture relating to defeasance and covenant defeasance (which
terms are described below) to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the subordination provisions summarized below or different subordination provisions will apply to the
debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms, if any, upon which the holders may or are required to convert or exchange such debt securities into or
for MetLife, Inc.&#146;s common stock or other securities or property or into securities of a third party, including conversion price (which may be adjusted), the method of calculating the conversion price, or the conversion period;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any of the debt securities will be issued in global or certificated form and, if so, the terms and
conditions upon which global debt securities may be exchanged for certificated debt securities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any change in the right of the trustee or the requisite holders of debt securities to declare the principal
amount thereof due and payable because of an Event of Default; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the depositary for global or certificated debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, a discussion of certain material U.S.&nbsp;federal income tax considerations applicable to
specific debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any trustees, authenticating or paying agents, transfer agents or registrars or other agents with respect to the
debt securities;&nbsp;and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the debt securities not inconsistent with the provisions of the Indentures, as amended or
supplemented. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the debt securities will not be
listed on any securities exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified in the applicable prospectus supplement, the debt securities will be issued
in fully registered form without coupons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Debt securities may be sold at a substantial discount below their stated principal amount,
bearing no interest or interest at a rate which at the time of issuance is below market rates. The applicable prospectus supplement will describe the federal income tax consequences and special considerations applicable to any such debt securities.
The debt securities may also be issued as indexed securities or securities denominated in foreign currencies or currency units, as described in more detail in the prospectus supplement relating to any of the particular debt securities. The
prospectus supplement relating to specific debt securities will also describe any special considerations and certain additional tax considerations applicable to such debt securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Subordination </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement
relating to any offering of subordinated debt securities will describe the specific subordination provisions. However, unless otherwise noted in the prospectus supplement, subordinated debt securities will be subordinate and junior in right of
payment to all of MetLife, Inc.&#146;s Senior Indebtedness (as described below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of subordinated debt securities,
&#147;<I>Senior Indebtedness</I>&#148; means all amounts due on obligations in connection with any of the following, whether outstanding at the date of execution of the Subordinated Indenture or thereafter incurred or created: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the principal of (and premium, if any) and interest in respect of indebtedness of MetLife, Inc. for borrowed
money and indebtedness evidenced by securities, debentures, bonds or other similar instruments issued by MetLife, Inc.; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all capital lease obligations of MetLife, Inc.; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all obligations of MetLife, Inc. issued or assumed as the deferred purchase price of property, all conditional
sale obligations of MetLife, Inc. and all obligations of MetLife, Inc. under any title retention agreement (but excluding trade accounts payable in the ordinary course of business); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all obligations of MetLife, Inc. for the reimbursement on any letter of credit, banker&#146;s acceptance,
security purchase facility or similar credit transaction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all obligations of MetLife, Inc. in respect of interest rate swap, cap or other agreements, interest rate future
or options contracts, currency swap agreements, currency future or option contracts and other similar agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all obligations of the types referred to above of other persons for the payment of which MetLife, Inc. is
responsible or liable as obligor, guarantor or otherwise;&nbsp;and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all obligations of the types referred to above of other persons secured by any lien on any property or asset of
MetLife, Inc. (whether or not such obligation is assumed by MetLife, Inc.). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Senior Indebtedness does not include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">indebtedness or monetary obligations to trade creditors created or assumed by MetLife, Inc. in the ordinary
course of business in connection with the obtaining of materials or services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">indebtedness that is, by its terms, subordinated to, or ranks equal with, the subordinated debt
securities;&nbsp;and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any indebtedness of MetLife, Inc. to its affiliates (including all debt securities and guarantees in respect of
those debt securities issued to any trust, partnership or other entity affiliated with MetLife, Inc. that is a financing vehicle of MetLife, Inc. in connection with the issuance by such financing entity of preferred securities or other securities
guaranteed by MetLife, Inc.) unless otherwise expressly provided in the terms of any such indebtedness. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of
Senior Indebtedness which MetLife, Inc. may issue is subject to limitations imposed by its board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Senior Indebtedness will
continue to be Senior Indebtedness and be entitled to the benefits of the subordination provisions irrespective of any amendment, modification or waiver of any term of such Senior Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise noted in the accompanying prospectus supplement, if MetLife, Inc. defaults in the payment of any principal of (or premium, if
any) or interest on any Senior Indebtedness when it becomes due and payable, whether at maturity or at a date fixed for prepayment or by declaration or otherwise, then, unless and until such default is cured or waived or ceases to exist, MetLife,
Inc. will make no direct or indirect payment (in cash, property, securities, by <FONT STYLE="white-space:nowrap">set-off</FONT> or otherwise) in respect of the principal of or interest on the subordinated debt securities or in respect of any
redemption, retirement, purchase or other requisition of any of the subordinated debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of the acceleration of the
maturity of any subordinated debt securities, the holders of all senior debt securities outstanding at the time of such acceleration will first be entitled to receive payment in full of all amounts due on the senior debt securities before the
holders of the subordinated debt securities will be entitled to receive any payment of principal (and premium, if any) or interest on the subordinated debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of the following events occurs, MetLife, Inc. will pay in full all Senior Indebtedness before it makes any payment or distribution
under the subordinated debt securities, whether in cash, securities or other property, to any holder of subordinated debt securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> or liquidation or reorganization of
MetLife, Inc., whether voluntary or involuntary or in bankruptcy, insolvency or receivership; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any general assignment by MetLife, Inc. for the benefit of creditors;&nbsp;or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other marshaling of MetLife, Inc.&#146;s assets or liabilities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In such event, any payment or distribution under the subordinated debt securities, whether in cash, securities or other property, which would
otherwise (but for the subordination provisions) be payable or deliverable in respect of the subordinated debt securities, will be paid or delivered directly to the holders of Senior Indebtedness in accordance with the priorities then existing among
such holders until all Senior Indebtedness has been paid in full. If any payment or distribution under the subordinated debt securities is received by the trustee of any subordinated debt securities in contravention of any of the terms of the
Subordinated Indenture and before all the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Senior Indebtedness has been paid in full, such payment or distribution or security will be received in trust for the benefit of, and paid over or delivered and transferred to, the holders of the
Senior Indebtedness at the time outstanding in accordance with the priorities then existing among such holders for application to the payment of all Senior Indebtedness remaining unpaid to the extent necessary to pay all such Senior Indebtedness in
full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the Indentures limit the issuance of additional Senior Indebtedness. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrictive Covenants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless an
accompanying prospectus supplement states otherwise, the following restrictive covenants will apply to each series of senior debt securities: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Limitation on Liens.</I>&nbsp;So long as any senior debt securities are outstanding, neither MetLife, Inc. nor any of its subsidiaries will
create, assume, incur or guarantee any debt which is secured by any mortgage, pledge, lien, security interest or other encumbrance on any capital stock of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Metropolitan Life Insurance Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any successor to substantially all of the business of Metropolitan Life Insurance Company which is also a
subsidiary of MetLife, Inc.;&nbsp;or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any corporation (other than MetLife, Inc.) having direct or indirect control of Metropolitan Life Insurance
Company or any such successor. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, this restriction will not apply if the debt securities then outstanding are secured at least
equally and ratably with the otherwise prohibited secured debt so long as it is outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Limitations on Dispositions of Stock of
Certain Subsidiaries.</I>&nbsp;So long as any senior debt securities are outstanding and subject to the provisions of the Senior Indenture regarding mergers, consolidations and sales of assets, neither MetLife, Inc. nor any of its subsidiaries will
sell or otherwise dispose of any shares of capital stock (other than preferred stock having no voting rights of any kind) of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Metropolitan Life Insurance Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any successor to substantially all of the business of Metropolitan Life Insurance Company which is also a
subsidiary of MetLife, Inc.;&nbsp;or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any corporation (other than MetLife, Inc.) having direct or indirect control of Metropolitan Life Insurance
Company or any such successor; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">except for, in each case: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a sale or other disposition of any of such stock to a wholly-owned subsidiary of MetLife, Inc. or of such
subsidiary;&nbsp;or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a sale or other disposition of all of such stock for at least fair value (as determined by MetLife, Inc.&#146;s
board of directors acting in good faith); or a sale or other disposition required to comply with an order of a court or regulatory authority of competent jurisdiction, other than an order issued at MetLife, Inc.&#146;s request or the request of any
of MetLife, Inc.&#146;s subsidiaries. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Limitations on Consolidation, Merger, Sale of Assets and Other Transactions.
</I>(i)&nbsp;MetLife, Inc. may not merge with or into or consolidate with another corporation or sell, assign, transfer, lease or convey all or substantially all of its properties and assets to, any other corporation other than a direct or indirect
wholly-owned subsidiary of MetLife, Inc. and (ii)&nbsp;no corporation may merge with or into or consolidate with MetLife, Inc. or, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
except for any direct or indirect wholly-owned subsidiary of MetLife, Inc., sell, assign, transfer, lease or convey all or substantially all of its properties and assets to MetLife, Inc., unless:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc. is the surviving corporation or the corporation formed by or surviving such merger or consolidation
or to which such sale, assignment, transfer, lease or conveyance has been made, if other than MetLife, Inc., has expressly assumed by supplemental indenture all the obligations of MetLife, Inc. under the debt securities and the Indentures;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after giving effect to such transaction, no default or Event of Default has occurred and is
continuing;&nbsp;and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc. delivers to the trustee an officers&#146; certificate and an opinion of counsel, each stating that
the supplemental indenture complies with the applicable Indenture. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default, Notice and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless an accompanying prospectus supplement states otherwise, the following will constitute &#147;Events of Default&#148; under the Indentures
with respect to each series of debt securities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc.&#146;s failure to pay any interest on any debt security of such series when due and payable,
continued for 30&nbsp;days; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc.&#146;s failure to pay principal (or premium, if any) on any debt security of such series when due,
regardless of whether such payment became due because of maturity, redemption, acceleration or otherwise, or is required by any sinking fund established with respect to such series; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">MetLife, Inc.&#146;s failure to observe or perform any other of its covenants or agreements with respect to such
series for 90&nbsp;days after MetLife, Inc. receives notice of such failure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain defaults with respect to MetLife, Inc.&#146;s debt which result in a principal amount in excess of
$100,000,000 becoming or being declared due and payable prior to the date on which it would otherwise have become due and payable (other than the debt securities or <FONT STYLE="white-space:nowrap">non-recourse</FONT> debt); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain events of bankruptcy, insolvency or reorganization of MetLife, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Event of Default with respect to any debt securities of any series outstanding under either of the Indentures shall occur and be
continuing, the trustee under such Indenture or the holders of at least 25% in aggregate principal amount of the debt securities of that series outstanding may declare, by notice as provided in the applicable Indenture, the principal amount (or such
lesser amount as may be provided for in the debt securities of that series) of all the debt securities of that series outstanding to be due and payable immediately; <I>provided</I> that, in the case of an Event of Default involving certain events in
bankruptcy, insolvency or reorganization, acceleration is automatic; and, <I>provided further</I>, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the
outstanding debt securities of that series may, under certain circumstances, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. Upon the acceleration of the
maturity of original issue discount debt securities, an amount less than the principal amount thereof will become due and payable. Reference is made to the prospectus supplement relating to any original issue discount debt securities for the
particular provisions relating to acceleration of maturity thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any past default under either Indenture with respect to debt
securities of any series, and any Event of Default arising therefrom, may be waived by the holders of a majority in principal amount of all debt securities of such series outstanding under such Indenture, except in the case of (i)&nbsp;default in
the payment of the principal of (or premium, if any) or interest on any debt securities of such series, or (ii)&nbsp;default in respect of a covenant or provision which may not be amended or modified without the consent of the holder of each
outstanding debt security of such series affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee is required, within 90&nbsp;days after the occurrence of a default (which is
known to the trustee and is continuing), with respect to the debt securities of any series (without regard to any grace period or notice requirements), to give to the holders of the debt securities of such series notice of such default; <I>provided,
however</I>, that, except in the case of a default in the payment of the principal of (and premium, if any) or interest, or in the payment of any sinking fund installment, on any debt securities of such series, the trustee will be protected in
withholding such notice if it in good faith determines that the withholding of such notice is in the interests of the holders of the debt securities of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee, subject to its duties during default to act with the required standard of care, may require indemnification by the holders of the
debt securities of any series with respect to which a default has occurred before proceeding to exercise any right or power under the applicable Indenture at the request of the holders of the debt securities of such series. Subject to such right of
indemnification and to certain other limitations, the holders of a majority in aggregate principal amount of the outstanding debt securities of any series under the applicable Indenture may direct the time, method and place of conducting any
proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee with respect to the debt securities of such series. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No holder of a debt security of any series may institute any action against MetLife, Inc. under either of the Indentures (except actions for
payment of overdue principal of (and premium, if any) or interest on such debt security or for the conversion or exchange of such debt security in accordance with its terms) unless (i)&nbsp;the holder has given to the trustee written notice of an
Event of Default and of the continuance thereof with respect to the debt securities of such series specifying an Event of Default, as required under the applicable Indenture, (ii)&nbsp;the holders of at least 25% in aggregate principal amount of the
debt securities of that series then outstanding under such Indenture shall have requested the trustee to institute such action and offered to the trustee reasonable indemnity against the costs, expenses and liabilities to be incurred in compliance
with such request, and (iii)&nbsp;the trustee shall not have instituted such action within 60&nbsp;days of such request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. is
required to furnish annually to the trustee statements as to MetLife, Inc.&#146;s compliance with all conditions and covenants under each Indenture. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discharge, Defeasance and Covenant Defeasance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If indicated in the applicable prospectus supplement, MetLife, Inc. may discharge or defease its obligations under each Indenture as set forth
below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may discharge certain obligations to holders of any series of debt securities issued under either the Senior
Indenture or the Subordinated Indenture which have not already been delivered to the trustee for cancellation and which have either become due and payable or are by their terms due and payable within one year (or scheduled for redemption within one
year) by irrevocably depositing with the trustee cash or, in the case of debt securities payable only in U.S.&nbsp;dollars, U.S.&nbsp;government obligations (as defined in the applicable Indenture), as trust funds in an amount certified to be
sufficient to pay when due, whether at maturity, upon redemption or otherwise, the principal of (and premium, if any) and interest on such debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If indicated in the applicable prospectus supplement, MetLife, Inc. may elect either (i)&nbsp;to defease and be discharged from any and all
obligations with respect to the debt securities of or within any series (except as otherwise provided in the relevant Indenture) (&#147;<I>defeasance</I>&#148;) or (ii)&nbsp;to be released from its obligations with respect to certain covenants
applicable to the debt securities of or within any series (&#147;<I>covenant defeasance</I>&#148;), upon the deposit with the relevant trustee, in trust for such purpose, of money and/or government obligations which, through the payment of principal
and interest in accordance with their terms, will provide money in an amount sufficient, without reinvestment, to pay the principal of (and premium, if any) or interest on such debt securities to maturity or redemption, as the case may be, and any
mandatory sinking fund or analogous payments thereon. As a condition to defeasance or covenant defeasance, MetLife, Inc. must deliver to the trustee an opinion </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of counsel to the effect that the holders of such debt securities will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such defeasance or covenant
defeasance and will be subject to U.S. federal income tax on the same amounts and in the same manner and at the same times as would have been the case if such defeasance or covenant defeasance had not occurred. Such opinion of counsel, in the case
of defeasance under clause&nbsp;(i) above, must refer to and be based upon a ruling of the Internal Revenue Service or a change in applicable U.S. federal income tax law occurring after the date of the relevant Indenture. In addition, in the case of
either defeasance or covenant defeasance, MetLife, Inc. shall have delivered to the trustee (i)&nbsp;an officers&#146; certificate to the effect that the relevant debt securities exchange(s) have informed it that neither such debt securities nor any
other debt securities of the same series, if then listed on any securities exchange, will be delisted as a result of such deposit, and (ii)&nbsp;an officers&#146; certificate and an opinion of counsel, each stating that all conditions precedent with
respect to such defeasance or covenant defeasance have been complied with. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may exercise its defeasance option with respect
to such debt securities notwithstanding its prior exercise of its covenant defeasance option. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Indentures, MetLife, Inc. and the applicable trustee may supplement the Indentures for certain purposes which would not materially
adversely affect the interests or rights of the holders of debt securities of a series without the consent of those holders. MetLife, Inc. and the applicable trustee may also modify the Indentures or any supplemental indenture in a manner that
affects the interests or rights of the holders of debt securities with the consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of each affected series issued under the Indenture. However,
the Indentures require the consent of each holder of debt securities that would be affected by any modification which would: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">extend the fixed maturity of any debt securities of any series, or reduce the principal amount thereof, or reduce
the rate or extend the time of payment of interest thereon, or reduce any premium payable upon the redemption thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of principal of an original issue discount debt security or any other debt security payable
upon acceleration of the maturity thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">change the currency in which any debt security or any premium or interest is payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impair the right to enforce any payment on or with respect to any debt security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adversely change the right to convert or exchange, including decreasing the conversion rate or increasing the
conversion price of, any debt security (if applicable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the percentage in principal amount of outstanding debt securities of any series, the consent of whose
holders is required for modification or amendment of the Indentures or for waiver of compliance with certain provisions of the Indentures or for waiver of certain defaults; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the requirements contained in the Indentures for quorum or voting;&nbsp;or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">modify any of the above provisions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Indenture permits the holders of at least a majority in aggregate principal amount of the outstanding debt securities of any series
issued under such Indenture which is affected by the modification or amendment to waive MetLife, Inc.&#146;s compliance with certain covenants contained in such Indenture. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Payment and Paying Agents </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
otherwise indicated in the applicable prospectus supplement, payment of interest on a debt security on any interest payment date will be made to the person in whose name a debt security is registered at the close of business on the record date for
the interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, principal, interest and
premium on the debt securities of a particular series will be payable at the office of such paying agent or paying agents as MetLife, Inc. may designate for such purpose from time to time. Notwithstanding the foregoing, at MetLife, Inc.&#146;s
option, payment of any interest may be made by check mailed to the address of the person entitled thereto as such address appears in the security register. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, a paying agent designated by MetLife, Inc. and located in the Borough of
Manhattan, The City of New York, will act as paying agent for payments with respect to debt securities of each series. All paying agents initially designated by MetLife, Inc. for the debt securities of a particular series will be named in the
applicable prospectus supplement. MetLife, Inc. may at any time designate additional paying agents or rescind the designation of any paying agent or approve a change in the office through which any paying agent acts, except that MetLife, Inc. will
be required to maintain a paying agent in each place of payment for the debt securities of a particular series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All moneys paid by
MetLife, Inc. to a paying agent for the payment of the principal, interest or premium on any debt security which remain unclaimed at the end of two years after such principal, interest or premium has become due and payable will be repaid to MetLife,
Inc. upon request, and the holder of such debt security thereafter may look only to MetLife, Inc. for payment thereof. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Denominations, Registrations
and Transfer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless an accompanying prospectus supplement states otherwise, debt securities will be represented by one or more global
certificates registered in the name of a nominee for The Depository Trust&nbsp;Company (&#147;<I>DTC</I>&#148;). In such case, each holder&#146;s beneficial interest in the global securities will be shown on the records of DTC and transfers of
beneficial interests will only be effected through DTC&#146;s records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder of debt securities may only exchange a beneficial
interest in a global security for certificated securities registered in the holder&#146;s name in limited circumstances, as described in an applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If debt securities are issued in certificated form, they will only be issued in the minimum denomination specified in the accompanying
prospectus supplement and integral multiples of such denomination. Transfers and exchanges of such debt securities will only be permitted in such minimum denomination. Transfers of debt securities in certificated form may be registered at the
trustee&#146;s corporate office or at the offices of any paying agent or trustee appointed by MetLife, Inc. under the Indentures. Exchanges of debt securities for an equal aggregate principal amount of debt securities in different denominations may
also be made at such locations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indentures and debt securities will be governed by, and construed in accordance with, the internal laws of the State of New York, without
regard to its principles of conflicts of laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relationship with the Trustees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee under (i)&nbsp;the Senior Indenture is The Bank of New York Mellon Trust&nbsp;Company, N.A. (as successor in interest to J.P.
Morgan Trust Company, National Association (as successor to Bank One Trust Company, N.A.)) and (ii)&nbsp;the Subordinated Indenture is The Bank of New York Mellon Trust&nbsp;Company, N.A. (as successor in interest to J.P.&nbsp;Morgan
Trust&nbsp;Company, National Association). MetLife, Inc. and its subsidiaries maintain ordinary banking and trust relationships with a number of banks and trust companies, including the trustee under the Indentures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion or Exchange Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement will describe the terms, if any, on which a series of debt securities may be convertible into or exchangeable for
securities described in this prospectus. These terms will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at MetLife, Inc.&#146;s option. These provisions may allow or require the number of shares
of MetLife, Inc.&#146;s common stock or other securities to be received by the holders of such series of debt securities to be adjusted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_10"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s authorized capital stock consists of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">200,000,000&nbsp;shares of preferred stock, par value $0.01 per share, of which 25,572,200&nbsp;shares were
issued and outstanding as of November 3, 2022: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">27,600,000&nbsp;shares of Floating Rate <FONT STYLE="white-space:nowrap">Non-Cumulative</FONT> Preferred Stock,
Series&nbsp;A (the &#147;<I>Series</I><I></I><I>&nbsp;A Preferred Stock</I>&#148;), of which 24,000,000&nbsp;shares were issued and outstanding as of November&nbsp;3, 2022; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">500,000 shares of 5.875%
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate <FONT STYLE="white-space:nowrap">Non-Cumulative</FONT> Preferred Stock, Series&nbsp;D (the &#147;<I>Series</I><I></I><I>&nbsp;D Preferred
Stock</I>&#148;) of which 500,000&nbsp;shares were issued and outstanding as of November&nbsp;3, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Depositary Shares (the &#147;<I>Series E Depositary Shares</I>&#148;), each representing a 1/1,000<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> interest in a share of 5.625% <FONT STYLE="white-space:nowrap">Non-Cumulative</FONT> Preferred Stock, Series&nbsp;E (the &#147;<I>Series</I><I></I><I>&nbsp;E Preferred Stock</I>&#148;) of which
32,200,000 Series E Depositary Shares representing 32,200&nbsp;shares of Series E Preferred Stock were issued and outstanding as of November 3, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Depositary Shares (the &#147;<I>Series F Depositary Shares</I>&#148;), each representing a 1/1,000<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F (the &#147;<I>Series F Preferred Stock</I>&#148;) of which 40,000,000 Series F Depositary Shares representing 40,000 shares of
Series F Preferred Stock were issued and outstanding as of November 3, 2022; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">10,000,000&nbsp;shares of Series&nbsp;A Junior Participating Preferred Stock, par value $0.01 per share, of which
no shares were issued or outstanding as of the date of this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G (the &#147;<I>Series G Preferred
Stock</I>&#148;), of which 1,000,000 shares were issued and outstanding as of November 3, 2022; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,000,000,000&nbsp;shares of common stock, par value $0.01 per share, of which 784,606,205&nbsp;shares were
outstanding as of November 3, 2022. The remaining shares of authorized and unissued common stock will be available for future issuance without additional stockholder approval. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dividends.</I>&nbsp;The
holders of common stock, after any preferences of holders of any preferred stock, are entitled to receive dividends as determined by MetLife, Inc.&#146;s board of directors. The declaration and payment of common stock dividends will also depend on
MetLife, Inc.&#146;s financial condition, results of operations, cash requirements, future prospects, regulatory restrictions on the payment of dividends by MetLife, Inc.&#146;s insurance subsidiaries and other factors deemed relevant by MetLife,
Inc.&#146;s board of directors. There is no requirement or assurance that MetLife, Inc. will declare and pay any dividends. The certificates of designation for the Series&nbsp;A Preferred Stock, the Series&nbsp;D Preferred Stock, the Series E
Preferred Stock, the Series F Preferred Stock and the Series G Preferred Stock (the &#147;Preferred Stock&#148;) all prohibit the declaration or payment of dividends or distributions on common stock if dividends are not paid on the Preferred Stock,
and the certificate of designations for the Series A Preferred Stock further prohibits the payment of dividends on the Series A Preferred Stock under certain circumstances. In addition, (i)&nbsp;MetLife, Inc.&#146;s 6.40% <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2066 (the &#147;6.40% JSDs due 2066&#148;), (ii)&nbsp;MetLife, Inc.&#146;s 10.75% <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2069 (the &#147;10.75% JSDs due 2069&#148;), (iii) upon an exchange of the 7.875%
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Exchangeable Surplus Trust&nbsp;Securities of MetLife Capital Trust&nbsp;IV, the related 7.875% <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2067 of MetLife, Inc. (the &#147;7.875% JSDs due 2067&#148;), and (iv)&nbsp;the 9.250%
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Junior Subordinated Debentures due 2068 of MetLife, Inc. (the &#147;9.25% JSDs due 2068&#148;), all prohibit the declaration or payment of
dividends or distributions on common stock under certain circumstances if interest is not paid in full on such securities, whether because of a mandatory or optional payment deferral, subject to certain exceptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Voting Rights.</I>&nbsp;The holders of common stock are entitled to one vote per share on all matters on which the holders of common stock
are entitled to vote and do not have any cumulative voting rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidation and Dissolution.</I>&nbsp;In the event of MetLife, Inc.&#146;s liquidation,
dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> the holders of common stock are entitled to share equally and ratably in MetLife, Inc.&#146;s assets, if any, remaining after the payment of all of MetLife, Inc.&#146;s liabilities
and the liquidation preference of any outstanding class or series of preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other Rights.</I>&nbsp;The holders of common
stock have no preemptive, conversion, redemption or sinking fund rights. The holders of shares of MetLife, Inc.&#146;s common stock are not required to make additional capital contributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Transfer Agent and Registrar.</I>&nbsp;The transfer agent and registrar for MetLife, Inc.&#146;s common stock is Computershare Inc.
(successor in interest to Mellon Investor Services LLC). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>General.</I>&nbsp;MetLife, Inc.&#146;s board of directors has the authority to issue preferred stock in one or more series and to fix the
title and number of shares constituting any such series and the designations, powers, preferences, limitations and relative rights including offering price, any dividend rights (including whether dividends will be cumulative or <FONT
STYLE="white-space:nowrap">non-cumulative),</FONT> dividend rate, voting rights, terms of any redemption, any redemption price or prices, conversion or exchange rights and any liquidation preferences of the shares constituting any series, without
any further vote or action by stockholders. The specific terms of the preferred stock will be described in the prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. has authorized 10,000,000&nbsp;shares of Series&nbsp;A Junior Participating Preferred Stock for issuance in connection with a
stockholder rights plan. The stockholder rights plan expired at the close of business on April&nbsp;4, 2010 and was not renewed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Voting Rights.</I>&nbsp;The Delaware General Corporation Law provides that the holders of preferred stock will have the right to vote
separately as a class on any proposal involving fundamental changes in the rights of holders of such preferred stock. The prospectus supplement will describe the voting rights, if any, of the preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Conversion or Exchange.</I>&nbsp;The prospectus supplement will describe the terms, if any, on which the preferred stock may be convertible
into or exchangeable for securities described in this prospectus. These terms will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at MetLife, Inc.&#146;s option. These provisions may set forth
the conversion price, the method of determining the conversion price and the conversion period and may allow or require the number of shares of MetLife, Inc.&#146;s common stock or other securities to be received by the holders of preferred stock to
be adjusted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Redemption.</I>&nbsp;The prospectus supplement will describe the obligation, if any, to redeem the preferred stock in
whole or in part at the times and at the redemption prices set forth in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated
in the applicable prospectus supplement, MetLife, Inc. may not purchase or redeem any of the outstanding shares or any series of preferred stock unless full cumulative dividends, if any, have been paid or declared and set apart for payment upon all
outstanding shares of any series of preferred stock for all past dividend periods, and unless all of MetLife, Inc.&#146;s matured obligations with respect to all sinking funds, retirement funds or purchase funds for all series of preferred stock
then outstanding have been met. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Provisions in MetLife, Inc.&#146;s Amended and Restated Certificate of Incorporation, As Amended (the
&#147;Certificate of Incorporation&#148;), and Amended and Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> (the <FONT STYLE="white-space:nowrap">&#147;By-Laws&#148;)</FONT> and in Delaware and New York Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A number of provisions of MetLife, Inc.&#146;s Certificate of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws</FONT> deal with
matters of corporate governance and rights of stockholders. The following discussion is a general summary of selected provisions of MetLife, Inc.&#146;s Certificate of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws</FONT> and regulatory
provisions that might be deemed to have a potential &#147;anti-takeover&#148; effect. These provisions may have the effect of discouraging a future </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
takeover attempt which is not approved by MetLife, Inc.&#146;s board of directors but which individual stockholders may deem to be in their best interests or in which stockholders may receive a
substantial premium for their shares over then current market prices. As a result, stockholders who might desire to participate in such a transaction may not have an opportunity to do so. Such provisions will also render the removal of the incumbent
board of directors or management more difficult. Some provisions of the Delaware General Corporation Law and the New York Insurance Law may also have an anti-takeover effect. The following description of selected provisions of MetLife, Inc.&#146;s
Certificate of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws</FONT> and selected provisions of the Delaware General Corporation Law and the New York Insurance Law is necessarily general and reference should be made in each case to
MetLife, Inc.&#146;s Certificate of Incorporation and <FONT STYLE="white-space:nowrap">By-Laws,</FONT> which are incorporated by reference as exhibits to the registration statement of which this prospectus forms a part, and to the provisions of
those laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exercise of Duties by Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s Certificate of Incorporation provides that while the MetLife Policyholder Trust (as described below) is in existence, each
MetLife, Inc. director is required, in exercising his or her duties as a director, to take the interests of the trust beneficiaries into account as if they were holders of the shares of common stock held in the trust, except to the extent that any
such director determines, based on advice of counsel, that to do so would violate his or her duties as a director under Delaware law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restriction on
Maximum Number of Directors and Filling of Vacancies on MetLife, Inc.&#146;s Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to MetLife, Inc.&#146;s <FONT
STYLE="white-space:nowrap">By-Laws</FONT> and subject to the rights of the holders of any class of preferred stock, the number of directors may be fixed from time to time exclusively by resolution adopted by a majority of the entire board of
directors, but the board of directors will at no time consist of fewer than three directors. Stockholders may remove a director with or without cause at a meeting of the stockholders by a vote of a majority of the combined voting power of the
outstanding stock entitled to vote generally in the election of directors, in which case the vacancy caused by such removal may be filled at such meeting by the stockholders entitled to vote for the election of the director so removed. Any vacancy
on the board of directors, including a vacancy resulting from an increase in the number of directors or resulting from a removal where the stockholders have not filled the vacancy, subject to the rights of the holders of any class of preferred
stock, may be filled by a majority of the directors then in office, although less than a quorum. These provisions give incumbent directors significant authority that may have the effect of limiting the ability of stockholders to effect a change in
management. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advance Notice Requirements for Nomination of Directors and Presentation of New Business at Meetings of Stockholders; Action by Written
Consent </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s <FONT STYLE="white-space:nowrap">By-Laws</FONT> provide for advance notice and other provisions in
respect of stockholder proposals and nominations for director. In addition, pursuant to the provisions of both the Certificate of Incorporation and the <FONT STYLE="white-space:nowrap">By-Laws,</FONT> stockholder action may not be taken by written
consent. Rather, any action taken by the stockholders must be effected at a duly called meeting. The chairman, the chief executive officer or the secretary pursuant to a board resolution or, under some circumstances, the president or a director who
also is an officer, may call a special meeting. MetLife, Inc.&#146;s <FONT STYLE="white-space:nowrap">By-Laws</FONT> also permit stockholders representing ownership of 25% or more of the combined voting power of the outstanding shares of common
stock to call a special meeting of the stockholders, provided that the stockholders satisfy the requirements specified in the <FONT STYLE="white-space:nowrap">By-Laws.</FONT> These provisions make it more difficult for a stockholder to place a
proposal or nomination on the meeting agenda and prohibit a stockholder from taking action without a meeting, and therefore may reduce the likelihood that a stockholder will seek to take independent action to replace directors or with respect to
other matters that are not supported by management for stockholder vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Director Liability </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc.&#146;s Certificate of Incorporation contains a provision that is designed to limit the directors&#146; liability to the extent
permitted by the Delaware General Corporation Law and any amendments to that law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Specifically, directors will not be held liable to MetLife, Inc. or its stockholders for monetary damages for an act or omission in their capacity as a director, except for liability as a result
of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a breach of the duty of loyalty to MetLife, Inc. or its stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">payment of an improper dividend or improper redemption or repurchase of MetLife, Inc.&#146;s stock under
Section&nbsp;174 of the Delaware General Corporation Law;&nbsp;or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director received an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principal effect of the limitation on liability provision is that a stockholder is unable to prosecute an action for monetary damages against a director
of MetLife, Inc. unless the stockholder can demonstrate one of the specified bases for liability. This provision, however, does not eliminate or limit director liability arising in connection with causes of action brought under the federal
securities laws. MetLife, Inc.&#146;s Certificate of Incorporation also does not eliminate the directors&#146; duty of care. The inclusion of the limitation on liability provision in the certificate may, however, discourage or deter stockholders or
management from bringing a lawsuit against directors for a breach of their fiduciary duties, even though such an action, if successful, might otherwise have benefited MetLife, Inc. and its stockholders. This provision should not affect the
availability of equitable remedies such as injunction or rescission based upon a director&#146;s breach of the duty of care. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife,
Inc.&#146;s <FONT STYLE="white-space:nowrap">By-Laws</FONT> also provide that MetLife, Inc. will indemnify its directors and officers to the fullest extent permitted by Delaware law. MetLife, Inc. is required to indemnify its directors and officers
for all judgments, fines, amounts paid in settlement, legal fees and other expenses reasonably incurred in connection with pending or threatened legal proceedings because of the director&#146;s or officer&#146;s position with MetLife, Inc. or
another entity, including Metropolitan Life Insurance Company, that the director or officer serves at MetLife, Inc.&#146;s request, subject to certain conditions, and to advance funds to MetLife, Inc.&#146;s directors and officers to enable them to
defend against such proceedings. To receive indemnification, the director or officer must succeed in the legal proceeding or act in good faith and in a manner reasonably believed to be in or not opposed to the best interests of MetLife, Inc. and
with respect to any criminal action or proceeding, in a manner he or she reasonably believed to be lawful. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Combination Statute </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as a Delaware corporation with a class of voting stock listed on a national securities exchange, MetLife, Inc. is subject to
Section&nbsp;203 of the Delaware General Corporation Law, unless it elects in its certificate of incorporation not to be governed by the provisions of Section&nbsp;203. MetLife, Inc. has not made that election. Section&nbsp;203 can affect the
ability of an &#147;interested stockholder&#148; of MetLife, Inc. to engage in certain business combinations, including mergers, consolidations or acquisitions of additional shares of MetLife, Inc. for a period of three years following the time that
the stockholder becomes an &#147;interested stockholder.&#148; An &#147;interested stockholder&#148; is defined to include any person owning, directly or indirectly, 15% or more of the outstanding voting stock of a corporation. The provisions of
Section&nbsp;203 are not applicable in some circumstances, including those in which (1)&nbsp;the business combination or transaction which results in the stockholder becoming an &#147;interested stockholder&#148; is approved by the
corporation&#146;s board of directors prior to the time the stockholder becomes an &#147;interested stockholder&#148; or (2)&nbsp;the &#147;interested stockholder,&#148; upon consummation of such transaction, owns at least 85% of the voting stock of
the corporation outstanding prior to such transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrictions on Acquisitions of Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The insurance laws and regulations of New York, the jurisdiction in which MetLife, Inc.&#146;s principal insurance subsidiary, Metropolitan
Life Insurance Company, is organized, may delay or impede a business combination involving MetLife, Inc. In addition to the limitations described in the immediately preceding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
paragraph, the New York Insurance Law prohibits any person from acquiring control of Metropolitan Life Insurance Company, either directly or indirectly through any acquisition of control of
MetLife, Inc., without the prior approval of the New York Superintendent of Financial Services. That law presumes that control exists where any person, directly or indirectly, owns, controls, holds the power to vote 10% or more of MetLife,
Inc.&#146;s outstanding voting stock, unless the New York Superintendent of Financial Services, upon application, determines otherwise. Even persons who do not acquire beneficial ownership of more than 10% of the outstanding shares of MetLife,
Inc.&#146;s common stock may be deemed to have acquired such control, if the New York Superintendent of Financial Services determines that such persons, directly or indirectly, exercise a controlling influence over MetLife, Inc.&#146;s management or
policies. Therefore, any person seeking to acquire a controlling interest in MetLife, Inc. would face regulatory obstacles which may delay, deter or prevent an acquisition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The insurance holding company laws and other insurance laws of many other states also regulate changes of control (generally presumed upon
acquisitions of 10% or more of voting securities) of domestic insurers (including insurers owned by MetLife, Inc.) and insurance holding companies such as MetLife, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MetLife Policyholder Trust </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under a plan
of reorganization adopted in September 1999, Metropolitan Life Insurance Company converted from a mutual life insurance company to a stock life insurance company subsidiary of MetLife, Inc. The MetLife Policyholder Trust was established to hold the
shares of common stock allocated to eligible policyholders. A total of 494,466,664&nbsp;shares of common stock were distributed to the MetLife Policyholder Trust for the benefit of policyholders of Metropolitan Life Insurance Company on the
effective date of the plan of reorganization. As of October 31, 2022, the trust held 124,312,703&nbsp;shares of MetLife, Inc.&#146;s common stock. Because of the number of shares held by the trust and the voting provisions of the trust, the trust
may affect the outcome of matters brought to a stockholder vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trustee will generally vote all of the shares of common stock held
in the trust in accordance with the recommendations given by MetLife, Inc.&#146;s board of directors to its stockholders or, if the board gives no such recommendation, as directed by the board, except on votes regarding certain fundamental corporate
actions. As a result of the voting provisions of the trust, MetLife, Inc.&#146;s board of directors will effectively be able to control votes on all matters submitted to a vote of stockholders, excluding those fundamental corporate actions described
below, so long as the trust holds a substantial number of shares of MetLife, Inc.&#146;s common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the vote relates to fundamental
corporate actions specified in the trust, the trustee will solicit instructions from the beneficiaries and vote all shares held in the trust in proportion to the instructions it receives, which would give disproportionate weight to the instructions
actually given by trust beneficiaries. These actions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an election or removal of directors in which a stockholder has properly nominated one or more candidates in
opposition to a nominee or nominees of MetLife, Inc.&#146;s board of directors or a vote on a stockholder&#146;s proposal to oppose a board nominee for director, remove a director for cause or fill a vacancy caused by the removal of a director by
stockholders, subject to certain conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a merger or consolidation, a sale, lease or exchange of all or substantially all of the assets, or a
recapitalization or dissolution of MetLife, Inc., in each case requiring a vote of MetLife, Inc.&#146;s stockholders under applicable Delaware law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction that would result in an exchange or conversion of shares of common stock held by the trust for
cash, securities or other property; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any proposal requiring MetLife, Inc.&#146;s board of directors to amend or redeem the rights under the
stockholder rights plan, other than a proposal with respect to which MetLife, Inc. has received advice of nationally-recognized legal counsel to the effect that the proposal is not a proper subject for stockholder action under Delaware law.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_11"></A>DESCRIPTION OF DEPOSITARY SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following outlines some of the general terms and provisions of the depositary shares. Further terms of the depositary shares and the
applicable deposit agreement will be stated in the applicable prospectus supplement. The following description and any description of the depositary shares in a prospectus supplement may not be complete and is subject to and qualified in its
entirety by reference to the terms and provisions of the deposit agreement, a form of which has been or will be filed as an exhibit to the registration statement of which this prospectus forms a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The particular terms of the depositary shares offered by any prospectus supplement and the extent to which the general provisions described
below may apply to such depositary shares will be outlined in the applicable prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may choose to offer fractional interests in debt securities or fractional shares of common stock or preferred stock. MetLife,
Inc. may issue fractional interests in debt securities, common stock or preferred stock, as the case may be, in the form of depositary shares. Each depositary share would represent a fractional interest in a security of a particular series of debt
securities or a fraction of a share of common stock or of a particular series of preferred stock, as the case may be, and would be evidenced by a depositary receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will deposit the debt securities or shares of common stock or preferred stock represented by depositary shares under a deposit
agreement between MetLife, Inc. and a depositary which will be named in the applicable prospectus supplement. Subject to the terms of the deposit agreement, as an owner of a depositary share, you will be entitled, in proportion to the applicable
fraction of a debt security or share of common stock or preferred stock represented by the depositary share, to all the rights and preferences of the debt security, common stock or preferred stock, as the case may be, represented by the depositary
share, including, as the case may be, interest, dividend, voting, conversion, redemption, sinking fund, repayment at maturity, subscription and liquidation rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interest, Dividends and Other Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary will distribute all payments of interest, cash dividends or other cash distributions received on the debt securities, common
stock or preferred stock, as the case may be, to you in proportion to the number of depositary shares that you own. In the event of a distribution other than in cash, the depositary will distribute property received by it to you in an equitable
manner, unless the depositary determines that it is not feasible to make a distribution. In that case, the depositary may sell the property and distribute the net proceeds from the sale to you. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption of Depositary Shares </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a
debt security, common stock or series of preferred stock represented by depositary shares is redeemed, the depositary will redeem your depositary shares from the proceeds received by the depositary resulting from the redemption. The redemption price
per depositary share will be equal to the applicable fraction of the redemption price per debt security or share of common stock or preferred stock, as the case may be, payable in relation to the redeemed series of debt securities, common stock or
preferred stock. Whenever MetLife, Inc. redeems debt securities or shares of common stock or preferred stock held by the depositary, the depositary will redeem, as of the same redemption date, the number of depositary shares representing, as the
case may be, fractional interests in the debt securities or shares of common stock or preferred stock redeemed. If fewer than all the depositary shares are to be redeemed, the depositary shares to be redeemed will be selected by lot, proportionately
or by any other equitable method as the depositary may determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exercise of Rights under the Indentures or Voting the Common Stock or Preferred </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon receipt of notice of any meeting at which you are entitled to vote, or of any request for instructions or directions from you as holder of
fractional interests in debt securities, common stock or preferred stock, the depositary will mail to you the information contained in that notice. Each record holder of the depositary shares on the record date will be entitled to instruct the
depositary how to give instructions or directions with respect to the debt securities represented by that holder&#146;s depositary shares or how to vote the amount of the common stock or preferred stock represented by that holder&#146;s depositary
shares. The record date for the depositary shares will be the same date as the record date for the debt securities, common stock or preferred stock, as the case may be. The depositary will endeavor, to the extent practicable, to give instructions or
directions with respect to the debt securities or to vote the amount of the common stock or preferred stock, as the case may be, represented by the depositary shares in accordance with those instructions. MetLife, Inc. will agree to take all
reasonable action which the depositary may deem necessary to enable the depositary to do so. The depositary will abstain from giving instructions or directions with respect to your fractional interests in the debt securities or voting shares of the
common stock or preferred stock, as the case may be, if it does not receive specific instructions from you. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment and Termination of the Deposit
Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. and the depositary may amend the form of depositary receipt evidencing the depositary shares and any provision
of the deposit agreement at any time. However, any amendment which materially and adversely affects the rights of the holders of the depositary shares will not be effective unless the amendment has been approved by the holders of at least a majority
of the depositary shares then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The deposit agreement will terminate if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all outstanding depositary shares have been redeemed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the debt securities and the preferred stock represented by depositary shares have been converted
into or exchanged for common stock or, in the case of debt securities, repaid in full;&nbsp;or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there has been a final distribution in respect of the common stock or preferred stock, including in connection
with the liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of MetLife, Inc., and the distribution proceeds have been distributed to you. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Resignation and Removal of Depositary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary may resign at any time by delivering to MetLife, Inc. notice of its election to do so. MetLife, Inc. also may, at any time,
remove the depositary. Any resignation or removal will take effect upon the appointment of a successor depositary and its acceptance of such appointment. MetLife, Inc. must appoint the successor depositary within 60&nbsp;days after delivery of the
notice of resignation or removal. The successor depositary must be a bank or trust company having its principal office in the United States and having total assets of not less than $1,000,000,000. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Charges of Depositary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. will
pay all transfer and other taxes and governmental charges arising solely from the existence of the depositary arrangements. MetLife, Inc. will pay charges of the depositary in connection with the initial deposit of the debt securities or common
stock or preferred stock, as the case may be, and issuance of depositary receipts, all withdrawals of depositary shares of debt securities or common stock or preferred stock, as the case may be, by you and any repayment or redemption of the debt
securities or preferred stock, as the case may be. You will pay other transfer and other taxes and governmental charges, as well as the other charges that are expressly provided in the deposit agreement to be for your account. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Miscellaneous </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The depositary will forward all reports and communications from MetLife, Inc. which are delivered to the depositary and which MetLife, Inc. is
required or otherwise determines to furnish to holders of debt securities, common stock or preferred stock, as the case may be. Neither MetLife, Inc. nor the depositary will be liable under the deposit agreement to you other than for its gross
negligence, willful misconduct or bad faith. Neither MetLife, Inc. nor the depositary will be obligated to prosecute or defend any legal proceedings relating to any depositary shares, debt securities, common stock or preferred stock unless
satisfactory indemnity is furnished. MetLife, Inc. and the depositary may rely upon written advice of counsel or accountants, or upon information provided by persons presenting debt securities or shares of common stock or preferred stock for
deposit, you or other persons believed to be competent and on documents which MetLife, Inc. and the depositary believe to be genuine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_12"></A>DESCRIPTION OF WARRANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may issue warrants to purchase debt securities, preferred stock, common stock or other securities described in this prospectus,
or any combination of these securities, and these warrants may be issued independently or together with any underlying securities and may be attached or separate from the underlying securities. MetLife, Inc. will issue each series of warrants under
a separate warrant agreement to be entered into between MetLife, Inc. and a warrant agent. The warrant agent will act solely as MetLife, Inc.&#146;s agent in connection with the warrants of such series and will not assume any obligation or
relationship of agency for or with holders or beneficial owners of warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following outlines some of the general terms and
provisions of the warrants. Further terms of the warrants and the applicable warrant agreement will be stated in the applicable prospectus supplement. The following description and any description of the warrants in a prospectus supplement may not
be complete and is subject to and qualified in its entirety by reference to the terms and provisions of the warrant agreement, a form of which has been or will be filed as an exhibit to the registration statement of which this prospectus forms a
part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The applicable prospectus supplement will describe the terms of any warrants that MetLife, Inc. may offer, including the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title of the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the total number of warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices at which the warrants will be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency or currencies investors may use to pay for the warrants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of the underlying securities purchasable upon exercise of the warrants;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price at which and the currency, currencies, or currency units in which investors may purchase the underlying
securities purchasable upon exercise of the warrants; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which the right to exercise the warrants will commence and the date on which the right will expire;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the warrants will be issued in registered form or bearer form; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">information with respect to book-entry procedures, if any; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the minimum or maximum amount of warrants which may be exercised at any one time;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the designation and terms of the underlying securities with which the warrants are issued and the
number of warrants issued with each underlying security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, the date on and after which the warrants and the related underlying securities will be separately
transferable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, a discussion of material United States federal income tax considerations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the identity of the warrant agent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the procedures and conditions relating to the exercise of the warrants;&nbsp;and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the warrants, including terms, procedures and limitations relating to the exchange and
exercise of the warrants. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrant certificates may be exchanged for new warrant certificates of different
denominations, and warrants may be exercised at the warrant agent&#146;s corporate trust office or any other office indicated in the applicable prospectus supplement. Prior to the exercise of their warrants, holders of warrants exercisable for debt
securities will not have any of the rights of holders of the debt securities purchasable upon such exercise and will not be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled to payments of principal (or premium, if any) or interest, if any, on the debt securities purchasable upon such exercise. Prior to the exercise of their warrants, holders of warrants
exercisable for shares of preferred stock or common stock will not have any rights of holders of the preferred stock or common stock purchasable upon such exercise and will not be entitled to dividend payments, if any, or voting rights of the
preferred stock or common stock purchasable upon such exercise. Prior to the exercise of their warrants, holders of warrants exercisable for other securities described in this prospectus will not have any rights of holders of such securities
purchasable upon such exercise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exercise of Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A warrant will entitle the holder to purchase for cash an amount of securities at an exercise price that will be stated in, or that will be
determinable as described in, the applicable prospectus supplement. Warrants may be exercised at any time up to the close of business on the expiration date set forth in the applicable prospectus supplement. After the close of business on the
expiration date, unexercised warrants will become void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Warrants may be exercised as set forth in the applicable prospectus supplement.
Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement, MetLife, Inc. will, as soon as practicable,
forward the securities purchasable upon such exercise. If less than all of the warrants represented by such warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Enforceability of Rights; Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of warrants, without the consent of the warrant agent, may, on their own behalf and for their own benefit, enforce, and may
institute and maintain any suit, action or proceeding against MetLife, Inc. to enforce their rights to exercise and receive the securities purchasable upon exercise of their warrants. Unless otherwise stated in the prospectus supplement, each issue
of warrants and the applicable warrant agreement will be governed by, and construed in accordance with, the internal laws of the State of New York, without regard to its principles of conflicts of laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_13"></A>DESCRIPTION OF PURCHASE CONTRACTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As may be specified in a prospectus supplement, MetLife, Inc. may issue purchase contracts obligating holders to purchase from MetLife, Inc.,
and MetLife, Inc. to sell to the holders, a number of debt securities, shares of common stock or preferred stock, or other securities described in this prospectus or the applicable prospectus supplement at a future date or dates. The purchase
contracts may require MetLife, Inc. to make periodic payments to the holders of the purchase contracts. These payments may be unsecured or prefunded on some basis to be specified in the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement relating to any purchase contracts will specify the material terms of the purchase contracts and any applicable
pledge or depositary arrangements, including one or more of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The stated amount that a holder will be obligated to pay under the purchase contract in order to purchase debt
securities, common stock, preferred stock, or other securities described in this prospectus or the formula by which such amount will be determined. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The settlement date or dates on which the holder will be obligated to purchase such securities. The prospectus
supplement will specify whether the occurrence of any events may cause the settlement date to occur on an earlier date and the terms on which an early settlement would occur. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The events, if any, that will cause MetLife, Inc.&#146;s obligations and the obligations of the holder under the
purchase contract to terminate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The settlement rate, which is a number that, when multiplied by the stated amount of a purchase contract,
determines the number of securities that MetLife, Inc. will be obligated to sell and a holder will be obligated to purchase under that purchase contract upon payment of the stated amount of that purchase contract. The settlement rate may be
determined by the application of a formula specified in the prospectus supplement. If a formula is specified, it may be based on the market price of such securities over a specified period or it may be based on some other reference statistic.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Whether the purchase contracts will be issued separately or as part of units consisting of a purchase contract
and an underlying security with an aggregate principal amount equal to the stated amount. Any underlying securities will be pledged by the holder to secure its obligations under a purchase contract. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The type of underlying security, if any, that is pledged by the holder to secure its obligations under a purchase
contract. Underlying securities may be debt securities, common stock, preferred stock, or other securities described in this prospectus or the applicable prospectus supplement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The terms of the pledge arrangement relating to any underlying securities, including the terms on which
distributions or payments of interest and principal on any underlying securities will be retained by a collateral agent, delivered to MetLife, Inc. or be distributed to the holder. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The amount of the contract fee, if any, that may be payable by MetLife, Inc. to the holder or by the holder to
MetLife, Inc., the date or dates on which the contract fee will be payable and the extent to which MetLife, Inc. or the holder, as applicable, may defer payment of the contract fee on those payment dates. The contract fee may be calculated as a
percentage of the stated amount of the purchase contract or otherwise. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The descriptions of the purchase contracts and
any applicable underlying security or pledge or depository arrangements in this prospectus and in any prospectus supplement are summaries of the material provisions of the applicable agreements and are subject to and qualified in their entirety by
reference to the terms and provisions of the purchase contract agreement, pledge agreement and deposit agreement, forms of which have been or will be filed as exhibits to the registration statement of which this prospectus forms a part. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_14"></A>DESCRIPTION OF UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As specified in the applicable prospectus supplement, MetLife, Inc. may issue units comprised of one or more of the other securities described
in this prospectus in any combination. Each unit may also include debt obligations of third parties, such as U.S.&nbsp;Treasury securities. Each unit will be issued so that the holder of the unit is also the holder of each security included in the
unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The prospectus supplement will describe: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation and terms of the units and of the securities comprising the units, including whether and under
what circumstances the securities comprising the units may be held or transferred separately; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of the terms of any unit agreement governing the units; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of the provisions for the payment, settlement, transfer or exchange of the units;&nbsp;and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the units will be issued in fully registered or global form. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The descriptions of the units and any applicable underlying security or pledge or depositary arrangements in this prospectus and in any
prospectus supplement are summaries of the material provisions of the applicable agreements and are subject to, and qualified in their entirety by reference to, the terms and provisions of the applicable agreements, forms of which have been or will
be filed as exhibits to the registration statement of which this prospectus forms a part. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_15"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may sell the securities being offered hereby in one or more of the following ways from time to time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to underwriters or dealers for resale to the public or to institutional investors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to institutional investors;&nbsp;or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents to the public or to institutional investors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The prospectus supplement with respect to each series of securities will state the terms of the offering of the securities, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of any underwriters or agents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchase price of the securities and the proceeds to be received by MetLife, Inc. from the sale;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any underwriting discounts or agency fees and other items constituting underwriters&#146; or agents&#146;
compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any initial public offering price; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any discounts or concessions allowed or <FONT STYLE="white-space:nowrap">re-allowed</FONT> or paid to
dealers;&nbsp;and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any securities exchange on which the securities may be listed. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If MetLife, Inc. uses underwriters in the sale, the securities will be acquired by the underwriters for their own account and may be resold
from time to time in one or more transactions, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negotiated transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed public offering price or prices, which may be changed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to prevailing market prices;&nbsp;or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities may also be offered and sold, if so indicated in the prospectus supplement, in connection with a remarketing upon their
purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting as principals for their own accounts or as agents for MetLife, Inc. The prospectus supplement will identify any
remarketing firm and will describe the terms of its agreement, if any, with MetLife, Inc. and its compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise stated
in a prospectus supplement, the obligations of the underwriters to purchase any securities will be conditioned on customary closing conditions and the underwriters will be obligated to purchase all of such series of securities, if any are purchased.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If MetLife, Inc. sells the securities directly or through agents designated by it, MetLife, Inc. will identify any agent involved in the
offering and sale of the securities and will list any commissions payable by MetLife, Inc. to the agent in the accompanying prospectus supplement. Unless indicated otherwise in the prospectus supplement, any such agent will be acting on a best
efforts basis to solicit purchases for the period of its appointment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MetLife, Inc. may authorize agents, underwriters or dealers to
solicit offers by certain institutional investors to purchase securities and provide for payment and delivery on a future date specified in an accompanying prospectus supplement. MetLife, Inc. will describe any such arrangement in the prospectus
supplement. Any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such institutional investor may be subject to limitations on the minimum amount of securities that it may purchase or on the portion of the aggregate principal amount of such securities that it
may sell under such arrangements. Institutional investors from which such authorized offers may be solicited include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commercial and savings banks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pension funds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investment companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">educational and charitable institutions;&nbsp;and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">such other institutions as MetLife, Inc. may approve. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Underwriters, dealers, agents and remarketing firms may be entitled under agreements entered into with MetLife, Inc. to indemnification by
MetLife, Inc. against certain civil liabilities, including liabilities under the Securities Act, or to contribution with respect to payments which the underwriters, dealers, agents and remarketing firms may be required to make. Underwriters,
dealers, agents and remarketing agents may be customers of, engage in transactions with, or perform services for MetLife, Inc. and/or MetLife, Inc.&#146;s affiliates in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each series of securities will be a new issue of securities and will have no established trading market other than the common stock which is
listed on the New York Stock Exchange. Any common stock sold will be listed on the New York Stock Exchange, upon official notice of issuance. The securities, other than the common stock, may or may not be listed on a national securities exchange.
Any underwriters to whom securities are sold by MetLife, Inc. for public offering and sale may make a market in the securities, but such underwriters will not be obligated to do so and may discontinue any market making at any time without notice.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_16"></A>LEGAL OPINION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered hereby will be passed upon for
MetLife, Inc. by Willkie Farr &amp; Gallagher LLP, New York, New York, and will be passed upon for any agents, dealers or underwriters by counsel named in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom939353_17"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of MetLife, Inc. as of December&nbsp;31, 2021 and 2020, and for each of the three years in the period
ended December&nbsp;31, 2021, incorporated by reference in this Prospectus by reference to MetLife, Inc.&#146;s annual report on Form&nbsp;10-K for the year ended December&nbsp;31, 2021, and the effectiveness of MetLife, Inc.&#146;s internal control
over financial reporting have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their reports. Such consolidated financial statements are incorporated by reference in reliance upon the
reports of such firm given their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g939353g25m25.jpg" ALT="LOGO" STYLE="width:6.30556in;height:8.64095in;">
 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g939353g01j01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g939353g01j01.jpg
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M#@\,$!<4&!@7%!86&ATE'QH;(QP6%B L(",F)RDJ*1D?+3 M*# E*"DH_]L
M0P$'!P<*" H3"@H3*!H6&B@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H_\  $0@ 40&F P$B  (1 0,1 ?_$ !T
M 0 " @,! 0             '" 4& P0) @'_Q !4$  ! P,! P8$#PL*!P$
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MR9);YCPWG>''K[H<1Y1Y5O\ #+'-$V2%[9(W#5KFG4$=H*J6L]C&677')1Z
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M9BEV=9/4:'[F\TWMDE8W]FNJKMFQU]5H^Z^FFS7]-)G_ %**KD=;A4\=0)'
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'(B("(B#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g939353g01j02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g939353g01j02.jpg
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M*"@H*/_  !$( 2\&.@,!(@ "$0$#$0'_Q  <  $  @,! 0$
M P<$!08"" '_Q !=$  ! P,!!@,$! <-!00&"04!  (#! 41!@<2%"$Q4A-1
MD0@B06$R<8&A%187-72RT2,W0E15<G."DI2QL](D,S9BDS16=<$X0U/"P^$E
M)B=$8X.BHZ2T&$7QA/_$ !L! 0$! 0$! 0$            !!@4#! <"_\0
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MU#;*RK9!)4.@A?*(8QETA:"=T?,XPN8V6:QGUOIV2YU-JEMCF3NA$;W%P>
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M%OJ8#+QLAQN.#23EN,;H(W<[W5!:J(OSKT0?J(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MUNW89:.+Z# 1[I9_RG!^>0?K(=/J#5%KL4T5/62RR5LS2Z*DI87SS/:.I#&
MG'S/):[3.T'3^HKG+;*.JE@ND6=ZCJX702\NN&N'/Z@J[V/WB_7NIU3J"WVR
MW5T]9<71.EJJYT+XXV-&Y&&B)WN@.ZYY^7)>M>:"UEJ;5]GU%14UEM==0;N7
M,KI)#)NNWAD^$/F/J*"Q-2[0=,Z<JF4ERNL/&O>(Q30_ND@).!D-^C]N%@ZJ
MVJZ2TQ<S;[G<B:MIQ)'!&Z7POYQ'('Y=?DJY]I^AIA6Z/ECB9%++5R-?)& U
MQR8SU'QSS5I:LT[:H=G=[MD%%!'2<%,[=#<^\&$AY/4NR,[QYYYH.BM5PI+M
M;J>OMT[*BDJ&!\4K#R<"M5?M76JS5G!3.J:JX;GB<)14[ZB4-[BU@.Z/F<*O
M/9PN#J?9!//,2^.BJ*@M;Y- #R/4GU6+L0N&I*S2]7>*.U6NNJ+G6RSU-547
M!\4CW@X#2T1.PT <AGIY(BQ=):[L&JIYZ:TUAXV#/BTL\;HIF8.#EKAGE\<=
M%77M(:MH?Q,N%BI9YQ7FHB9,SAY W=SO8WRW=/1O0KU<] ZMN&U6UZO@@L]L
M\%\0J8XJQ\CI6@D/.?";DEAW<?+JMA[3_P"]@_\ 3(?_ 'D5O-G.K;%<M.V:
MSQ2RNGCMT3)&2TDK(\-B =ESFAI'(_'FL^S:TTD;[2Z7L-92R5):_<@HF9BC
M#07$;S?='0\@MGHAK7Z'L#7M#FNMU."",@CPFJGXJ6&D]JUC:>*.)CZ4OW6-
MP,\.>>/L1'0[?-H8TUI^JM-MCG=<ZQG@NF$;A' UP.3O]"\C. .G7X<^RT+J
MBUWJAI:.WR5+IX*5CGB2EEB&  .3G- /,_ K@O:M_>[H?_$X_P#*E5D.I:BM
MT&:6BD\.JGMOA1/SC=>Z+#3ZD(,"7:!909WT[+E64<#BR6LI*&6:!A'7WVM(
M./B1D!;C3.H+;J6V_A"RU'$49D=&V7=+0XMY' //"H_9=M5I]&T,&D-<4%1;
M)Z F)E1X9(P7$^^T<_C](9!^]7/HFWVVAM$KK%40U%NK*B6LB="06#Q';Q#2
M.6 <_P""#&M6N]/W35E;IRBK2^ZTF]XC-PAI+3AP#NA(^/\ \EU"T%OT?8;=
MJ.KOU%;8HKM5 B6H!.79ZD#. 3CF0.:WZ B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@+T.B\KT.B#XE1$6V881$0$1$!$1 1$095H_.M%_3,_6
M"OM4):/SK1?TS/U@K[7Y_KIQ*/*>SL:+^-H1$6(=07?Z8_,E-_6_6*X!=_IC
M\R4W];]8KLZ$X]KEWAZTO=M$1%J'T"(B B(@(B("(B#\(!&",A?J(@(B("(B
M B(@+7:AJZ>BL=?/5S1PPL@>YSWN  &Z5L5@W&T6VYEAN5OHZPLR&\1"V3=S
MY9!P@^?O96OEKMEMU!!<KC1T<KYHGL;43-CWAAP)&2,__-79<-<:6M]+)456
MH;4V-@).[5,>X_4T$DGY +(_%/3O\@6C^YQ_Z4_%/3O\@6C^YQ_Z45I]'ZK;
M<-+UNJ;O,**TS2OEI6S8;X5.SW03_P SBUSOC]( +06RPT>T^UUU]O[1)1U\
M3Z:V0 @FDAWO]YY"5SFAQ\@ WS5B5%HMM30Q451;Z.6CBQX<#X6NC9@8&&D8
M& 2O=OMM#;870VZBIJ2)QWG,@B;&TGS( ZHBC=B6K7Z6U!7[/=2U<1-+.YE#
M4%_NDYSX>?AGJ!YDCK@+8^U?!)+H*VRQL+HXK@TO<.>Z#&\ GY9Y?:K2.D].
MDY-@M)/GP<?^E;&>AI*BA-%/2P2T9:&&!\8+"T?#=/+'R0<9!>K/M!TK7V:R
MU1J14VUS)9F-.Y3N>W#6N)_A9)./^4YQRS4VR7:4-GK*G2&N:>HI&TDKO"F#
M"[PLG):0.9:3EP<,]?)?15LMU%:Z5M-;*.GHZ9IR(J>,1M!^H#"P[YIFR7YS
M'7JTT-<]G)KIX6O<T>0)&<(.7L&NH=;7^GI])&=]IHW&6OKWQ%C'>Z0V%F\,
MDDD.)P,!OS5?ZNKZ5OM0Z;>:B(,BIFQ/=O##7EDN&GYG>;ZA7K;K?1VRC926
MZD@I*5GT8H(PQ@^P<EKSI/3I.38+23^AQ_Z4'%^T=40Q[)[JQ\K ^5\+8VD\
MW'Q6GEY\@3]BUU+93K#V<J.UVV1DM4ZW1>& X?[V,AVX?(DMW?M5EU.G;+5"
M(5-GMTPB8(X_$IF.W&CHT9'(?)36VTVZU^)^#+?24?B8W^'A;'O8Z9P!GJ4%
M+;!-HUJH--MTQJ:JCM5PMKWQL-8[PFO87$X)=@!S22,'Y?/&AUIJRSS>T%IF
M[Q58=:X(61.J@T^&[WI1O-/\)N78WARY'R5\W72.G;O6BLNECMM75#'[K-3M
M<XXZ9)'/[5EBQVH7&*O%MH^-BB$,<_@MWV,&<-:<<AS/((K+I*B.KIHYX"71
M2-#FDM+<CZCS7[55$-+ ^:IECAA8TN<][@T- ZDDJ58=QM=!<VL;<J&EJVLS
MNBHA;(&YZXR#A$<'[/M=356S.@9!,Q[XIJAKVAPRTF9[AD?#D0?M57[2-&76
MW;8X8]-2/IJ?5+'Q2/C')H<,5 /V>_\ ;\E]"46G[-05#9Z&T6^FG;]&2&F8
MQP^'(@96P?#&^2.1\;'21YW'%H);GD<'X(,&..@L%B9 UT=+045.&-WG !C&
M-QS/U!4%[)5;3LK-4T[YF-FE\"2-CG %S09,D#Y;P]5]!7&U6^YA@N5!25@9
MG=%1"V3=SUQD''0+";I33S3EMAM((^(HX_V(*9VWPW71NT:T:^M=.9Z1K&P5
M(^ (RTM<?@'-. ?,?4NKIMNVD*F@CDIW5\EPDPUEO93.,KGGHT$>Z>?S5HU$
M,51"^&HC9+"\;KV/:'-</(@]5IK3I#3MHK#5VNQVVDJOA+#3M:X?40.7V(-%
MJ2GNU3LAOC;HW?NM1;ZF5\+.?AEP<X1#'7=!#?GA<9[/&L+1#H.U6,5!EO J
M)(^$C:2_#I"[?\@P-.2?D1UP#=JUM!8K3;YJB6@M=#2RU'^^?#3L89/YQ Y_
M:@^??:<N5*S7&E<3,<ZD;XLS6G)8TR-(S_9*N^/7FDI(P]NI[)ND9YUT8^XN
MY++.D].DY-@M)/Z''_I7Y^*>G?Y M']SC_THKEZ_:!;+WJ*UZ;TK<&5M74S"
M2IJ*5V\R"!GOO]\<B7;N[RZ;WU9XOVM:B(:6LM-XC?'=6F0,SSW0QP)Q_6'J
MKEM]BM%NG,]NM5!23%N[XD%.R-V/+('3DO-;IZRUU0^HK;1;JB=_TI)J9CW'
MX<R1E$9-OJ8)[;3U$,T;X'QM<V1K@6D$=<JA]CUTHI=NVN'1U,1;5&8P.WQB
M3$PSNGX\N?U*\F6.U,H'T++90MHGNWG4XIV"-Q\RW&">0]%C#2>G0<BP6D']
M#C_TH*K]HZSW.&2PZQL3'236:3,NZ-[=;O!S7D=H((/\[ZUL;)M\TC5VAD]R
MDJ:*N#??I? =(2[R:X#!'EG"MF.&**!L,<;&0M:&-C:T!H:!@ #RQ\%HZ;1>
MF::X"OI]/VN*L#MX2LI6!P/F.7(_-!^Z+J[E<K7)<KM#)2FME,U/22 !U/#@
M!C7?\QQO$? NQ\%OT1!QVN-94^D[[IR.Y2LAMMQDF@FE?TC< TL<3\!G(/UY
M^"KCVAM':<DTW^,%K9!3WQ\T;8.$(_VPN<!C='TG8.]D<^2NRXVNWW-K6W*A
MI:MK00T3Q-D SUQD'K@+76O2&G;56"KMMCMM+4M^C+%3M:YOU''+[$&5I=E;
M'IJTLNI+K@VDB%22<DR;@WL_;E;(D 9)P%^J*I@AJH'P5,4<T+QNOCD:'-</
M(@]4%"[)J^EDV_:X<VHB(F$PB.\,/Q*W.//HL;:L^Y[.]KM/KBCIGU%KKHVQ
M5('($AH:YA/P)#6N!/Q'R*NYFE=/,<',L-I:X'((HXP1]RVE72P5E-)3UD$4
M]/(,/CE8'-</(@\BBJR9MPTM64D0M KJZZSX9!;F4[A(^0]&D_1'/X@E<Y[0
ML]^H-F-EAK)GR>-4-%T?#R:207!F1_ SD#^:U6W9M)Z?LE2ZHM%EM]%4.&#)
M!3M:['ED#./DMI64M/6TTE-6P15%/(-U\4K ]KAY$'D414^K=;Z8N.RZZ6[2
MTG%N?:Y&QTE'$2::,,.3(.C T=<_9E:78W446IMC4^D*>5[KA)3U3)<,.[!O
M.<6%[NG,N&!U.#Y%7/:[%:;32RTUKME%1T\O^\C@@:QK_K '/[5+:K5;[13&
MGM5#2T4!.\8Z>)L;2?/  YH*#V":VI=(,N&CM8O%JJH*ESXGU)W& G&\PN/(
M<QD$\CGKTSB;<=5V>NU]HJMH:QE314%3O35,(+HN4L;B&N')Q '/&<9"ON]Z
M6L5]E9+>;/05TK!AKYX&O<!Y9(SCY*0Z=LQEHI#:J'?HFEM,? ;^X ]=SE[O
M0=$54OM VZIONG;'JW2[GSOM$SI@Z-ASN$M/B $9(:Y@/U'/19VFMONE:RSQ
MRWN2>WW%K?W6 0ND:YW_ "%H/(_/'_FK@^&%S[=%:8;<>/;I^U"LWM_Q12LW
MM[SZ=?FB(='7:LNELJ[W=6/H**I?OT=/48:Z*G#>3G^3G'+L? $*I_97KJ5T
MNK*<3Q^/)4LE8PN&7,]\9 ^(Z>H5[5]#27"G\"OI8*J#.?#FC#VY\\'DL&GT
MS8J:>.:FLELBFC<',DCI(VN:1T(('(H--M U?%I"HT_/72-CMU76FFJ7D?0:
M8W%KOD X-S\LK@=O^DM+U^CZG4=-PL%U&X8)Z9P_VLN<!ND#Z9(.01SY=<*X
M[A;:&Y1M9<:.FJV,)+6SQ-> 2,9 (\B0M7;]&Z:MU:VKH+#;*>I8<LDCIF-+
M#YMY<OL05]KR2JHO9R=#?Y=RY.M]/'(V5WOE^\SD<]7>?U%=!L(J89=E-@$<
ML;C'$YKP'#W2)'<CY+L;C9K9<WL?<K=15CV##75$#9"T>0R#A10:=LM/'-'3
MV>W11S-W9&LIF-#QG.' #F,CXH*3V35E,[V@-<%M1$1,)A&0X8?B5F<>:]^U
M)64[*O1T3IF![*F25XWN;6YCYGR'7T*N2/2VGXI&R16*U,>TY:YM)&"#Y@X7
MNJTW8ZNH?/56:VSSO.7224K'.<?,DC)16CVMR,EV6ZD?$]KV.H7D.:<@C'FN
M;]FV\455LSH:&*HCXNB?*V:(NPYN9'.!QY$'K]?DM[M3HZ2W;*-2P4--!2P"
MCD(CA8&-R?D.2YG8CIJQ7W9389;M::&MFC$S!)-"US@/&?RSC./D@PKA1MUY
MMVMU7;\36?3<3>(JF\V.G#G.#&GH2"6Y_FE78L:WT-);:1E+;Z6"EIF?1BAC
M#&M^H#DLE$:?6-1%2Z4O,U1(V.-M',2YQP/H%5?[*E1"=GM;")6>*RX2.<S>
MY@%D>"1Y<CZ*W;C;:&Y1-CN5%35<;3O-;/$V0 ^8!!6'#IFQ0%Q@LELC+FEC
MBRDC&0>H.!T04OLUKZ5_M':R<VHB+98961G>&'N:^/('F>1]"I_:RJ(18+!"
M96>-QCG[F>>Z&$$X\N8]5;PTIIT$$6"T@CXBCC_TJ6KTY9*RH?/5V:VSSOYN
MDEI6.<[ZR1DHK.H9HJBCAFIY&21/8'->PY!!'4%3.:'M+7 .:1@@]"%CV^@H
M[= 8+?24]+"3O>'!&&-SYX Z\EDHCYLFL]QV*[19+W2TLU5H^M)CE=$-XPL<
M<[KO(M.,$]1RSDG%_6+4-HOU"RLL]QIJNG<,[T;P2WY$=0?D5LWM:]I:]H<T
MC!!&00N9J]G^DJJ9TL^G+49'?2<VF:TGZ\#F@I;VF*NGO.IM*T-GFCKZV$RB
M2"E=XKV%SH\ AN2"<'E\E=FTFHAIMGVHWU$K(VFW3M!<<9)C< /K)("V-FT_
M9[(TBSVNAH=[D33P-83]9 YJ>Y6JWW-K&W*@I*QL>2P5$+9-W/7&0<(*O]E^
MKIY=FK::.:-T\-5+XD8<-YN2",CYA:;VC;!<*6ZV+6]IA=,ZU.8VH:T9W&L?
MOL<?^7)<#Y9"N.AL%GM]0)Z"TV^EG ($D-,QC@#UY@96R<T.:6N +2,$'H4'
M.V?6M@NFFF7R*YTL=#X?B2.DD ,1QS:X9Y$>2X#8789YK[JC6M7 ^!EZJ9#1
M,D;NN,!D+]XCR/NX_F_,+OV:%TJRMXMFG+2*C.]OBD9D'SZ=5T0  P.00?/D
M%UH]&^TK?:G4$PHZ.XTF[#42<F>\(R"3\!F-S<^:QO:5U/0:@TI;FV5SJRBA
MK\/K8Q^XE_AO]QKOX9QDDC('+GDJ^+YIVS7X1"]6NBK_  OH&HA:\M^HD<E^
MU&G[/4TM)2U%KHI*6D<'T\+H&ED3@" 6MQ@=2BJ^VFWNAOVPN\UELF\: T\(
MWMTM&=]AQS'-9FP"\T-;LPM,$%3$:BB8Z*HC+@'1G>)&1Y$$$%96W?=9LDU"
M!AK1%& .@_WK%J]DVE]/WS9CININEGM];.VF+/%E@:YV ]W(G&<?)!IZ*C&N
M=O7X>HL2V33\ I^);S9-.-X[K3\<%Y.1V_,*ZU!14E-0TL=-14\5/3QC#(HF
M!C6CY <@IT1S^OZNGH]%7Z6JFCB8*&89>X#)+' #ZR>2IKV7+]:+9IB[4URN
MM#1U#ZW?;'45#(W.;N-&0"1D9!5[7&S6RYO:^Y6ZBJW,&&FH@;(0/(9!6'^*
M>G?Y M']SC_TH./VF[3M.6?3-?!27*DN-RJ87PP4U+()27.! +MW( &<\^OP
M6@]F71EQT]9;C=+O!)337(QB*"0;KFQLWO>(^&2[H?@/FK8HK%::"024-KH*
M9XZ.AIV,/J MD@^8M-Z@J-BVT"\VB^TL[[!7R^+%+&W)#<G=D;Y\CAPZY'RY
MV@-I]NU740V70LM15W&I($E3X#F,HXL^_(XN Y@=!\7$+OKS9K;>J84]XH*6
MN@!R&5$37@'S&1R*\62Q6JQ0.ALUNI*&)QRYM/$UF\?,X'/[4%*>U'5T\=;H
MV-TS ^.JDE>W/-K<Q\SY#KZ*W]9UE-'HJ]U#YXA :"8B3>&Z?W-V,%9%5INQ
MU<[YZJS6V>=YR^22E8YSCYDD9*].T[97TK*9]GMSJ9CBYL1IF%C2>I Q@'D$
M%4^S(*>NV75] ^1I+ZN:.1@/O!KF-'3ZLKC-FVLYMD5\N>D]8T\[;>9S+%/&
MPG=)Y;X'\)C@ >7,$=.J^BZ"PVBWSB>WVJ@I9@,>)!3L8['ED#*_+W8+1?8F
M1WJV4=<QGT140M?N_5D<D5QEOVBTFLKQ26O1+ZBH:V5DU=7&%S(X(6G);[P!
M+GXW0,="3\%H_:DJZ>/9RRF?,P3S5L>Y'O#>( <2<>0_\PK4M%IMUFI.&M-#
M345/G/AT\08TGSP/BH:W3UEKJA]16VBW5$[_ *4DU,Q[G<L<R1E$8&SJKIZO
M0FGY*:9DC. @!+7 X(C (/S!!"J.6OI3[5L3N(BW6T_@EV\,;_#GW<^?/HKM
MH;%:*![W4-JH*9SVECC#3L87-/4' YCD.2Q_Q3T[G/X M.?T./\ TH*V]JB"
M2;9O3OB87,BN$3WD#Z+=R1N3]I ^U;^UZ\MU?H>IDTY4\35T-G?4O>UF64[V
M1>ZU^?X1(/N_\I7>S4E-/1NI)J>&2E<W<,+V L+?+=Z8^2QZ*S6RAM\E!16Z
MCIZ&0%KZ>*%K(W C!!:!@Y"#C8QI#:MHV&KKXZ6=ABS([>#9J-^/>&]U:0?L
M/S"YGV9:&KH;3J*(3/GLK:\LH)7?1E#<ASV_(X9TY9RK%JM#Z6JI_&GT[:7R
M?%QI6<_KY<_M6^@ABIX60P1LBB8 UK&-#6M ^  Z(*]T[M>T]?=:3:;IV545
M2'OBBFE8!',YN<@<\CH<9 SA6,JX.F[9>=;6ZX6:S04=+05+ZVJN IA$ZJFW
M2UK&' +AEQ<YW0D#&3G%CH"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B O0Z+RO0Z(/B5%]!?D#M_\ +E7_ -%O[4_(';_Y<J_^BW]JT^\KOF_)
M9;=EYR_L/GU%]!?D#M_\N5?_ $6_M3\@=O\ Y<J_^BW]J;RN^;\DW9><O[#Y
M]1?07Y [?_+E7_T6_M3\@=O_ )<J_P#HM_:F\KOF_)-V7G+^P^?47T%^0.W_
M ,N5?_1;^U/R!V_^7*O_ *+?VIO*[YOR3=EYR_L/GU%]!?D#M_\ +E7_ -%O
M[4_(';_Y<J_^BW]J;RN^;\DW9><O["A[1^=:+^F9^L%?:_:78104]3#,+W5$
MQO#P#"WG@Y\UV_XDP?QR7^P%D-9J=K2%NG-W]=D3M_G_ %T;C=*M&+46X]W#
MHNX_$F#^.2_V GXDP?QR7^P%F-TWK+^P^_R[3AUW^F/S)3?UOUBH/Q)@_CDO
M]@+>6VU,H:..G;*YX9GF1C//*Z6B[C6N]6;52-D;.\/[IV)LSZOQ%E<*.XIP
MH[BNZ]F*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q
M08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLK
MA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X
M4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!B
MHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'
M<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W
M%!BHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BR
MN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3
MA1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q0<[J'35JU%"(;U3.JH,8,1F>UAYYY
MM:X _:%%IS2=ETV'"QT9HV.SF-DTA9D_'=+B,\NN,KI^%'<4X4=Q08J+*X4=
MQ3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<
M4&*BRN%'<4X4=Q08J+*X4=Q3A1W%!BHLKA1W%.%'<4&*BRN%'<4X4=Q0<UJ/
M2UGU&P,O=(ZKB '[DZ:0,Y'(.Z' 9Y]<97[IS2]HTY&8[)2NI(2"/";-(Y@R
M<DAI<0#\\972<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.XIPH
M[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"CN*#%1
M97"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.X
MIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"CN*
M#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<
M*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"
MCN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5
M%E<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[
MBG"CN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.X
MH,5%E<*.XIPH[B@Q465PH[BG"CN*#%197"CN*<*.XH,5%E<*.XIPH[B@Q5Z'
M19'"M[BOWAAW%!.B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@^./QZU5_WANG
M]Y=^U/QZU5_WANG]Y=^U<XBV7DT\L=&*\ZIFGJZ/\>M5?]X;I_>7?M3\>M5?
M]X;I_>7?M7.(GDT\L=#SJF:>KH_QZU5_WANG]Y=^U/QZU5_WANG]Y=^U<XB>
M33RQT/.J9IZNC_'K57_>&Z?WEW[4_'K57_>&Z?WEW[5SB)Y-/+'0\ZIFGJZ/
M\>M5?]X;I_>7?M3\>M5?]X;I_>7?M7.(GDT\L=#SJF:>KK+9KC5$ERI&/U!<
MW-=*P$&H=@C(^:NG\,W+^/5'_4*^=+1^=:+^F9^L%?:P>N$S2J4O+]/2?;T^
MG7T;;M6K-K;+8?AFY?QZH_ZA3\,W+^/5'_4*UZ+&^?5S3U=+;+8?AFY?QZH_
MZA7:Z>JIYK1!)-*][SG+G')/,JNEW^F/S)3?UOUBNOH:I;MUIBU,SZ=X>M*9
MF6W\5_>[U3Q7][O5>$6E>[WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO
M[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O
M=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O=ZKPB#WX
MK^]WJGBO[W>JT&I=66/3,;'7RY04KI/]W&272/\ YK&Y<?L"U$>TG3W)U4ZX
MT,!.!45EOGAB/]=S<#[2$';>*_O=ZIXK^]WJM1;=06NZ7"HHK;6P54T$4<\G
M@O#VAKRX-]X<N>Z>7ECS6T0>_%?WN]4\5_>[U7A$'OQ7][O5/%?WN]5X1![\
M5_>[U3Q7][O5<=<=H%FM^NJ+2<_$_A.J:'-<V/,;202 3G.3CX A=<@]^*_O
M=ZIXK^]WJO"(/?BO[W>J>*_O=ZKPN'UKM0TSI&;A[C5OGK<XX:E9OO!^9Y-'
MU$Y0=WXK^]WJGBO[W>JC<0UI)Z 9*Y+9_K^SZZ9<'605(X*1K)!/'NY#L[KA
M@GD=T_/Y(.Q\5_>[U3Q7][O5>$0>_%?WN]4\5_>[U7A$'OQ7][O5/%?WN]5X
M1![\5_>[U3Q7][O5>$0>_%?WN]4\5_>[U7A$'OQ7][O5/%?WN]5X1![\5_>[
MU3Q7][O5:>_Z@MM@@\>[3OIX,%QE\&1[&@=SFM('VK&TQJ^PZH=4-L%SAK74
M^Z90P$%N<XZ@>10=#XK^]WJGBO[W>J\*&LJ8:*DGJJN5L5/ QTDDCC@-:!DD
M_4 @R?%?WN]4\5_>[U7(V?:%IB]5!@M%SXZ48RVGIY7[N3C)PWD/F5U:#WXK
M^]WJGBO[W>J\(@]^*_O=ZIXK^]WJH9I&Q1/D?O;K&EQW6EQP/(#F?J"Y"OVG
M:0M]4^FK[RREJ6?2BF@E8\?6"W*#M?%?WN]4\5_>[U6MM%VI+O"9J%TSHACW
MI()(@<]"-]HS]BST'OQ7][O5/%?WN]5QVO=H%FT1);67KB2:][F1^#'O;H;C
M+G<QR&\.F3\EUR#WXK^]WJGBO[W>JYV_:IH;16,H1%5U]S?&96T5#%XLNX#C
M?(Y!K<\LN(R>BU>C-H]BU7<:FVTAJJ.ZT^?$HJV+PI1@X/+)!Q\1G(0=MXK^
M]WJGBO[W>J\+\) !). $$GBO[W>J>*_O=ZKC]+[1-,:HNU1;;+<V3UD()W"Q
MS-\#J6$CWA]2ZU![\5_>[U3Q7][O5>$0>_%?WN]4\5_>[U7A$'OQ7][O5/%?
MWN]5X1![\5_>[U3Q7][O5>$0>_%?WN]4\5_>[U7'5&T"S0:_AT>_B?PI*S>#
MA'^Y EI>&DYSG=&>F/FNN0>_%?WN]4\5_>[U7A$'OQ7][O5/%?WN]5X1![\5
M_>[U3Q7][O5>$0>_%?WN]4\5_>[U7A$'OQ7][O5/%?WN]5X1![\5_>[U3Q7]
M[O5>$0>_%?WN]4\5_>[U7A$'OQ7][O5/%?WN]5QVAMH%FUI672FL_$B2WO#9
M#-'NAX)(#F\SR]T]<'Y+KD'OQ7][O5/%?WN]5X1![\5_>[U3Q7][O5>$0>_%
M?WN]4\5_>[U7A$'OQ7][O5/%?WN]5X1![\5_>[U3Q7][O5>$0>_%?WN]4\5_
M>[U7A$'OQ7][O5/%?WN]5X1![\5_>[U3Q7][O5>$0>_%?WN]4\5_>[U7A:C4
MVI+3IF@-9?*V.EAYXR"YSL=<-&2?AT'Q0;KQ7][O5/%?WN]5S>A]6V_6=F?<
M[0V=M*V9T ,S0TN+<<\ GES70H/?BO[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\+
M3Z@U%06,T\=499:NI);3TE/&9)IB!D[K1\ .I. /B4&[\5_>[U3Q7][O5<%8
M-I]CNNI'6"HBK[5> <-IKA!X3GG&< @D=.8\_AE=T@]^*_O=ZIXK^]WJO"(/
M?BO[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>
M*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O=ZKPB
M#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O=ZKPB#WXK^]WJ
MGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\
M(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=
MZIXK^]WJO"(/?BO[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJ
MO"(/?BO[W>J>*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[
MW>J>*_O=ZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J>*_O=
MZKPB#WXK^]WJGBO[W>J\(@]^*_O=ZIXK^]WJO"(/?BO[W>J]"1^/I'U42]#H
M@^)41%MF&$1$!$1 1$0$1$&5:/SK1?TS/U@K[5"6C\ZT7],S]8*^U^?ZZ<2C
MRGL[&B_C:$1%B'4%W^F/S)3?UOUBN 7?Z8_,E-_6_6*[.A./:Y=X>M+W;1$1
M:A] B(@(B("(B B(@Q+E<J&UP>/<ZVFHX<X\2HE;&W/EEQ 4M)4P5E.RHI)X
MIX'C+)(GAS7#Y$<BOE#VHY+D[:&R.L,G -I6&C!^A@_3(^&=[.?J'R77>R/)
M<C3W^-YD-I:Z,Q[WT1,<[V[\\8S]B+L?0Z(B((B("(B N5VFZKCT9HZNN[FM
MDG8!'3QNZ/E=R:#\AS)^0*ZI45[6KY!I2R,:3X+JTEWED,=C_%R#8[ --NKK
M=)K?43C77VYR.=%-/[QBC!+?=\B2#TZ# &.:N)[&O8YCVAS'#!:1D$+E=DS6
M-V::9$6-W@(CR\]T9^_*ZQ!7ND-%PZ3VCWJIM-/X-INE(R4,8WW(I6OPYH\@
M0[('UXY!==>]06>Q,8Z\W2BH0_Z/$3-87?4">:VBJW3^FZG3NO\ 56KM8W"W
M\'.=RAGFEP88MXD-][ ;@8& >?/[0L"RWZTWR)TEFN5'7,9](T\S7[OUX/)3
M72YT-JIN(N=93T<&<>)/(&-SY9/Q5!6RX4+O:9H:C3HDBHKA3.\;]Q="V8^$
M\EP#@,@EC3GH2,KU[4]FHJ>.Q7."(BNGJG1OD<]SLMP"!@G  /EA%7?>M36.
MR31PWB[T%#+)S8RHG:QQ'G@GI\UM()HJB%DU/(R6)X#F/8X.:X'H01U"KJZ;
M'M.7B@JC=VSU5YJ@7RW-TCA)XA^(;G=#1T#<8P /FN)]FFY5]OO.I-%W*1TC
M;>YSXQD_N9;)N2 ?(DM/KYHBY:YVGX]1T+JW\&B^O:8Z4R!G$%N"2&9][&,]
M/FN:VP;0*+16G*@,G8Z]5$9924X.7!QY>(1\&CK\R,*M;I9:*R>T[IZ*W0F&
M*>#QW@O+LO,<K2<DD_P0M_[4U!2-T'%6MI8!6.KXF.G$8\0MW'\B[KCD/1%6
M5HZ^T%TL]OCI[I2UE:*2-\S(ZALD@.Z,EP!)ZGGGXE2WG5FG[).(+O>K?1SD
M9\.:H:UV//!.5C:.M-#2:;MT]OHJ.EJY:&,&:.!K7'+ >9 R>>"N+V;65FSN
MR76IU[<+=^$[E5N>Z<OWWS-P &\QO.).\=T ]419MKN5#=:5M3;*RGK*8G E
M@D#VY\L@JD?:RC!LFG),#>;5O:#\>;1^Q0;")XHMK>MZ.UME@M4@=-'3OC=%
MNXE&[[C@"W <1@@<EE>UC_P_I[]-=^HBKV6ETX=/MDKX=.?@T.9+FK;1!@Q(
M>_=_A?7S67>[117NWOH;I"9J5_TH]]S0[D1SP1GKT5*>R='X5NU1&/X%7&WG
M\@Y$7)4ZEL=+42055ZMD,\9W7QR54;7-/D03D*+\;-._R_:/[Y'_ *EKK?HV
MQV^2\7"YT5OJ9ZNJEJYJBHA:[<83R&7#D&M'U=2J6H[12;7MHSC;;?3T.C+0
M[#WP0-B-2<],@ Y=C[&^1/,/I"">&HIV3P2QRP/:'MD8X.:YI^((Y$+1MUMI
M=U?P3=0VDU6=WPQ5,SGRZ]?DN&VOW?A[MI31])35#J&OD+JJFH@&ODIXQRA;
MS #78(/,<AA1[0:"EU'HRKM-)H.[0U#(CP3A2P,$,@^C@B3('P./@@MY%7VP
MV'45'H>.@U;33P5=),Z*'QG!SG0X!;S!/0DCZ@%8*#&N-?26VE?4W&J@I:9G
MTI9Y QH^T\EKK+JJPWR9T-GO-OK9FC)C@G:YV// .<*K=$U\>T+:_J"MN(%1
M;+ / M],\9C:\N+3+N]"X[CCGX9'D%L/:$TO!-I1^I;8P4E[M#F3,J8/<>YF
M\ 02/+.\/+'S*"VGN:QCGO<&M:,DDX "UL6H+/+;9[A%=*)U! \LEJ1.WPV.
M'4%V<?$*NZ6KI=H^Q!]RO4/B53*&??W7.:!-&UPW\ XZM#AGIE<S[.^D[9?]
M!">^QFX4\-;*(:.;G!&[#<OW>CG'IEV< <L<\A=EDOMJOL#YK+<:2NB8=U[J
M>4/W3Y''1;)?/VE[?!I+VEJFTV5G#VVMI"YU.T^ZW]RW\ ?SFG'EG"^@4&%>
M8V2V>NCD:',?!(US3T(+3R7R9LZJY]G&L=,7:HD<+/?:1OBO/0-<=UV?YKP'
M?4?FOK:Z_FNL_H7_ *I5$7K2?XS>S?8YJ>/>K[92\5#@<RT$^(W[6\_K:$6'
MT!UZ*L]ME7/<*&DTG;I"RHNC7SU3V]8J2(;SS\MX@-'GS4NP?5[=3;/J=U5*
M#6VT<+4EQYD-'NO/UMQS\P5B:2:Z_P &KM:U#3N5\,M';@X?1I(@X CRWW9<
M?J"(Y?V1V-&GM0/ &^:J-I/F SE_B5>U340TL$D]5+'#!&-Y\DC@UK1YDGD%
M1?LD?\-7[]+9^HMKJ>^B\[876.KME;=;59*05!HJ9C'B2H=ND/D:YS06M:X8
M'/!15CVK5^G;O6<):[Y;:NI^$4-2QSC]0!Y_8L+:)K:VZ)L,U=7RL-26D4U-
MO>_,_P"  \L]3\%6.V.RU6K+91S:=T=>*.^TD[7QU)BAB.Y@Y&\V0GD=TCRP
ML_:G35%7L#EN&H[?%'J&.FIXYI)(VF5KA,P'#OAGF< _PB@[39;J>EO.D;+Q
M5VI:F\3TXDFB\=IEWN9.6YSR^Y5/MP@BDV\Z(8]C2V4T;7\OI#BG#G]BL_8S
M:K='L^TW6QT%(RL=1M)G;"T2'(Y^]C*K7;9^_P":"_G4?_\ 5.0A]$(B(C2Z
MF=I^..EEU+^#0V.4.IW5H9[LGPW-[^%]7-;"X7"CML FN-73TD)=NB2>1L;2
M?+)/7D?14![2EDH:*_Z4N5-"6U=75/;/(7N=OX=&1U/+&7=/-7_<+?1W* 0W
M&DIZN$.WA'/&V1H/G@@\^904=L@U103[2]H-RN]THX?%G9%3R3U#6AT;7R!H
M:2>8W6MZ*VH--Z>.H?QL@I:<W*2#'&L>=UT9'TNNZ?=_A=<?%4WL(LUKKM=;
M08:VVT51%!6;L3)8&O;&/%E&&@CET'3R73;3[LU^M],:-CH:BHM+HC65=#1-
M:'3L8'>'%@EHW 6$D9YC"*[^FUKIBJKQ14VH+5+5D[HB95,))\ASYGY+?D @
M@C(*IG:E;(]5Z/FH+?H:[07*(--'*:>",1$$9&6R9#2,C"[/8^+]'H6AI]5P
M30W.F+H3XQ!>]@/NDD$YY''V(CE;!H;3\&TV@N.CJ%U-2VOB#7U+7O=%)*]N
MXV%F\2"6Y>3N\AR'7D+7K:NFH*62IKJB*GIHQE\LKPQK1\R>04P&.BIW;[>)
M;%>-&7&MI'UFGZ:K?)5P@9:Y^ &9!Y$@%Y /Q""Q*#66FZ_E17ZV3NWFLW65
M+"=YQ :,9SS) 'UK?JMZHZ8VGTEKK[#64<]QMM93U<;C[LT362-+V.;C> +<
MCRSA60@PKE=;?:Q&;G7TE&),AAJ)FQ[V.N,D97JCN5#6TCZJBK::HIF9#IHI
M6O8,<SEP..2UVMZ>&JT=>XJB)DL9HILM>,CZ!5=^RS^]G+^GR_JL0691:@LU
M?4MIZ&[VZIJ'9W8H:ECW' R< '/137:[6^STW$76NIJ.#. ^>0,!/D,]2J2E
MIX:?VKJ001,C#Z1SW!C<9<:=^3]?)87M3V2BIX['=((BVNGJG1R2%[G;PP"!
M@G  QT'FBKQO6I;)8WQ,O-VH:%\OT&U$[6%P\P">GS6S@ECGA9+!(R2)[0YC
MV'+7 ]"".H7 :DV::>K--W5U?2"MNLU.][[C4'>G,@:<.!_@@'&&C QRPM%[
M,%9-7[,I::I>Y\=-62P1^\00PM:[ /PYN<B+&J':?CU/2F?\&C4,D;F0%P9Q
M)8 20W^%C&3Y=5NE\[P6>CLGM3VVGMT/@P24[YBW>+O>--)DY))YD+K]L%[J
M:W56FM#451)3,N\@DKI(G;KS3@D;@/PWMU^?J'F45W$NM=,15_!2:AM3:O.[
MX1JF9!\NO7Y+8B]6PLK'BXTFY1N#*E_C-W87'X..< \QU6#5:2L,VGI+*;51
MMMQC,8B;$ &\NHY<G?'/7*J?V3&@:8OS3S'&M'/X^X$1<UNO=JN<KHK;<Z&K
ME:W><R"H9(0.F2 3RYA156H[)25#Z>JO-M@G8<.CDJF-<T^1!.0J:V5014WM
M"ZYBIXV11-AD(8P8 S+&3R^LK\]K*FA_ M@J/"9X_%N9XF[[V[NYQGRY!!?:
MT-RUCINV5O!W&_6RFJ@<&*6I8US3\QGE]JYK;IJ:JTUH9[K;(Z*NKYV44,C/
MI1[V2YP^>ZT@?,A8L-/:(]-FQNT!>WT+H]QX?30%SSCF\N\7)?\ '>ZY063!
M-'/"R6"1DL3P'->QP<UP\P1U4BIGV=K3JK3T=VM6H*"JIK6"):,SN:=UV2'
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M1';(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M5MC9$QLOO1,:P8 $?T?4)J/9UIC4DT<M[M\M68AB-CJR=K(QR&&,:\-:.0Z
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M6\>@^0P$55WM%R,I];[.ZB=PC@CJRY[W<@T"6$DD_4KOIKA2555/34U1'+-
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M4$"*?A7=S4X5W<U! BGX5W<U.%=W-00(I^%=W-3A7=S4$"*?A7=S4X5W<U!
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MO1N<;_\ Z'HZE]LI/*1[ '2O'RWG!N?CNKZGT_204-DH*>DB9%#' QK6L:
M T+YV]H>PPZ9T!HNT4YWFTSY6N?WO+6E[OM<2?M7T%4W*&SZ4DN53GP:.C,[
MP.I#69(^Y!LYYHH&;\\C(V=SW #[UZ8YKVAS'!S3S!!R"J/T?<=,ZELXO6NH
M*FZ76N+W^');:F>&ECWB&QQ886@8 RX<R2<E:G9S45VF=KL]JT]3W:715>_#
M!/33-CA<6;V1OM!&'9;D]1USR1%FZOUS!;=9:<TU03,?<:ZJ;Q+1AWA0X)P?
M(N.,?'&3Y+I]3TD%;IVYT]7$R6)]-(US7M!!&Z50>T+2UE@V^:5M\5 P4E?$
MV6IC+G'Q7E\H)))SGD/C\%>,=CMU@TS<:2STK*6F='+(6-)(WBS!/,GR"*IG
MV2:"F?;[_6O@C?4B:.)LCF@N:W=)(!^&3_@%]"JA/9'_ .']0?I4?ZA5]H2+
M0:>TM8-/W&XU%EH8*6LK7"2I+'$EW,D<B3NC.>0P%M+I1?A"BDIC45-,'\C)
M32>&\#Y.^'V*C?9KCDAU=KZ&:>:H?#/%$99G%SW[KYAEQ/4\D1V?M#7NILFS
M*N=12.BFJY&4GB-."UKLEV/K:TC[5N;7IFUWO9A:K)<*9KZ"6WP-+6\BT[@(
M<T_!P//*KGVFM,VBDTE)>J>B:RZ3UT;9)]]Q+@6NSRSCX#X+O= Z3T[8[);+
MU24$=/5\ Q\L^^\\C&"XX)P@WND[#;]':9I;3132"BI0[$E1("X[SBXDGD.I
M*W44C)6!\3VO8>CFG(*H[26H-/:RCJ[[K6&JKGS5#V45$ZWU%13TL#3@8#6%
MA>>9+N9^'):.T33:4VP4GXCTEV?I.XOC954[J2=D43GG=<0'M&-WD[/D2,X1
M5N;5-(V#5-CC.IZN6CI*!YGXB.4,W1C!!R",'ZL],*#8I9JBQZ"IJ6H$[8W3
M334\<XP]D+GDL#A\"1AQ'PWEVM32T]4(Q5013"-XD8)&!VZX='#/0CS4R(BF
MJ(8-WQI8X]XX;ON R?EE>PYI<6@@N',C/,*A]FE\TSJ2_:@IM=0T4NI9*^2.
M-ER8UP$(.&Q1;_)NZ0>0P3UYJQ]!Z0;I.\ZB%&'"UUDD,M*US][PP&D.8,G.
M >GR(\D'9HBIWV@=1UU'4::TY0U$M)#>:G<JIXG;K_"#F-+0?AG?.?J^906X
MRI@DF=$R:)TK?I,#P2/K"F56[5M#62GV=U]19J""VUUI@-32U-*T1RL+.9]\
M<SD ]3UY]5K]A=LEOFB8KS67[4<E75,DII6RW!SV-W9/I1@CW20T#/49<@N#
MQ&>(8]]N^!O%N>>//"_(I8YF;\,C)&9QO-.0OFC9CIVHN^TC75CGN=;^#F/?
M#53&8FHFC;*YK6;_ ,_X1^(&/B5W<=GI=A^@=15]'73U[II&NIHIP &R'W6#
M Z]<N/+(;\,(+:GJ(:<-,\T<0<<#?<&Y]5("" 0<@JLMGFC+9>M(4-WU92Q7
MJ[W6$5,]16M$A:'\VL9GZ  (Y-PN.M-PJMEVV&GTLVIFETM=]QU+#*\NX8O)
M:W=)Z8>"#\B">:"_T7SKM[TW0Z9U3I[54%&TVR6K:VXTS?\ =R.#M[);T]YH
M>#\.7S5@;:-/6B\[.;A7[L$,])2":DJV#=(#>;6 C^"[. .GO(+*15-[--5;
MJS9ZQU)3Q17"&5T%:\#WY' ES7./4^Z[E]JR=!Z7L]SU-J74C*")M/+4NHJ$
M,]UH;&W<EE;CH7/W^8Y\OF4&UEUS!4[4J'2MLF9+X4$TU<YN"&N &['GS',G
M[!YKFO:;ME$_9W45YI(.-94P@3^&/$QDC&]UQ@]%QE#I&Q.]H^OLAML7X*92
MB04^\[=#C"QQ.<YZDGK\5V?M VVDM&QJ:AML#8*2&HA$<;22&Y>2>OS)17=[
M/I8X=G>FGS2,C8+939<XX _<F_%=(TAS06D$'F"/BJDT[LWM^KM"6"75=35U
MCC;H!3112NBBI6^&W=W6CD7XQESLY/P P%K?9CKZME-J;3]5.^:&TU;6P%QS
MN@EX('D,LSCYE$7<M=?[+;]06F>VWFF954,P&_&XD9P<@Y&"#D=0MBJJ]HRW
M/DV>7&XQ7"O@?3"("&&8MB>'2!IWVCZ7)WQ\@@L>R4%#:[32T5HBCAH(&;D+
M(SEH;]?Q^M9@>QSW,:YI>W&\T'F,],K@=F5O%SV0:>I75572M?2-S)2R^')C
MGT<.8^Q55L$L-1?I=84%;=:ME *F-M5X4A;-5$>( '2=0WKG',\N8&<A](Q3
M13%W@RLDW#AVZX'!\BI%\YW2QT^S+;=I9FF'306Z[;L,U.Z0O!WG[A&3S(YM
M(SG!"^C$!05U5#0T515U3Q'3P1NED>>C6M&2?0*=5]M:EDNC+1H^C>YL]]J-
MVH<WK'21^]*[Y9&&CSR4%/Z(U;=+9MI@NU_8^GH]51AS&O/(1/)$!^S=:/J)
M7U"J5]I;2C:K15'=K=%X<UD< !&,8@.&\OYI#3\AE=_LNU,W5NA[7="X&H='
MX=0!\)6\G>IY_40BNK4,=3!(U[HYXGM9](M>"&_7Y*KO:!OK[/;].QU0F_ =
M5<&MN7@D@OA;S,>1SPX9Y?'=POV]Z/TIK#2[*[0T-N95PN9)#+;PV+? <"8Y
M ,=1GD[H<(BUE"RJ@D$ACGB<(_IEKP=WZ_)5C[05\ELUALHD\<6FIN,<=Q,)
M(<^ 9<Z/(Z;P!],?%17S2&D=:Z,EJ=#06UE9&P.IY: -A<2.?A2 8^D.6'],
MY06RHGU,#)FQ/FC;*[Z+"X!Q^H+@]L^JY]-V&BI[?,Z"ONM4RCCG:PO="T_3
MD#0"20.@ SDA<GJ&S;.[AIRJHXJ&X&XF(F.O=:ZLU)EQR>Z0QY<<]<\D%V.<
M&M+G$!H&23T 7#:&UO%JW5VIJ:VRMEM5L;!%%(T#$DA,F^\'XCD /A[N?BN3
MV&RW/4^B[E8-<T-;)%2O8UAK&21F:)V2&DG!=@M/V$!<EL)TC8KSJ/6]/<[=
M%40T=4UD#'.<!&W?E&!@^31Z(KZ36-<*.FKZ*:FK8(YZ>5A8^.1H<' ]0IHH
MVQ1LCC&ZQ@#6CR 7IWT3]2(^/-E5QJ-GVL=/7*K?NV>^0F.1_P#!#/$+,GYM
M>T'ZC\U]B+YQK])_C)[-EHJ:>/>K[6)JJ+ YN9XK_$;_ &>?UM"LO83JS\:M
M TCIY-^X4/\ LE1D\R6CW7'ZVXY^>45/M@N=3'8(+#:G[MUOTO!0D=8X\9ED
M^IK,^H58>R-1P/9J6J?$QU0QT$;7EH):T[Y(!^&<#T"L+3'_ -:=<7[4S_?M
M]M8^TVWR)'.>4?6[#0?(%<)[(?\ V#4_]+3_ .$B#Z#<X-:7.(#1S)/P4=/4
M05 )IYHY0.1+'!V/15EK'3E]U)M5LT5PI>(T130F66,R 1OEP[&^W.7'>W.6
M",?:N#VNOLNE-?:5K=%2T5#<14>%6T] YK6EN\S >QO(9!<#D<_L1'T<HC/"
M(/&,L8AQG?WANX^M5A[1EN?)LZN5QBN%? ^E$0$$4Q9%('2AIWVCZ7)WQ\@M
M;H'9_1:MV<6!^J:FJK*84C134D4KH881SP[#3[S_ #)Y? #S"Y&.:]@<QP<T
MC((.04D>R-A?(YK&#JYQP J,]G::IM.J-9:2?423T-MJ#P^^<[N[(YAQY9 :
M?K"Z"OTO>=0[89I]2T3:K1]'3 T4<KVNA=*0WFZ//O.R7]1\!\D%HP3Q5#-^
M"6.5G3>8X.'W*1?.FHY[3IS;KI?\2:BE@BK9(Z:X4U"\>%ETFZ0YK>0.'#E\
M" >JL7;WJFNTIH"6IM3S%654[:1DPZQ;P<2X?/#2!Y9R@L!U3 V<0NFB$QZ,
M+QO'[%,JYLVSS3URV=4='/0P2U-91LE?7N8'3F9S [Q?$/O9WCGK\NBX/V;H
MJN_"LK;I?+_+56JH#&PNKWNIWL<T@!S#G."#\?)!] N<&M+G$!HYDGH%X@GB
MJ&;\$L<K,XWF.#A]RIB/4UFU;K._C4YJZBRVJ?@Z*ACI)YX9'MSORR"-I#CD
M>Z'=!\/BN1UHZ/3&L[5?MEM!=&,?D5]'#05$4+P", M<P##@2.73 /(H/I=[
MFL87/<&M:,DDX "\2SPQ1"266-D9_A.< /549[4="_\ %*BNL=?<&B6J9$ZE
M,Q$.Z8W'Z'3.6CF?,KJY-F5KU9IZBEU145=96/I&"%S)G1QTHW!@1Q@X\LEV
M23Z +,!! (.05XAGBF+A#*R3<.';K@<'R*^>-A%#<=3V&\Z:NMVJFV6V5(8Z
M*!Y9)*'9'A^)G+8\L)W1S.>N.1\W^P4NS';'I!VE7ST]%=I&P3TSI2]I!D#'
M<SS(PX$9S@A%?1JB%3 9S")HS,.9CWAO>BK;:[JDT-WT_IJ.JJ:1ETD<^LJ*
M5CWS,IV<RU@8"X%W,9 Y %<AM#L^B*S2M0=,6RNI+[3-\6CFIK75QR.>#G#G
MF,9SYN/7GE$7ZO#9&.+PU[3N'#L'Z)\BJHT3->=7[(YV:BGNUMN=()873,+J
M>6;=9EKG'&3U&?,@Y7&^S[IK\:]#7&"\5U3^"#<'F2E@D,9J'EC,F1X.2W&,
M-&.>2<\L!]$0S13LWH)&2-SC+' C/V+B-K6N8-'6-C89F"\5KVQ4D7(D9.#(
M0?@!Y\LX"K73-M;L^]H6'3]DEF;9KI3%YIWO+@W]S>X=>I#F'!//!(4?M.V*
MVTU9I^X0TK6UE;5N942ESB9&@-P.9Y 9/1%?1*\,D9(7ACVN+#AP!SNGR*U&
MG=+V;3AJ#9*".D-1N^+N.<=[=SCJ3YGU7*[,]FHT1>[W<!>*BN_"+N3'LW=T
M;Q=EQR=YW/KR^/FB+$1%PNV:GU-5Z*EIM&->ZX33,CD\.0,>(3G>W22,'.Z.
MO0E!VG%4_C^!X\7C?^SWQO>BF5)[3-(Z1L.RV6&>FME#>X*5LE/,"UM1).T
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MQK&-#6-&  , #R6NOMKENM*:>.Z5]O8YKFO-'X8<X'YO8XC'/FW'7ZD');"
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MT<<C7.B/DX Y!^M!LN*=VA.*=VA8Z(,CBG=H3BG=H6.L>GK:6IGGAIJF"::
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MESCPVOZL:#G)'/W3SZ(+314QM-HKYL[H8M3:5O-RJ**GD:VMM]PJ7U,;F..
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MEGSF2,=0"6]<>1!_P73[4-GMSVBPT+)+U3VZA@/C1PBB<^3><T?2=X@SCGT
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M657'7NZR^+5U(C\-O+.&,;DX:,^9)6FLF@+G;]JMRU5-?I)J"I:X-I/>SS
M:>>-UOP^Q$6,B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(
MB B(@+T.B\KT.B#XE1$6V881$0$1$!$1 1$095H_.M%_3,_6"OM4):/SK1?T
MS/U@K[7Y_KIQ*/*>SL:+^-H1$6(=07?Z8_,E-_6_6*X!=_IC\R4W];]8KLZ$
MX]KEWAZTO=M$1%J'T"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@*I=M&B
M-3:\%!36]MJI*6BE=*V2:I>7R$C ]T1X;R^9ZJVD08-GDN,E&TW>GI:>J'(M
MIIG2L/(<\EK2.>>6/M6<B("(B B(@(B("(B B(@(B("(B B(@(B(*GU5LTO3
M-7U6J=":@_!MSJP.(@J6[T4G(?'!Y<AR(//H0LF@MNU>H<(KE?=.T<)Y&:FI
MG2R#YAK@&Y5GH@T^F;#3V&CDBBEFJ:F=_BU-74.WI9Y,8WG'Z@  .0  "W"(
M@(B(-#KC3-+J_3-99:^26*&H#3XD1]YKFD.:?GS Y*N+3I3:IIJGCM]FU)9;
MA;80&0\?&X/8T=!R:3T^&\5<J(."M6E-07.6&;7E[@K887ME9;J&'PJ<O!R#
M(3[SP#@AIP,CXKO41 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 7H=%Y7H=$'__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g939353g25m25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g939353g25m25.jpg
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MQ  ; 0$  P$! 0$              0(#! 4&!__$ #D1 0 " @$# @,&! <
M 04!   ! @,1$@0A,1-!(C)1%#-A<8'P!2,TL4)2D:'!T>$D!A538O%#_]H
M# ,!  (1 Q$ /P"U@/HWB@
M
M
M
M               ,V#V)\PP>Q/F(6AA 2J
M
M
M
M                            S8/8GS#![$^8A:&$!*H
M
M
M
M                                        #-@]B?,,'L3YB%H80$J@
M
M
M
M                                                     ,V#V)\P
MP>Q/F(6AA 2J
M
M
M
M      S8/8GS#![$^8A:&$!*H
M
M
M
M                  #-@]B?,,'L3YB%H80$J@
M
M
M
M                               ,V#V)\PP>Q/F(6AA 2J
M
M
M
M                                            S8/8GS#![$^8A:&$
M!*H
M
M
M                                                        #-@]
MB?,,'L3YB%H80$J@
M
M
M
M         ,V#V)\PP>Q/F(6AA 2J
M
M
M
M                      S8/8GS#![$^8A:&$!*H
M
M
M
M                                  #-@]B?,,'L3YB%H80$J@
M
M
M
M                                               ,V#V)\PP>Q/F(
M6AA 2J
M
M
M
MS8/8GS#![$^8A:&$!*H
M
M
M
M            #-@]B?,,'L3YB%H80$J@
M
M
M
M                         ,V#V)\PP>Q/F(6AA 2J
M
M
M
M                                      S8/8GS#![$^8A:&$!*H
M
M
M
M                                                  #-@]B?,,'L
M3YB%H80$J@
M
M
M
M   ,V#V)\PP>Q/F(6AA 2J
M
M
M
M                S8/8GS#![$^8A:&$!*H
M
M
M
M                            #-@]B?,,'L3YB%H80$J@
M
M
M
M                                         ,V#V)\PP>Q/F(6AA 2J
M
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MIC^'\9[_ /G^[7T>WE# /LV
M
M                                 #-@]B?,,'L3YB%H80$J@
M
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MCGW?"/@D7K1WCN\V?/8
M                                                    !FP>Q/F&
M#V)\Q"T,("50
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M>/5YJ<5S89GF:6_?$^Z4Z]"MHM&X<=JS6=2 )0
M
M      S8/8GS#![$^8A:&$!*H
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M,
M                            !FP>Q/F&#V)\Q"T,("50
M
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M=LWRN@O%[Z36VBLUK$SV+^ZW'X3_ .#N3JZ:]+UY5C3#/6U+:M.P!T,
M
M                       &;![$^88/8GS$+0P@)5
M
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MWW>4<0F@=-:Q6-0PF9M.Y $H
M                                                    9L'L3YA@
M]B?,0M#" E4
M                                       8=3I\6IQ]C-2+1XQ\F83$
MS$[A6U8O'&T;A'?H;1_U+?\ >D_0VC_J6_[TI$:>MD_S2YOL/3__ (X_T1WZ
M&T?]2W_>ECS[#H<^*V/)2\UGQ^O*5#ULG^:4QT73Q.XI'^BO?Z(;3_V67_,D
M_P!$-I_[++_F2L(CU+_5I]GQ?Y85[_1#:?\ LLO^9+>V?9-%M&KG4Z*EJY9K
M-.;6F>Z?_LDQGD_FUFE^\3YA-<..L[B(VV/IF7XQ]Q],R_&/N:XX/_M?1_\
MXJ_Z0WYV^K8^F9?C'W/.34Y+U[,V[I^$,(M3^&])2T6KBK$Q^$(Y3]0!VH
M
M
M        9L'L3YA@]B?,0M#" E4
M
M
M
M                    !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                 &;![$^88/8GS$+0P@)5
M
M                                              'O#AR9[Q3#CODO
M/A6E9F67;M+;6Z[3Z7'/%LUXI$_#F?%?>K*6Z:V/38-FK."N6W9RYZ^W/$>^
M?GW_ ',LF7C:*1YEI3'RB;3XA3-;L>Y:+%CR:C1YHI>O;B8K,\1\_A/RE&KO
MON^;AME=CS:;47YOHZ6O6\]JMY^<?O\ %J]9:G1[CM6V[CI<&/%ES6O7+V8X
MGM1QW3\5,>6\ZY1Y6MCK&]3X5(!T,0
M
M                       &;![$^88/8GS$+0P@)5
M
M                                    ;.UZN=#N.FU58[4X<D7X^/$^
M#L^.^AWS:XF(IJ-+FCOB?R^4PX>D=DWK6;/G]9H\G%9]O';OK;SC][FZCI_5
MU-9[PWP9O3[3XE<NN.G-3FP:/)MV/UN'2X8Q>KB>;\1X3'Q<_MDR>JC#:UO5
MUM-NQ/A%O"9_"/N=LV[<\.JQ:2+VK34Y\%<\8N?=,>[XJ?Z2=FQ4Q4W/3TBE
MYM%,T1'=;GPMY^YS]-GF)C%>&N?#$Q-ZJ  ]%Q@
M
M                                ,V#V)\PP>Q/F(6AA 2J
M
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MY@
M                                                       &;![$
M^88/8GS$+0P@)5
M
M
M
M        9L'L3YA@]B?,0M#" E4
M
M
M
M                    !FP>Q/F&#V)\Q"T,("50
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M-66?KX_\T+>E?Z*X)+<MAW+;:S?6:3)3'']..+5^^$:TK:+1N)5F)CM( E
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MB8E6UZT^:=+5K-O$*Z-C<-'FT&LRZ74Q$9<<\6B)YCPY:ZT3N-PK,:[
M    <3Q,\3Q'O                2>T;)JMUYC1WT]LD<SZNV6(MQ\>$6M%
M8W*8B9G4(P36[=,[CM>DG4ZNF.N*+17FMXF>90I6U;QNL[+5FLZD 2@
M $OLG3NX;Q$WTN**X8GB<N2>*\_O^Q(Z_H?=M+AG)CC#J(B.9KBM/:^Z8CEG
M.:D3QF>Z\8[S&XA5PM$UM,6B8F.Z8GW,FGP9=3FIAP8[9,MYXK6L<S,M%&,6
M/_1+55R4PY]9H,.KO'-=/?-]>?NCA#;CH-3MNIMI];BMBR1W\3X3'QB??"E<
ME;3J)6FEJ]YAJ@G=MZ5W3<='CU6FQ8_4WY[,VO$3/$\)M>M(W:=(K6;=HA!"
MS?Z#[S_V6'_-A"[MMNHVK5_1M7V(RQ6+3%;<\<HKEI>=5G:;8[5C<PTQ(;-M
M&KWC/DQ:&E;6I7M6[5N(B.>$M_H/O/\ V6'_ #8+9:5G5I3&.UHW$*R)G=NF
MMPVK2?2-;7%7'VHK'%XF9F?E]B&6K:+1NL[5M6:SJ0!*
M      &;![$^88/8GS$+0P@)5                      'VE>U>M?C/#X
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MW*G3&WZ;3[3@PXKY9GCZO=%8\9^<]\>*V3/QO&.L;F5:8N59O,ZA&^BF9_\
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MN_$CJYFDWBO@^SZMQFSE8M/I#VS#M^[X\FFI&/'J*=J:UCB(M$]_'X)#T?\
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M.;8]7%+6]9I\G,X\G''/RGYH9ZF**12.'AP9)M-IY>0!HH
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MVCIZS-@OVHK'C:LQW\?@F_\ +ZF+3X*?'AF(\J]Z+/YQUW]U'YMCTK>.U_\
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MH8@                     ,V#V)\PP>Q/F(6AA 2J
M       -W4;KK=1H,6BRYN=+B]C'%8K$?='?]K2$3$3Y(F8\ "1+8.I-WP8J
MX\>NR=FL<5[41:8\IF.4;J,^749K9=1DODR6[YM>>9EC$12M>\0F;3/F0!*$
MA7>]TI6*TW'5UK'NC+;^+U^G=V_WEK/\ZW\4:*\*_1/*WU9M5JL^KR>LU6;)
MFO$<=J]IF>&$%HC7A#?Q;SN>''7'BW#54QUCBM:Y;1$1][SJ-VW#4XK8M1KM
M3EQV\:WR3,3]C2%>%?.D\I^J1C?=UB.(W+5Q']];^+'BW?<<-KSBUVII-Y[5
MIKDF.U/QEI!PK]#E/U2/Z=W;_>6L_P ZW\4?>UKWM>\S:UIYF9\9E\$Q6(\0
M3,SY2VDZDW?288Q8-=EBD1Q$6XMQY<Q+1UVMU.NS>MUF?)FR>'-YYX\O@UQ$
M4K$[B";3,:F1+:7J3=]+@C#AU^6,<1Q$3Q;B/E,HD3:L6\QLBTQXE(:7>MQT
MM]1?!K,M<F?B<E^>;6XYX[Y[_>UM3K-3JK<ZG49<T_')>;?FP!%8B=Q!RGQL
M 2@2%M[W.VG]1;7ZF<7''9]9/A\$>(FL3Y3$S'@;VW;OK]NB8T6JRXJSWS6)
MYK]T]S1"8B8U*(F8[PD=PWS<MPQ^KU>LRWQ_U(^K6?LA' 16*QJ(3,S/>0!*
M&_BWG<\6.M,6X:JE*QQ%:Y9B(C[WO].[M_O+6?YUOXHT5X5^B>5OJSZO6:G6
M7BVKSY<UHCB)R6FTQ][ "T1KPCRW=/NVX:;#7%I]=J<6*OA6F28B/L>LN\[G
MEQVQY=PU5\=HXM6V6TQ,?>T!7A7SI/*?JD*;WNE*16FXZNM8CB(C+:(C\7C'
MN^XX\F3)CUVIKDR<=NT9)B;<?%I!PK]#E/U27Z=W;_>6L_SK?Q1^7)?-DMDR
MWM?):>;6M/,S+R)BL1X@F9GRE-!O^Z:#%&+2ZW+3''A6>+1'ESX-;<-RUFXW
MB^MU&3-,>':GNCRCPAJ"(I6)W$=SE,QK8E=%U#NNBPQATVMRUQQ'$5GBW'ES
MX(H3:L6[3!$S'A(8-[W'!J,VHQ:O+&?-'%[SWS,><^#7U6NU6KGG5:G-FG_C
MO-FN$5K$[B#E,]MCUBR7Q9*Y,5K4O6>8M6>)B7D2A(QONZQX;EK/\ZW\2=]W
M68XG<M9_G6_BCA7A7Z+<[?5ZR7OER6ODM-KVGFUIGF9EN8-XW+!BKBPZ_58\
M=8XK6N68B(^]HB9K$^41,QX;>KW+6ZS'%-7J\^:D3S%<EYM$3\>]]V[=-=ML
MS.AU.3#SXQ6>Z?L\&F'&NM:['*=[VDMPWW<]PQ^KUFLR9,?OIW5B?.(:.GS9
M-/GQYL-NSEQVBU;?"8[X8PBL1&H@FTS.Y2FDZ@W;23:<.OSQVIYF+3VHY\IY
M:NX;AJ]PRQDUNHR9K1X=J>Z/*/<U1$4K$[B";3,:F2.[P3&GZFWG!BC'CU^7
ML1'$=KBTQ]LQRAQ-JUM\T;(M-?$LVKU6?69IS:K-?-DG^E>>98:S-9B:S,3'
M?$P"8C79"0S;UN>?3^HS:_47Q3'$UF\]\?/XH\$16(\)F9GR-[!N^XX,5<>#
M7:G'CK'$5KEF(B&B$Q$^41,QX27Z=W;_ 'EK/\ZW\6IJ]9J=9:MM7J,N:U?"
M<EIMQ][ $5K'B$S:9\RV-'KM7HNU]#U.;!V_:]7>:\^?#8MOFZ6K-;;CJYK,
M<3$Y;=_XH\)K6>\P1:8]TAMN];CMF.U-#JKXJ6GF:]TQS\>):^JUVJU6IC4:
MC49<F:)YB]K3S'E\&N'&L3O7<Y3K6TKJ>HMVU.FG3Y]=EMBF.)CNCF/G,=\H
MH"M8KX@F9GRD(WO<XT_J(U^IC%QQV?63X?!'@16(\$S,^6_MN\;AML371:O)
MBK/?V8GFOW3W&X[SN&Y5BNMU>3+2._LSW5^Z.YH".%=\M=SE.M; %D,V/59\
M>ERZ:F2U<.68M>L?TICGCG[VWH-\W/04[&EUF6F/^I,]JL?9/<CA$UK/F$Q:
M8\2E-=U!NFMQ3CU.MRVQSW36O%8GSB.$6!6L5[1!,S/EETNIS:3/7-ILM\66
MOA:L\2WM?O\ NFOPSBU6MRWQ3XUCBL3Y\>*,":UF=S!%IB-1+?Q;SN>'%7'B
MW#54QTCLUK7+:(B/A'>U]7K-3K+Q?5Y\N:\1Q%LEIM,1]K $5B.\0<IGMMM:
MK<=7JKXK9]1DM;%$5Q]_'8B/#CCP;]>J-ZKB[$:_+QQQS,1,_?QRAA$TK/:8
M3%[1XEDSYLNHRVRY\E\F2WC:\\S/VL8+*I#;MYW';J=C1ZO+CI_4YYK]T]QN
M&];CN-.QK-7ER4_J<\5^Z.Y'BO"N]Z[IY3K6WK'>V+)6^.TUO6>:VB>)B6_^
MG=V_WEK/\ZW\4<)FL3Y@B9CPV=9N&LUE:QJ]5FSQ7OB,EYMQ][6!,1$=H1,[
M\MG0;AJ]ORSDT6HR8;SX]F?'SCWMC7[YN6X=B-7J\F2M9BT5[HCGX\1W(X1-
M*S.]=T\IB-;26LWW=-9S&HU^>T3XUBW9C[H[FMI-?J]':\Z34YL,W]J<=YKS
MY\-8(I6(U$'*9G>TC^G=V_WEK/\ .M_%AP;EKM/ERY,&KSX\F6>;VKDF)M/S
M^+4$<*_0Y3]4C^G=U_WEK/\ .M_%XP;ON.GQQCP:[4XZ1,SV:9)B._OEHAPK
M]#E/U;V?=]QU&*V+/KM3DQV[IK?),Q/V&V;MKMLFTZ'4WPQ;VHCB8G[)[FB)
MX5UK1RG>]MG7[AJ]?EC)K-1DS7CPFT^'E'N;MNH]WMI?H\Z_-ZKCCQCGCS\?
MQ1(B:5GMHY3]1OZ;>=RTV#U&GUVHQXH[HK6\\1Y?!H"9K$^41,QX?;VM>TVO
M:;6F>9F9YF6WMVZ:W;;3.AU.3#SXQ6>Z?./!IA,1,:DB9CO"2W#?=SW#'ZO5
MZS)DQSXT[JQ/G$(T"*Q6-1"9F9[RW=MW77;;:9T.IR8>UXQ$]T_9/<R:G?-R
MU.JPZC/J\E\N&T6QS/'%9^,1X(X1PKO>CE.M;;^LWG<=9S])UN>\3_1[<Q'W
M1W- $Q$1VA$S,^1OX]ZW/%2*8]PU5*5CB(KEM$1^+0":Q/E,3,>$E^G=V_WE
MK/\ .M_%CR[ON6:O9RZ_57K\)RV_BT1'"OT.5OJ3/,\SWR LAFTFJSZ/-&72
MYKXLD>%J3Q*2S]3[SGQ3CR:_+V9CB>S$5G[XCE#BLTK:=S"8M,=HDGOGF6S;
M7ZJVAIHYS7^BTF;1CCNCF??/Q:PM,1*-Z2VCZBW;1X8Q8-=DC'7NB+1%N/+F
M)X:6NU^JU^7UFLU&3->/";SSQY?!K"L4K$[B$S:9C4R-[;MVU^V\_0=5DQ1/
M?-8GFL_9/<T1,Q$QJ41,QWA([CO>X[C3L:S5Y,F/^IX5^Z.YI:?/ETV:N73Y
M+XLM?"])XF/M8PBL1&HA,S,SN4E^G=V_WEK/\ZW\6*F[[C3-?+37:FN6\1%K
MQDGFW'AS+2$<*_0Y6^J1_3NZ_P"\M9_G6_BC[3-K3:TS,S/,S/O?!,5B/$$S
M,^4A&][G&G]1&OU,8N..SZR?#X(\"*Q'@F9GRD=MWO<=MQS31:O)BQSW]GNF
M/NECR[KK\NLKJLFLSSJ*]U<G;F)KY?!I".%=[T<IUK:1G?=UF.)W+6<?WUOX
ML.DW+6Z.EJZ75Y\-;3VIC'>:Q,_'N:@GA7Z'*?JD?T[NO^\M9_G6_BC[VM>]
MK7F9M:>9F??+X$5B/$$S,^1+Z7J7>-+BC%AU^7L1'$1;BW'WPB M6+?-&R+3
M7Q+/K=9J==F];J\^3-D\.;SSP^Z;6ZG2XLF/39[XJ9)K-NQ/$S,<\=_VM<.,
M:T;G>TQ'4^\QA]5&X9NSX<]W:^_Q1%[6O>UKVFUK3S,S/,S+X%:5KX@FTSYD
M 2AO[;O.X;;6:Z+5Y,5)[^SXU^Z>YZOOFY7U^/67U>2VIQ\Q2\\3V>8XGB/"
M$<*\*[WI/*WC;<UFZZ_6<_2M9GRQ/NM>>/N\&F"T1$=H1,S/E+TZEWBFGC!7
M<,T8XCB/#G[_ !_%IZ;<]=IIR3I]9J,4Y)[5YIDF.U/QGXM05BE8\0MSM]6Y
MJ=UU^JQ3BU.MU&;'/C6^2;1]TM;#ER8,M<F&]L>2L\Q:L\3'VO F*Q':$3,S
MW34]4[U.+U<[AE[/AS$1$_?QRA\E[9+VODM:U[3S-K3S,R\A6E:_+&B;3/F1
MDTVHS:;-7+I\M\66OA>D\3'VL8E"2_3N[?[RUG^=;^)^G=V_WEK/\ZW\4:*\
M*_1;G;ZLVKU>HUF2,FKSY,V2([,6R6FT\?#O88GB>8[I!:(UX53&+J;>,>'U
M5-?E[,1Q$SQ,Q]L]Z)RY;YLELF6]KY+3S-K3S,_:\B(I6OB$S:9\R]X,V73Y
M:Y<&2^/)7PM2>)C[4Q7JO>ZT[$;ADX^=:S/W\<H01:E;?-&R+37Q+/K-9J=;
MD]9J\^3-?XWM,\, +1&NT(WM*Z/J+=M'CC'@UV6*1W16W%HCRYY8M?O>Y:^D
MTU>LS9*3XUYXK/V1W(\5].N]Z[K<[:UL 65                        9
ML'L3YA@]B?,0M#" E4
M
M
M
M           !FP>Q/F&#V)\Q"T,("50
M
M
M
M                        &;![$^88/8GS$+0P@)5
M
M
M
M                                     9L'L3YA@]B?,0M#" E4
M
M
M
M                                                 !FP>Q/F&#V)
M\Q"T,("50
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M4)R4X3J0!HH
M                                 S8/8GS#![$^8A:&$!*H
M
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M( L@
M                         !FP>Q/F&#V)\Q"T,("50
M
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MC4,IG8
M                             #-@]B?,,'L3YB%H80$J@
M
M                      #)I\V33YJY<%[8\E?"U9XF&,!)_I_=O]Y:O_-E
MJZW<-7KNS],U.7/V?9]9:9X:PK%*QWB$S:9\R +(
M  ;6BW'6:&+1H]3FP1;OGU=ICEL_I_=O]Y:O_-E&"LTK/>83%ICQ+WFRY,^6
MV3->U\EIYM:T\S)ARY,&6N3#>:9*SS%JSQ,/ MKV0D_T_NW^\M7_ )LM;6[C
MK-;6L:S59L\5[XC):9X:HK%*QWB$S:9\R +(
M
M                    9L'L3YA@]B?,0M#" E4
M
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MZ-IXXHU:K5U]<--=J*Z7M3@K>8QS:>9FO/<P ]".SC
M
M                    9L'L3YA@]B?,0M#" E4
M
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M]\_@XK8HQYZS3W=-<G/%:+>SFP#O<@
M
M       #-@]B?,,'L3YB%H80$J@
M
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M 75
M                                         9L'L3YA@]B?,0M#" E4
M
M
M
M                                                     !FP>Q/F
M&#V)\Q"T,("50
M
M
M
M      &;![$^88/8GS$+0P@)5
M
M
M
M                   9L'L3YA@]B?,0M#" E4
M
M
M
M                               !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                            &;![$^88/8GS$+0P
M@)5
M
M
M                                                         9L'
ML3YA@]B?,0M#" E4
M
M
M
M         !FP>Q/F&#V)\Q"T,("50
M
M
M
M                      &;![$^88/8GS$+0P@)5
M
M
M
M                                   9L'L3YA@]B?,0M#" E4
M
M
M
M                                               !FP>Q/F&#V)\Q
M"T,("50
M
M
M
M&;![$^88/8GS$+0P@)5
M
M
M
M             9L'L3YA@]B?,0M#" E4
M
M
M
M                         !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                      &;![$^88/8GS$+0P@)5
M
M
M
M                                                   9L'L3YA@]
MB?,0M#" E4
M
M
M
M   !FP>Q/F&#V)\Q"T,("50
M
M
M
M                &;![$^88/8GS$+0P@)5
M
M
M
M                             9L'L3YA@]B?,0M#" E4
M
M
M
M                                         !FP>Q/F&#V)\Q"T,("5
M0
M
M      !LZ3;]9K*S;2:7-FK$\3..DVXG[&LR:7+?#J,>3%::WK:)B8GB8E$[
MUV(U[MW]!;M_NW6?Y-OX$[%NL1S.VZS_ ";?P=HU<S&ES3$\3%)XF/*7(MEZ
MFW';]9CO?59LV#M1V\>2\VB8]_'/A+DP]1DRQ,UB.SIR8:8YB)GRALV'+@O-
M,V.^.\>-;UF)_%DTFCU.LO--)@RYK1',QCK-IC[G9]YVO3;OH;X-12LS,?4O
MQWTGW3#BD3?!FYK::Y*6[IK/$Q,-,&?UHG7:84RX?2F-^&]^@MV_W;K/\FW\
M$?>EL=[4O6:WK/$Q,<3$NS]/;E&JT&BIJ,L6UE]/7-:)[IM'AS]\*YZ0.G/7
M4ONFBI_*5CG/2(]J/ZWG\66/JYF_"\::7Z?5>59VH6CT.JUDVC2:;-GFOCZN
MDVX^YGR[-N6+';)ET&JI2L<S:V*T1$?<TL62^+)6^*UJ7K/,6K/$Q*Q==ZK-
MJ-TPURY+36NGQVBONB9CF9X^UTVM:+Q$>&$1'&9E%8MFW++2M\6@U5Z6CF+5
MQ6F)C[GK]!;M_NW6?Y-OX)GT;9;TZA]76TQ2^*W:KSW3QQ*V^D3/FTVPUOI\
MN3%?U]8[5+36?"WP87SVKEC']6M,5;4F[F>IVS7:6O:U.BU.*L?TKXK1'W\-
M1TOT=[UJ=QQZG2:[).:V*(M2]N^9B>Z8F?>B?2-LNGT5\.NTE(QUS6FF2E8X
MCM>,3$?>M7J)]3TKQW1;#'#G65*;&DT.JUG:^B:;-G[/CZNDVX^YKOM+VI>+
M4M-;1/,3$\3#IG?LPC\4A^@MV_W;K/\ )M_!\OLFZ4K,VV[61$>_U-OX.TZ6
MTWTF&]IYM:D3,_8Y5T_U%K])O.*N359<VGOEBEZ9+3:.)GCF.?"7%BZC)DB=
M1'9U7PTIK<^5<O6U+36]9K:/&)CB8?'8NJ]DT^Z[=FFV.L:K'2;8\D1W\Q[I
M^3CK;!GC-&X99<4XYT,DZ?+&FKJ)QVC#:TTB_NF8B)F/QAYQ8[9<E,>.LVO>
M8K6(]\RZKN/3E)Z.C;L58MGP4]968]^2.^?O[X^U.7-&*8B?<QXIR1,Q[.4/
M6+'?+DKCQ5M>]IXBM8YF7D;,DC&Q;K,<QMNL_P FW\#]!;M_NW6?Y-OX+YZ+
M\M[[/J:7M-JTS?5B9\.8A%>DC6ZK3;U@KI]3GQ5G!$\4R36.>U;O[G)&>\Y9
MQZAT3BK&/FJ>?:MPT])OGT.JQTCQM;%:(^_AINB^CO?=5K<V?0ZW+;-V:>LI
M>\\VB.8B8F??XPU_21LNGP8L6XZ;'7':U^QEK6.(MS$S$^?<FO43&3T[PB<,
M33G65-TNVZW5T[>ETF?-3GCG'CFT?@S?H+=O]VZS_)M_!BV7+?#NVCOBM-;1
MFIWQ/S=JW&]L>WZJ])XM7%:8GX3$2C/GMBM$1'E.'#7)$S]'%,FV:[%FQXLF
MCSTRY.>Q2V.8FW'CQ#-^@MU_W;K/\FW\$?:TVM-K3,VGOF9][JGHVRWR=.S&
M2TVBF:U:\SX1Q$\?C*^?+;%3EY5Q8ZY+<7._T%NW^[=9_DV_@U]5M^LTD<ZK
M29\,?')CFL?BM77FXZW1]23&EU>?#$8J3%:7F(]_N6WH_<[;WL?K-76M\E;3
MBR<QW6XB)YX\IAG;J+TI&28[2O7#6UII$]W'Q8>NMJP[7O79TU8KAS4C+6D?
MT>^8F(^7=^*O.JEXO6+1[N>U9K,Q)$<SQ#)J<&739[X=12<>6D\6K/C$IWH7
M;/TCON.UZ\X-/_*W^<QX1]_Y2E_2;MGJM5AW''7ZN6/5Y./ZT>$_;'Y,YS1&
M6,;2,4S2;J."<Z+VS'NF^XL.>.UAI$Y;U_K1'N^^8:7M%*S:?9G6LVG4-7;]
MCW/<,?K-)H\N3'[KSQ6L^4SXL>X;1K]NB)UNDRXJS_2F.:_?'<LWI)S:O%N.
M'!$WQZ&,<>KK7NK,]_/V^"$Z?W_5;3J*\WMETDSQDP6GFLQ\N?"65+WO7G&O
MR_\ 6EJTK;C**SX,FGO6N:DTM:M;Q$_"8YB?NEC3_766F;J+-EQ3$X[X\=JS
M'OB:1P@&N.W*L6E2T<;3  LJ
M                          S8/8GS#![$^8A:&$!*H
M
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MDI%H<>2G"TU &B@
M                #-@]B?,,'L3YB%H80$J@
M
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M7="M@TI2*5BL*VM-IY2 +*@
M                        ,V#V)\PP>Q/F(6AA 2J
M
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MTF70ZW-I<\1&7%::VX\/-2N2MK36)[PM-+1$6F.S7 75
M                                                    9L'L3YA@
M]B?,0M#" E4
M
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M.QEK$>%HM/Y\\H-O29F-VCNQM$1.H %D
M                                  ,V#V)\PP>Q/F(6AA 2J
M
M                                                           /
MM/;KYOC>VO3Z7+EK;6:['IL<6CM1-+VM,?+B)C\43.HV1&W:]9_LF?\ N[?E
M+@T3Q/,>+KF3J_8<F.U+:V>+1,3_ "5_X*5I-#TUAU$9-3O&748JSS&*NGO7
MGY3/#S^DWBBW*)_TEV]1K),<9C_5TG8LN3/LNARYYF<M\%+6F??/$=ZEZ*,&
ME])V6F/LQ2TS$<>$6FG,_CRV-UZ]T^/!.+:,%K7X[-;Y([-:^4>_\%!C5YXU
MD:OUEOI$7]9V_?VN>>3!T]_BFW;<&7-7X8COIT;THQ/Z&TL^Z,__ "V:OHIC
M^2W*?=VL?_,QZ_?-OZFV*-+J]130ZVMHO'K(GL3:.[QCW=\O.R[KMO2^TYJ5
MU5-=K<MNUV<'/9\.(CM3[OXHBMHP3BUWV<J^KZF^R.])>2M^HJUKXX\%:V\^
M;3^4PO71OZL[?_=_OER34:B^Y;CDSZO-2E\UNU;):)XK]D1,\>YT?9>I=CV[
M:M-I)W#MSBI%9M&')WS[_<MU&.T8JTB-S",-XG):TSIS37?[;J/[RWYRGNDO
M5;?BU6\ZNMIQX.,.**]TVR6^'/PCG[T=K=/H[[I?U6XX9TV2]K>MG'D^K'/A
M,=GGGR3N\7V//L6CT&W[I6DZ>TWF<F')QDF8[YGBOBZ<EMUBNI[_ (2QI&IF
MWT1DZCIZ9F9T>XS,^_UU?X.E]+[I@W3:J9-/ZR(Q?R4QDF)MW1[Y^<.,7B*V
MM$6BT1/$6CPGY]ZX]#[EH-EG47UFY8^SFK7^2ICR3Q,?&>SQ\8[F74X>5.VY
MG_5?!EU;OX:'7NV?H_?<EZ5XPZG^5K\I_I1]_?\ :KCHG56[;!OFWQB_2$8\
M^.>UCO.')Q$^^)^KX2YY>(K>U8M%XB>(M'/$_/O:]-:TTB+1J89YJQ%IFL]G
MQ*=0[;^CM9CK6LQARXJ9:3\>:QS^/*+7S=MYV'<=%IMOUDYHMBQ5[.IQUB8I
M;LQS[^9CX]RV2]JVC4;A%*Q:)W*N[%U+N&T6K7%DG+I_?AR3S7[/A]CJ%-9I
MMWZ=R:F(_P"KYL-NU%O=W3$Q/DYE&QZ2;]K].;?ZC^M];M\?V>/WI#=^H=-I
M]DILVR3>V"*]G)GO'$WYGF>(^;FS8JY;1-([ML62<<3RGLEO15>OT;<,?].+
MTM]G$_P8.N=VW7:]Z[.GU,X]/DI%J1V*S'PGOF/C'XJUTOO-]DW*,\5F^&T=
MC+2/?7Y?.%]W'<^FM]T-:ZS58XB.^O:YI>D_+_S,*Y*33-SFNXE:EHOBXQ.I
MA1-1U'O&LTV7!EU=\F&U9B]?5U]G[(=&Z$R5R=+:+L_T>U68^$]J7/MYU>V:
M;!DT6Q5R6QY)_EM1D]J\1WQ6/#B.>_P[^YM=%=2QLU[Z?5Q:VCRSVN:]\TM\
M>/@OGQ>IB^"NE<63A?XIVB.H]';0[WK<%XXB,DVK\ZS/,?A*.=/WS4]+;OBK
MFUFKQ]ND=U\<S%^/AQQ^Y1=[UNCRQ32[5IYPZ+'/:YOWWR6_K6G\H:X<LWB(
MFL[9Y<<5F9B71O1[^JVG_M7_ &I43+^O<_\ ]P__ 'B;Z"ZDTFBT5M!N&2,,
M5M-L=Y]F8GQB?AWFLU73FAW^-PPYKZO49,L7FL=^/%S/??P[Y\9B.]SUBU,M
M]Q/=M,Q:E>_A8NOOU5UGG3]N'/.BOUHV_P#MS^S*Y=1]0[+NNS:C1X]PBE\D
M1V;6PY..8F)[_J_)3^D\FCT>\XM7K=93%CP6F8B*7M-^Z8[N(\/-/3UM7#:L
MQ.^_M^",LQ.6LQ*[^DN9CIVO'OSUB?NLY8Z+U9O>S;SM,Z;!N-:9(O%ZS?#D
MXGCGNGZOS<ZGNGQY:]'$UQZF-*=3,3?<2Z#Z*?8W/SQ_\R*])GZPX_\ #U_.
MS;Z%W3:]ETNHMK-?6,N>:SV*XKSV>.?&>SX]_N:'7.LV_=-;CUF@UM<DQCC'
M;'..]9[IGOB9CCWLZQ/VF;:G2TS'H17?=>>AOU5T'E;]NSE.[_SKK?[^_P"U
M*Z=$]5:+1[930;C><,XIGL9.S,Q,3//$\>$]Z ZBR[/&?53MEKZC+J;]JV7)
M7BN*.>9BO=SSS[_@8*VIEMN/)EF+8ZZGPN_HX_5JG][=5+7KC](_:OX?2^/M
MGNA-]*[[LVS[/CTN;<:WR1:;6FF')QWS[OJJCU/FTV7>LVMV_65S5RW]9'%+
M5M2?GS$>_P"",5)G+?<3J=IO:(QUU/AT?K7/K-+L=]1M^2<>3%>MK3%8GZO?
M$^/G'W.=QU9O<>&NM'ECI_!==EZPV[7Z&,6Z7I@SS7LY*Y(^I?XS$_/X2@=T
MCI?;<EM1H.UK-3XX\/:F<59]TSW=\?+F5,$<-TO3<_DMEGE\=;=D!I==N6/=
MLFX4FTZS%_*9)FO'=W1/,?#OATSIOJ;2;U2,<3ZG5Q'UL5I\?G6??#GW2VXX
M,6]:C4[K?M8LN+)&7M1SV^?=]K;T6@VC'NF'6Z3>\>+38\D9.QDK:,E>)Y[/
MS\VN?'6_:T:F/$_\*8;S7O$MKTC[-@T6?#K=+6,<9YFN2D=T=KQYCS4M9NM^
MH,>\ZK%CTD6^BX.>+3'$WF??Q\%9;]/%HQQ%_+'--9O/'P -F8
M                                                   #-@]B?,,'
ML3YB%H80$J@
M
M
M
M    ,V#V)\PP>Q/F(6AA 2J
M
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M?)%*32\6[7=,\QQ[NY$)K:+1NLDUFO:0!*
M          &;![$^88/8GS$+0P@)5
M
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M+J9[-IQ17)BR1\YB.[Y3$N3M^FR>I3>M,L].%M; '0Q
M                   9L'L3YA@]B?,0M#" E4
M
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M2Q]1]2?I'1X=!HL,Z?08HB(K:>;6XCB.5<!-*12-51:TVG<@"RH
M                          #-@]B?,,'L3YB%H80$J@
M
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MY.\.,B:ZGU=9W/6:7!I=+@P8LLTK&/#6)^K/'//'/N0K>L\HVRM&IT )0
M
M                       S8/8GS#![$^8A:&$!*H
M
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M 'K+WLOUNF]%%N_G2TB?^Y#*^7)6E,G+RTKCI:UJ:<4 >DX0
M                                                           &
M;![$^88/8GS$+0P@)5
M
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MHOFR5QUO;OGL4BL?=#"[H<@
M                                  #-@]B?,,'L3YB%H80$J@
M
M
M,N+39\U9MAPY<E8GCFM9F 8AL?0=7_[+G_RY:]HFMIBT3$QW3$^XB8DT RXM
M-GS5[6+!EO7GCFM)F#>AB&Q]!U?_ ++G_P N6O,3$S$QQ,$3$F@
M      'VMIK:+5GB8GF)6O6=2:#>M+AQ[YH\T9L7LYM-:(GO\>Z53;.CT&KU
MLS]#TV;-QX^KI,\*7I6>]O9>EK1VCW24?Z.4GM1&ZY>/Z,^KK$_;WL>];Y?<
M-/@TF'#73:#!_J\-9Y^V9]\M'6;?K-%Q]+TN;#$^$WI,1+!DQ7QQ2;TFL7KV
MJ\QXQSQS^$HBE9F)WLFT^/#R T4      ![Q8LF:W9Q8[WMQSQ6.99+:/4TK
M-KZ;-6L1S,S28B#<&F
M                            &;![$^88/8GS$+0P@)5
M
M                                                     &WM>LU&
MDU>&^FS9,<Q>)XK:8B>_WM1DTW^T8O[4?FB8W'=,=I=NT&NIJLVLPQQ&339?
M5VC[.8G\?P<U](>V?0M[G44KQAU4=N/[7]*/RG[4OHMS^@>D/6XKVXPZJ\8K
M?VN([,_?W?:G^N-L_2.PYNQ7G-@_E:?9XQ]W/X/+Q_R,L3[3#OO_ #<<_6'(
MJUFUHK6)F9GB(CWNO])5II,&3;,<1VM'6GK;1[\EN;6^[N<YZ4PT^GWUNHCG
M3Z&DY[?.T>S'VSPMWHSSWU/Z6SYI[63)EK>T_.>TZ.L^*D_@QZ;M:/Q8?2?K
M,^&VAPX<U\>.T7M:*VF.U/=QRY[/?/,KUZ5/]IV_^Q?\X5OIG9LF][E&GK::
M8JQVLE_ZM?XK]-,4PQ:5,\3;+,0B1=^J+Z#IS4:?1:#;-)FM-(ODOJ:>LF>^
M8X_!L;OTSI-RV/'NFT8?49K8HRSAK/-;=W?$?"5HZB.TS&HE'HSWB)[PH EN
ME_H^3>-/I]7I<>HQ9[UQSVYF)KS[XXE>NH>E-N_1E_H.FQZ?+VJS.6;3Q2O/
MUIGF?ARG)U%<=HK;W13#-ZS:'+QT[;]%TM?9,WJ9T^7'2LQDRY.[)SQX]_?'
MRX5SHCIK'O%LFJUDV^B8[=F*Q/$WMY^Z/#[T1U-=3:8F-)G!.XB)WM5!<=\W
M#0[=O\Z'#M>AG189K3)VL7-[?&>UX]W/X)_?-BV+:M#?67VJ^;'68[<8\MHF
ML3[_ &O!$]3$:W$]_!&#>]3X<O%@Z:V3%OV\9ZTFV#18YF\Q'?:*S/=6/G\_
MDE-VS:7I_>JZ+]"Z*^E^K,7RQ-[WK/C/,SW=_/N:3FB+<(C<JQCF8Y3X4L='
MZTZ7T5-KS:[08:X,N&.U:M.ZMJ^_N]RE=.VP3NVFPZK38]1BS9*X[1?F)CF>
M.8XGYHQYZY*3>I?%-+<91HZIOO36QZ?:L^6V&NEK3BTY:S,S$<QS$1,^,^'V
ML/2N'8=XT>?'I]KI2,,Q6WK8BUIB?">UX^Z67VRLUYQ$Z:?9IY<9ES$2_5>V
M4VG>LVFQ<^IXB^/GQB)]WYPB'56T6B+0PM$UG4I'IS;HW7>=-I+3,4O;F\Q_
M5B.9_);.O]5J=J^AZ';IMI-%ZOG^2^KVIY\.8^S[U5Z9W"NU[WIM5DY]769B
M_']68XF?QY=?U6FT6\:&*YJ8]1ILD=JL_OB?<XNIR3CRUM:-U=6"G.DQ$]W)
M]HZCUFBRQ749+:O26GC)@S3VXM'RY\);?7N3!EW329-)%8T]M)2<<5CB(CFW
M'=[DEOO0>;#%LNTY)S4CO]3?NM'E/A/X*=J+YNW3'J>WSACU?9M'$UB)F>/O
MF6V/T\EN=&5^=(X6;W3NSYMYW"F#%$QBCORY..ZE?X_!\ZGTV+2;[K,&GI%,
M6._9K6/='$.E="Y=)FV3M:'2_1L=<DTF)MVK6F(COF>(^*J]6;CM=-RW#!DV
MB+ZOOK](]=,?6X[K<,Z9[6S377:%[8JUQQ._*F"Z=&]+8=PT-M?K8G)29F,6
M&+=F+3'QGS[F;IC4Z37[QDVS7;+H,7$6B.QC^M6:^,3,\\^$M;=1$;U&]>6<
M89G6^VU%%JZ\V#!M&HPYM%$UT^?F.Q,\]BT?#Y/?0.ET.YZG-I-=HL67L8_6
M5R<VBWC$<3W\>]/KU]/U(\(]*>?"?*I#H?5&U;!L]]-J,VFMQ]:(TV.T_P K
M/=WS,SW1'[TK39-GWS8\>73Z+%I_78^:7I6*VI/SX\>]G/5UB(MJ=2TCIYF9
MKONY;H\^73ZG'EP9+8\E;1,6K/$^+LO4OZN[C_A[_DXQV)QY^Q;NM6W$^<2[
M/U+^KNX_X>_Y,NL^>D_OV7Z;Y;.*#?V+;,N[[EBTF&>S-N^UI\*UCQE9^H_T
M?TSFTVCT>WZ;4Y9IZS+DU->W,QSQQ\O"77;+$6BD=Y<]<<S'*?"DB\=5]/Z6
M^S8MXVK%ZFEJ5R9,4>'9M[X^''+UT-IMGWC#DT^LT&+Z7AB)[46M';KX<^/C
M\?-G]HKPYZ7]&>7':BBV^D#;M-MFHTV+1:/%APY*]KUD3:;3:)GF.^>...&#
M8[:#] ;AJ==MV#)?3]BF*_-HF][<]T]_NXY[EXS1-(O$>59QS%IK,JR/62T7
MR6M%:TB9Y[-?"/E#RU9@
M                     ,V#V)\PP>Q/F(6AA 2J
M
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M:':*TOBYYF<E>:XN??S[O).]/:'0[;U-7#EU.36;O>+VR7KW4QS,<SYS*6Z
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M%9;9YK,1>/,M8!WN0
M                  !FP>Q/F&#V)\Q"T,("50
M
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MIN.?<M3Z[4=F.([-*4KV:TK\(CW0U%Z1,=Y\RBT[[0 +*@
M                                               ,V#V)\PP>Q/F(
M6AA 2J
M
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M')CB?";5F.6.];4M-;UFMH\8F.)@WL?
M                                         9L'L3YA@]B?,0M#" E4
M
M
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MX1(#N<H
M              #-@]B?,,'L3YB%H80$J@
M
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M\.(5SJO=:[QO.74XHF,,1&/'SX]F/?\ ?S*'"N+5^<SN2V3=>$> !JS
M
M   9L'L3YA@]B?,0M#" E4
M
M
M
M               !FP>Q/F&#V)\Q"T,("50
M
M
M
M                            &;![$^88/8GS$+0P@)5
M
M
M
M                                         9L'L3YA@]B?,0M#" E4
M
M
M
M                                                     !FP>Q/F
M&#V)\Q"T,("50
M
M
M
M      &;![$^88/8GS$+0P@)5
M
M
M
M                   9L'L3YA@]B?,0M#" E4
M
M
M
M                               !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                            &;![$^88/8GS$+0P
M@)5
M
M
M                                                         9L'
ML3YA@]B?,0M#" E4
M
M
M
M         !FP>Q/F&#V)\Q"T,("50
M
M
M
M                      &;![$^88/8GS$+0P@)5
M
M
M
M                                   9L'L3YA@]B?,0M#" E4
M
M
M
M                                               !FP>Q/F&#V)\Q
M"T,("50
M
M
M
M&;![$^88/8GS$+0P@)5
M
M
M
M             9L'L3YA@]B?,0M#" E4
M
M
M
M                         !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                      &;![$^88/8GS$+0P@)5
M
M
M
M                                                   9L'L3YA@]
MB?,0M#" E4
M
M
M
M   !FP>Q/F&#V)\Q"T,("50
M
M
M
M                &;![$^88/8GS$+0P@)5
M
M
M
M                             9L'L3YA@]B?,0M#" E4
M
M
M
M                                         !FP>Q/F&#V)\Q"T,("5
M0
M
M
M                                                      &;![$^
M88/8GS$+0P@)5
M
M
M
M       9L'L3YA@]B?,0M#" E4
M
M
M
M                   !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                &;![$^88/8GS$+0P@)5
M
M
M
M                                             9L'L3YA@]B?,0M#
M" E4
M
M
M                                                         !FP
M>Q/F&#V)\Q"T,("50
M
M
M
M          &;![$^88/8GS$+0P@)5
M
M
M
M                       9L'L3YA@]B?,0M#" E4
M
M
M
M                                   !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                                &;![$^88/8GS
M$+0P@)5
M
M
M
M 9L'L3YA@]B?,0M#" E4
M
M
M
M             !FP>Q/F&#V)\Q"T,("50
M
M
M
M                          &;![$^88/8GS$+0P@)5
M
M
M
M                                       9L'L3YA@]B?,0M#" E4
M
M
M
M                                                   !FP>Q/F&#
MV)\Q"T,("50
M
M
M
M    &;![$^88/8GS$+0P@)5
M
M
M
M                 9L'L3YA@]B?,0M#" E4
M
M
M
M                             !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                          &;![$^88/8GS$+0P@)
M5
M
M
M                                                       9L'L3
MYA@]B?,0M#" E4
M
M
M
M       !FP>Q/F&#V)\Q"T,("50
M
M
M
M                    &;![$^88/8GS$+0P@)5
M
M
M
M                                 9L'L3YA@]B?,0M#" E4
M
M
M
M                                             !FP>Q/F&#V)\Q"T
M,("50
M
M
M                                                          &;
M![$^88/8GS$+0P@)5
M
M
M
M           9L'L3YA@]B?,0M#" E4
M
M
M
M                       !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                    &;![$^88/8GS$+0P@)5
M
M
M
M                                                 9L'L3YA@]B?
M,0M#" E4
M
M
M
M !FP>Q/F&#V)\Q"T,("50
M
M
M
M              &;![$^88/8GS$+0P@)5
M
M
M
M                           9L'L3YA@]B?,0M#" E4
M
M
M
M                                       !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                                    &;![$^88
M/8GS$+0P@)5
M
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M %E0
M                       &;![$^88/8GS$+0P@)5
M
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M?']6N/AS^'Z*AN6/0XYQ_H_49LT3SV_68XIQ\..^5W__ )6?^Y_^]<\=#_\
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M+@S5[.7'::6CX3#$]Y\V349LF;->;Y+VFUK3XS,O#IC>N[&0
M
M   &;![$^88/8GS$+0P@)5
M
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M$VE]C49H\,V3_O2RG#:<<8]M(RQ%YOIGTF@U>37X]/739O7=J.:=B>8[_?\
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M9<F6_'':O:;3QYRUXVB8U/9GN-3N.[& NJ
M                                                S8/8GS#![$^8
MA:&$!*H
M
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M$
M                      #-@]B?,,'L3YB%H80$J@
M
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MW@OCXQ$^TL8#5F
M                  S8/8GS#![$^8A:&$!*H
M
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MCT]M=;7V#!;+K9B8IFOVNSB^<=KW_8I\SS/,^+IQVY=]:AA>./;>P!HH
M
MS8/8GS#![$^8A:&$!*H
M
M
M
M            #-@]B?,,'L3YB%H80$J@
M
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MZ-(2V[=/ZS:L<7UTX*3;V:^LB;6\H8MIV?4[KZSZ);!VJ1-K5ODBLQ$>_O\
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M+VBT_?$1^3&#=D
M        S8/8GS#![$^8A:&$!*H
M
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M@]B?,0M#" E4
M
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MD0P"M<=:SN(6F]I[3( LJ^TMV+UM$1,Q//$QS'W)O3]4[GIM/ZC3WP8\/?\
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MHZ98XR?1L?9F\?"9\>/DBA$TK,[TF+VB-; %E0
M                               &;![$^88/8GS$+0P@)5
M
M
M
M                                            9L'L3YA@]B?,0M#"
M E4
M
M
M                                                        !FP>
MQ/F&#V)\Q"T,("50
M
M
M
M         &;![$^88/8GS$+0P@)5
M
M
M
M                      9L'L3YA@]B?,0M#" E4
M
M
M
M                                  !FP>Q/F&#V)\Q"T,("50
M
M
M
M                                               &;![$^88/8GS$
$+0__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
